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Abstract 
 
 
Vascular diseases such as hypertension are marked by changes in calcium (Ca2+) 
and extracellular signal regulated kinase (ERK) signaling in the arterial wall.  The overall 
goal of this project was to better understand pathways leading to altered gene regulation 
in cerebral arteries.  Two models were tested to determine if, 1) Ca2+/cAMP response 
element binding protein (CREB) is regulated in intact cerebral arteries by multiple 
sources of Ca2+, and 2) hypertensive disease causes changes in genes regulated by ERK 
and CREB.  Ca2+-mediated phosphorylation of CREB (P-CREB) was measured by 
immunofluorescence in both cultured vascular smooth muscle cells (VSMCs) and in 
intact cerebral arteries.  The level of P-CREB was increased by both Ca2+ influx through 
voltage-dependent calcium channels (VDCCs) and store-operated Ca2+ entry (SOCE) in 
VSMCs.  A similar increase in P-CREB was observed following stimulation of VDCCs 
and SOCE in intact cerebral arteries.  However, unlike the results obtained from VSMCs 
phosphorylation of CREB following Ca2+ store depletion using thapsigargin, was partially 
dependent on Ca2+ entry through VDCCs, suggesting that communication between Ca2+ 
entry pathways in intact arteries may be lost during cell culture.  
The second model was tested using immunocytochemistry and RNA analysis to 
measure differences in cerebral artery signal transduction and gene expression caused by 
chronic hypertension in the Dahl salt sensitive genetic hypertensive rat model.  Arteries 
from hypertensive animals exhibited increased phosphorylation of ERK and expression 
of Ki-67, a marker of proliferation, when compared to controls.  In addition, microarray 
analysis of arterial RNA revealed overexpression of the matricellular ERK-regulated 
genes osteopontin (OPN), and plasminogen activator inhibitor 1 (PAI-1), and the 
activator protein transcription factor (AP-1) member junB in cerebral arteries, with 
validation using RT qPCR.  To elucidate a role for CREB, ERK and JunB in the 
transcriptional regulation of OPN and PAI-1, VSMCs were treated with angiotensin II 
(Ang II), a vasoconstrictor linked to hypertension, and confirmed activator of OPN and 
PAI-1 transcription.  Ang II induced an ERK-dependent transient increase in junB 
mRNA and protein prior to OPN, and PAI-1 induction.  Gene silencing experiments 
indicated that OPN and PAI-1 are reciprocally regulated by junB and CREB, 
respectively, and that CREB is a negative regulator of OPN.  Data from cell culture 
confirms that the Ang II response in VSMCs is transient, in contrast to the hypertensive 
in vivo model, suggesting that the CREB and ERK response induces long term changes.  
Together, these data have revealed mechanisms for regulation of gene expression that are 
linked to proliferation and remodeling in the arterial wall.  Future experiments will 
explore an in vivo role for Ang II and SOCE in the mediation of ERK- and CREB- 
regulated gene expression.  This research has the potential to help in defining therapeutic 
strategies to prevent arterial remodeling caused by arterial pathologies such as 
hypertension. 
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Chapter 1:  Comprehensive Literature Review 
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Introduction 
Hypertension, a major contributor to atherosclerotic disease, is a primary 
underlying cause of heart failure, renal disease and stroke. Although different types of 
hypertension exist, most types show direct alterations on the vasculature. Abnormal 
changes may be attributed to the ability of mature smooth muscle cells, unlike cardiac 
muscle, to proliferate (Somlyo and Somlyo, 1994).  Hallmark changes of the vasculature 
include, marked smooth muscle hyperplasia and events causing elevated arterial wall 
calcium (Ca2+), increased phosphorylation of Ca2+/cAMP response element binding 
protein (CREB) and transcription of the immediate early gene, c-fos (Wellman et al., 
2001).  In addition to hyperplasia, vascular smooth muscle hypertrophy plays an 
important role in the pathogenesis of hypertension (Seewald et al., 1997).  Numerous 
signaling molecules mobilize Ca2+ and have mitogenic effects as well, i.e., angiotensin II 
(Ang II), and arginine vasopressin (Hardman et al., 2001).  The common pathway 
amongst the listed ligands involve their activation of the mitogen activated protein kinase 
(MAPK) signal transduction pathway and their ability to increase cytosolic Ca2+ levels 
through phosphoinositide hydrolysis (Hardman et al., 2001).  In general, MAPKs are 
activated in the cytoplasm in response to various stimuli including growth factors, G-
protein coupled receptor (GPCR) activation, and certain environmental stresses 
(Hardman et al., 2001).  Cytoplasmic activation of MAPKs cause its nuclear translocation 
and subsequent phosphorylation of transcription factors, nucleosomal proteins and 
transcriptional co-activators necessary for the induction of immediate early genes 
(Hazzalin and Mahadevan, 2002).  Thus understanding the role of Ca2+ and MAPK in 
  3
gene regulation is important and critical to the development of therapeutic agents that 
have the potential to intervene and prevent downstream sequelae of hypertension. 
 
Hypertension 
Hypertension is a multifactorial disease with both genetic and environmental 
origins that affects over 600 million people worldwide, according to the World Health 
Organization (WHO statistics 2001-2002).  Hypertension is commonly classified as 
either essential (primary) or secondary.  In secondary hypertension, which represents 5-
10% of patients, an underlying primary condition exists causing an elevation of blood 
pressure whereas the etiology of essential hypertension is unknown.  Thus, a diagnosis of 
essential hypertension (~ 90-95% of patients) implies that all other suspected causes has 
been ruled out.  Despite exhaustive research, the underlying cause for essential 
hypertension cannot be proven, although genetic predisposition, diet, environment and 
renal defects could increase ones susceptibility (Mulvany, 2002a).   
There are many factors that are implicated in the pathogensis of hypertension i.e., 
sympathetic over-activity; increased or abnormal secretion of renin causing excess 
production of Ang II and aldosterone; chronic high salt (Na+) intake; and a decrease in 
the production of naturetic peptides, nitric oxide (NO) and prostacyclins as well as 
alterations in kallikrein-kinin system that affect handling of renal Na+ and vascular tone 
(Oparil et al., 2003).    
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Although different types of hypertension exist, hallmark changes in VSMCs 
likely show increased proliferation and vascular remodeling (Baumbach and Heistad, 
1989, Oparil et al., 2003, Somlyo and Somlyo, 1994).   
 
Remodeling in Hypertension  
In general, the cause of essential hypertension is difficult to determine because 
overall most parameters are normal i.e. plasma renin activity and sympathetic activity 
(Mulvany, 2002b).  However, a parameter that is consistently abnormal is an increased 
peripheral vascular resistance (Mulvany, 2005, 2002b).  Peripheral resistance is 
dependent on the diameter of the small arteries (<300 μm) and arterioles adjacent to the 
capillaries (Mulvany, 2005). An increase in peripheral vascular resistance is partly 
attributed to a decrease in the diameter of the resistance arteries and to a process known 
as rarefaction (decreased arteriolar density) (Mulvany, 2005).  Structural rather than 
functional changes in the arteries from individuals with essential hypertension suggests a 
decrease in the resistance artery diameter (Mulvany, 2005, 2002b).  Data obtained from 
human studies on arteries dissected from patients who underwent gluteal biopsies, 
suggest that patients with essential hypertension have a reduction in lumen diameter, and 
an increased media to lumen ratio (Aalkjaer et al., 1987) with no change in the media 
cross-sectional area compared to normotensive patients (Mulvany, 2002b, Short, 1966).  
Additionally, essential hypertensives show no differences in the size or function of  
arterial smooth muscle cells in comparison to normotensive individuals (Aalkjaer et al., 
1987, Korsgaard et al., 1993).  Since there is no difference in the amount of material in 
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the media of the vessel but rather a rearrangement of normal VSMCs (Short, 1966), this 
type of remodeling is referred to as inward eutrophic remodeling (Mulvany, 2002b).  
Although the factors that mediate eutrophic remodeling is unknown, it is suggested that 
neurohormonal activity and subsequent vasoconstriction increases the blood pressure 
(Mulvany, 2002b).  In accordance to the Laplace relation, wall tension is a product of 
pressure and radius of the vessel, (Laplace principle: pressure x radius = wall tension), 
thus a reduction in lumen diameter coupled to an increased wall thickness maintains a 
constancy in wall stress observed in eutrophic remodeling (Mulvany, 2002b).   
Changes observed in the structure of resistance vessels (small arteries and 
arterioles) are caused not only by pressure but also by blood flow and hormonal 
influences; thus, different types of remodeling exists depending on these factors 
(Mulvany, 2005).  Elevation of intravascular pressure without a reduction in lumen 
diameter causes an increase in blood flow that leads to dilation of the vessel wall, greater 
wall stress (tension) and ultimately hypertrophic remodeling (Mulvany, 2002b).  
Increases in wall tension can stimulate VSMCs to proliferate, and this hypertrophic 
response can be mediated by growth factors and mitogenic stimuli such as Ang II 
(Mulvany, 2002b).  Thus, elevated wall stress caused by a rise in flow, pressure or 
mitogenic stimuli cause hypertrophic rather than eutrophic remodeling that decrease 
lumen diameter and increase the amount of material in the vessel wall (Mulvany, 2002b). 
How is the cerebrovasculature affected by hypertension?  The function and 
structure of cerebral blood vessels are profoundly affected by chronic hypertension 
(Baumbach and Chillon, 2000).  Autoregulation, a mechanism that maintains a constancy 
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of cerebral blood flow despite changes in the mean arterial pressure within wide limits is 
mediated by constriction  or dilation of arterioles in response to increases or decreases in 
blood pressure, respectively (Strandgaard et al., 1973).  A right-ward shift in the 
autoregulatory “plateau” along with an altered pressure-flow relationship is confirmed in 
the cerebral circulation of chronic hypertensives (Strandgaard et al., 1973). Although 
elevations in the upper limit of cerebral blood flow (CBF) autoregulation is a protective 
mechanism that prevents over-perfusion, defects in pressure-dependent constriction and 
CBF autoregulation have been shown to precede hypertensive encephalopathy in 
genetically hypertensive rats (Smeda and Payne, 2003). In addition, the inability of 
cerebral arteries in hypertensive rats during late pregnancy to undergo remodeling 
predisposes them to autoregulatory breakthrough and neurological complications similar 
to those observed in eclampsia of pregnancy and hypertensive encephalophathy (Cipolla 
et al., 2006).         
What causes the structural changes in the vasculature observed in hypertension?  
Under normal physiological conditions, blood flow, which is pulsatile in nature, and 
shear stress cause dynamic changes in blood vessels in the form of stretch (Lehoux et al., 
2006).  Fluid shear stress is a force that acts in parallel to the vessel surface, and is caused 
by the friction of blood against the vessel wall; whereas blood pressure generates radial 
and tangential forces that oppose the effects of intraluminal pressure ultimately affecting 
all cells within the blood vessel (Lehoux et al., 2006).  Because endothelial cells lining 
the inner walls of the blood vessels lie between blood and the vessel wall, they are 
extremely sensitive to changes in fluid shear stress and pressure within the vessel 
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(Lehoux et al., 2006).  Acute changes in shear stress and stretch of the blood vessel will 
cause adjustments in the vessel diameter by the rapid compensatory release of vasoactive 
agonists, or a myogenic response (Lehoux et al., 2006).  However, chronic changes in 
these mechanical forces (stretch or shear stress) from blood flow and pressure activate 
complex signal transduction cascades causing the displacement of glycoproteins that 
associate with integrins on the surface of vascular cells (Lehoux et al., 2006). Thus, 
chronic elevations of blood pressure (stretch) or increases in fluid shear stress could 
activate signal transduction pathways likely involved in the mediation of vascular 
remodeling (Lehoux et al., 2006). 
 
Animal Models of Hypertension 
Dahl Genetic Rat Strains 
Since human studies of hypertension are extremely complex, genetic rat models 
are selectively bred for the purposes of research (Rapp, 2000).  Animal models of 
hypertension provide data that increase our understanding of how hereditary genetic traits 
increase susceptibility to hypertensive disease, and a means to explore the effects of 
specific gene mutations and altered gene regulation on vascular function.  The Dahl salt 
sensitive (Dahl S) model of hypertension was used in this project to examine changes in 
gene expression mediated by chronic hypertensive disease. 
In the 1950’s Dr. Lewis Dahl observed that some of his patients invariably 
developed hypertension when given a high salt (HS) diet.  After many years of  
exhaustive research on the effects of salt on human blood pressure, Dr. Dahl decided to 
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develop a rat model with the same pattern of salt sensitivity as humans (Meneely and 
Ball, 1958).  Young Sprague Dawley (SD) rats randomly chosen were fed high salt diets 
(HS, 8% NaCl) and blood pressure measurements were taken. After only 3 generations of 
selective inbreeding between siblings, two groups based on their sensitivity or resistance 
to the effects of salt on blood pressure were produced (Dahl, 1961). The hypertensive 
group was referred to as Dahl salt sensitive (Dahl S line) whereas the normotensive 
animals were referred to as Dahl salt resistant (Dahl R line) (Dahl, 1961, Rapp, 1982).  
 
Dahl Gene Mutations and Functional Abnormalities 
At least two gene mutations have been identified and confirmed in the Dahl S rat.  
First, throughout the nephrons of Dahl S rats, a Z276L mutation of the α1 Na+-K+ ATPase 
gene in the renal basolateral epithelia disrupts K+ transport, and increases the  Na+ 
gradient on the apical membrane causing an increase in Na+ reabsorption (Herrera and 
Ruiz-Opazo, 1990).  Secondly, a restriction fragment length polymorphism on the renin 
gene in the proximal tubule causes a loss of proximal tubular suppression of renin when 
animals are fed a HS diet, increases in local Ang II production, and tubular absorption of 
sodium chloride that contributes to salt sensitivity (Rapp, 2000, Rapp et al., 1989, Tank et 
al., 1998).  Thus, Dahl S rats fed chronic HS diets have systolic blood pressures 
maintained in excess of 200 mm Hg, develop compensatory -hypertrophy and congestive 
heart failure (Iwanaga et al., 1998, Kameyama et al., 1998).  Additionally, malignant 
hypertension in this rat model could cause hypertensive encephalopathy, a pathological 
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condition whereby a loss of cerebral blood flow autoregulation precipitates 
hyperperfusion and blood brain barrier disruption (Smeda and Payne, 2003). 
 
Hypertension vs. Salt Induced Changes in Dahl S Animals 
In addition to an abnormal renin Ang II-aldosterone system, Dahl S rats have 
significantly higher levels of glomerular extracellular signal regulated kinase (ERK) 
protein and transcription factor activator protein-1 (AP-1) binding activity following 5 
weeks on a HS diet compared to Dahl S rats on a LS diet or Dahl R animals on a HS diet 
(Hamaguchi et al., 2000).  Similar increases in glomerular ERK and AP-1 activity in the 
Dahl R animals are not observed until 10 weeks on HS compared to Dahl R on LS diets; 
suggesting that the early changes in ERK and AP-1 activity observed in the S model on 
HS is likely due to hypertension, whereas the changes observed later in the R model may 
be attributed the effects of  the HS diet (Hamaguchi et al., 2000).  Morphometric studies 
on different size mesenteric arteries from Dahl S and R rats were used to examine the 
effects of hypertension and HS on the arterial wall (Lee and Triggle, 1986).  Mesenteric 
arteries from hypertensive Dahl S rats only on HS showed damage to endothelial cells 
(Lee and Triggle, 1986).  All rats in the study showed intimal lesion formation with the 
greatest amount occurring in the Dahl S group on HS (Lee and Triggle, 1986).  Intimal 
lesion formation with hypertrophy or hyperplasia likely correlated with the degree of 
damage to the endothelial lining in the Dahl S HS group (Lee and Triggle, 1986).  Data 
from this study suggest the extent of lesion formation occurred in the following order; 
Dahl S HS > Dahl S LS> Dahl R HS > Dahl R LS; the observed changes may be due to 
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hyperreactiviy of Dahl S rat arteries due to hypertrophy or impaired relaxation because of 
endothelial cell damage (Lee and Triggle, 1986).  Thus, genetic predisposition, 
hypertension, and diet all contribute to hypertrophic changes and endothelial damage.   
 
Wistar Kyoto Hypertensive (WKHT) Rat Strain 
The spontaneously hypertensive rat (SHR) model of genetic hypertension 
closely resembles essential hypertension observed in humans (Bing et al., 2002).  Similar 
to humans, the SHR animals develop heart failure as part of the aging process (Bing et 
al., 2002).  However, the development of left ventricular hypertrophy (LVH) and 
subsequent heart failure as a consequence of severe hypertension is associated with a 
behavioral component that contributes to the pathological phenotype (Bing et al., 2002).  
Environmental stresses coupled to hyperactive behavioral patterns are linked to 
cardiovascular reactivity in the hypertensive SHRs (Knardahl and Hendley, 1990).  Thus, 
crossbreeding of hypertensive SHR males with normotensive Wistar-Kyoto (WKY) 
females and subsequent recombinant selected inbreeding produced two strains of rats 
with dominant traits for either hyperactivity (HA) or hypertension (HT) (Hendley et al., 
1983, Hendley et al., 1991).   
Similaries shared by SHR and WKHT rats not observed in WKY or WKHA 
strains include, hypertrophy of stellate ganglion cells and an increased innervation of the 
vasculature by fibers containing neuropeptide Y (Fan et al., 1995, Peruzzi et al., 1991).  
These data suggest that abnormal sympathetic function in the SHR and WKHT strains 
cosegrates with the hypertensive phenotype only and is not associated with hyperactivity 
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(Nemoto et al., 1996).  In addition, like the SHR the WKHT strain has a point mutation in 
the low affinity nerve growth factor receptor (LNGFR) gene that causes a substitution of 
alanine by threonine in the signal domain of the receptor (Nemoto et al., 1994, Nemoto et 
al., 1996).  NGF signal transduction in neuronal cells occurs via a low affinity NGFR 
which translocates various receptors to the neuronal cell membrane; and a high affinity 
receptor, TrKA (tyrosine kinase A) that contains an enzymatic domain important for 
signal transduction (Nemoto et al., 1996).  It is postulated that LNGFR modulates TrKA 
enzymatic activity hence, a reduction in LNGFR expression affects normal construction 
and function of sympathetic neurons by altering NGF mediated neurotropic effects on 
sympathetic neurons through altered TrKA signaling (Nemoto et al., 1996).  Because this 
data is confirmed in the SHR and WKHT strains only, NGF signaling is thought to 
cosegrate with the hypertensive rather than the hyperactive phenotype (Nemoto et al., 
1996).  
 The expression of a purely hypertensive phenotype (WKHT) without 
hyperactivity enables investigators to better interpret data gathered from hypertension 
studies.  The WKHT model of hypertension was used in this project to measure early 
effects of hypertension on gene expression, and to determine if data generated from this 
study correlates with data obtained from the Dahl S model. 
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Altered Gene Expression in Vascular Disease  
The main function of VMSC is to contract, and regulate vascular tone, blood flow 
and blood pressure (Owens, 1995).  Normally, mature VSMCs in adult blood vessels 
show low rates of proliferation and synthetic activity (Owens, 1995).  Additionally, they 
express ion channels, and contractile markers unique to VSMC and necessary for smooth 
muscle cell contraction (i.e., smooth muscle α-actin, smooth muscle myosin heavy chain, 
calponin and caldesmon) (Owens, 1995)  However, VSMCs are unique in their ability 
unlike skeletal and cardiac muscle to dedifferentiate, thus alter their phenotype in 
response to changes in their environment (Owens, 1995). 
Hallmark changes in the vasculature in response to injury, like that observed post-
angioplasty following bypass surgery or stent insertion include a simultaneous increase in 
proliferation, cellular migration and components of the extracellular matrix  along with a 
decrease in the expression of smooth muscle contractile markers (Sobue et al., 1999) .  
Products of the matricellular genes osteopontin (OPN) and plasminogen activator 
inhibitor -1 (PAI-1) are important for arterial responses to injury and in neointimal 
formation (Giachelli et al., 1993, Isoda et al., 2002, Vaughan, 2005).  OPN and PAI-1 
have recently been identified as biomarkers activated by the p38 MAPKs in end-organ 
damage from hypertensive disease  (Nerurkar et al., 2007).  OPN and PAI-1 were 
revealed as highly altered by hypertension in the studies presented here, thus their 
regulation is reviewed in more detail. 
Osteopontin (OPN) 
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OPN is a glycosylated secreted acidic protein that binds to integrin receptors on 
the surface of cells through its arginine-glycine-aspartate (RGD) recognition site, a 
binding site also found on the surface of extracellular matrix (ECM) associated proteins 
i.e. fibronectin (Oldberg et al ’86).  The RGD site on OPN suggests a possible role for 
OPN in vascular remodeling since integrin receptor interactions could activate focal 
adhesion kinase (FAK) (Lehoux et al., 2006).  In addition, OPN is a cytokine-like 
delayed-early gene highly linked to proliferating arterial SMCs in culture (Denhardt et 
al., 2001, Gadeau et al., 1993).  In coronary artery restenosis post-angioplasty, OPN’s 
chemotactic properties mediate ECM invasion by causing migration of VSMCs from the 
medial to the intimal layer (Panda et al).  Tissue transglutaminase (tTG), is an enzyme 
actively involved in wound healing, extracellular matrix production and reorganization, 
apoptosis and cell adhesion (Bakker et al., 2005, Mulvany, 2005).  A transglutamination 
site on the amino terminus of OPN suggests that OPN is a probable substrate for tTG 
(Aeschlimann et al., 1996).  There is a rapid upregulation of OPN and associated integrin 
receptors αvβ3 and αvβ5, at early time points following perivascular injury in a rabbit 
model used to study vessel injury, suggesting a role for OPN in neointimal formation 
(Corjay et al., 1999).  OPN transgenic (OPN-Tg) mice had significantly higher levels of 
proliferation, and medial thickening in aortic sections compared to non-transgenic (non-
Tg) mice (Isoda et al., 2002).  Additionally induction of injury to the femoral artery 
suggests a greater degree of neointima formation in OPN-Tg mice compared to non-Tg 
controls (Isoda et al., 2002).  Roles for OPN and the αvβ3 integrin as a chemoattractant 
for smooth muscle cell migration have been suggested in coronary artery restenosis post-
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angioplasty (Panda et al., 1997).  Finally, OPN was up-regulated in mice with left 
ventricular hypertrophy (LVH) and cardiac fibrosis following Ang II infusion;  LVH and 
fibrosis were attenuated in OPN knockout mice following Ang II infusion, suggesting 
that OPN modulates Ang II induced fibrosis (Collins, AR et al ’04).  Overall, these data 
strongly suggest a role for OPN in proliferation and neointima formation, migration and 
remodeling in the vasculature.   
 
Plasminogen Activator Inhibitor (PAI-1) 
PAI-1, a serine proteinase inhibitor, is the primary physiological antagonist to 
both tissue and urokinase plasminogen activators (Andreasen et al., 2000).  It is a potent 
chemotactic molecule and inducer of migration through its interactions with the low 
density lipoprotein receptor-related protein (LRP) (Degryse et al., 2004).  Although PAI-
1 is necessary in wound healing, an increased level of PAI-1 was detected in vascular 
lesions induced by atherosclerosis and balloon catheter injury as well as in the plasma of 
chronically hypertensive patients (Coban and Ozdogan, 2004, Sawa et al., 1994).  PAI-1 
promotes proliferation and is protective against arterial wall apoptosis, thus there is an 
increased likelihood of hyperplasia following angioplasty when PAI-1 expression is 
abnormally elevated (Chen et al., 2006b).  Like OPN, PAI-1 is expressed in response to 
arterial injury, but over expression could be detrimental to the arterial wall . 
 
Calcium  
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Calcium ions (Ca2+) are important in many signaling events in the cell, mediating 
short term responses i.e. muscle contraction and neurotransmitter release, to long-term 
responses such as cell proliferation and growth.  Because Ca2+ is vital in such a wide 
range of cellular processes, its intracellular concentration is tightly regulated.  Normally, 
the intracellular Ca2+ ion concentration [Ca2+]i is about 20,000 times less than that of the 
extracellular fluid with an [Ca2+]i of ~100 nM (Guyton and Hall, 2000).  Since the main 
functions of vascular smooth muscle is contraction, and to regulate vascular tone a brief 
overview comparing similarities and differences in contractile processes between striated 
and smooth muscle will be discussed (Owens, 1995).   
  
Calcium Ion (Ca2+) Source for Contraction 
Although contraction of striated (cardiac and skeletal) and smooth muscle require 
ATP and are activated by a rise in the free [Ca2+]i, the source of Ca2+ for contraction 
differs (Guyton and Hall, 2000).  The sarcoplasmic reticulum (SR), a specialized form of 
the smooth endoplasmic reticulum, mediates the release and sequestration of Ca2+ in 
muscle cells and provides virtually all the Ca2+ utilized in skeletal muscle contraction 
(Guyton and Hall, 2000).  Hence, depolarizing events that trigger an action potential 
through transverse tubules (T-tubules) in skeletal muscle are sufficient to activate voltage 
sensing dihydropyridine receptors (DHPRs) in the plasmalemma (Schwartz et al., 1985).  
T-tubules are so named because they are transverse to the muscle fiber, and allow 
transmission of the action potential through the muscle fiber (Guyton and Hall, 2000).  
DHPRs are voltage dependent Ca2+ channels (VDCCs) that bind to dihydropyridine 
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(DHP) with high affinity; however, in skeletal muscle DHPRs are voltage sensitive non-
functional Ca2+ channels that interact with ryanodine receptors (RyRs) coupling on the 
surface of the SR to trigger release of Ca2+ for contraction (Marty et al., 1994, Schwartz 
et al., 1985).  The mechanism described whereby an action potential from a depolarizing 
stimulus is transmitted and causes muscle to contract is known as excitation-contraction 
coupling (Guyton and Hall, 2000).   
RyRs are Ca2+ release ion channels located on the SR of skeletal, cardiac and 
smooth muscle (Pessah et al., 1985, Xu et al., 1994). The RyR gene family encodes at 
least three highly characterized receptor subtypes, RYR1, RYR2 and RYR3 on the SR of 
skeletal, cardiac and smooth muscle respectively; Ca2+ is released through RyRs upon 
stimulation by caffeine and is inhibited by ryanodine (Alexander et al., 2007, Marks et 
al., 1989, Pessah et al., 1985, Zhang et al., 1993).  Unlike skeletal muscle, the SR of 
cardiac muscle is not as highly developed, hence, cardiac muscle is largely dependent on 
influx of extracellular Ca2+ from the T-tubules in the SR at the plateau of the action 
potential to initate contraction (Guyton and Hall, 2000).  In addition, a contractile 
stimulus is further amplified through Ca2+-induced Ca2+ release through “tightly coupled” 
RyRs on the membrane of the SR in cardiac muscle (see Figure 1-1) (Lai and Meissner, 
1989).     
Although contraction and relaxation of striated and smooth muscle require an 
increase and subsequent decrease in free [Ca2+]i respectively, their regulation for 
contraction is quite different (Somlyo and Somlyo, 1994).  A depolarizing stimulus in 
striated muscle generates a rapid contractile response due to higher [Ca2+]i stores than 
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that of smooth muscle (Guyton and Hall, 2000).  In addition, Ca2+ interactions occurs 
through the Ca2+ binding protein troponin that regulates actin prior to actin-myosin 
interactions; hence contraction of cardiac and skeletal muscle is regulated by actin 
(Guyton and Hall, 2000).  
In smooth muscle, entry of Ca2+ into the cytoplasm occurs primarily through 
VDCCs and by release from the SR through Ca2+ release channels (RyR, inositol 
triphosphate receptors (IP3R) (Wellman and Nelson, 2003).  Ca2+ release mediated by the 
generation of IP3 through phosphoinoside hydrolysis leads to Ca2+ interactions with the 
Ca2+ binding protein calmodulin (CaM) (Somlyo and Somlyo, 1994).  Ca2+-CaM then 
activates Ca2+-CaM dependent myosin light chain kinase prior to phosphorylation events 
preceding myosin interactions with actin (Somlyo and Somlyo, 1994).  Thus, in contrast 
to striated muscle, contraction of smooth muscle is a myosin regulated process. 
Once Ca2+ is released from the SR it will diffuse into the cytosol and bind to 
contractile proteins, as long as the Ca2+ concentration remains elevated contraction 
pursues (Guyton and Hall, 2000).  In striated and smooth muscle, an ATP dependent Ca2+ 
ATPase (Ca2+ pump) located in the membrane of the sarco/endoplasmic reticulum 
(Sarco/Endoplasmic Reticulum Ca2+ ATPase or SERCA) is continually active to pump 
Ca2+ away from the contractile proteins (Guyton and Hall, 2000, Lytton et al., 1991, 
Thorens, 1979).  In cardiac and smooth muscle, phosphorylation of the membrane bound 
SERCA pump inhibitor phospholambam by various kinases further activates the SERCA 
pump, causing reduction of cytosolic Ca2+ with subsequent relaxation of cardiac and 
smooth muscle (Kirchberber et al., 1975, Raeymaekers and Jones, 1986).  Furthermore 
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the capacity for the SR to store Ca2+ is enhanced through the Ca2+ binding proteins 
calsequestrin and calreticulin (Somlyo and Somlyo, 1994).  Although skeletal muscle 
does not express phospholambam, processes that cause relaxation are initiated by loss of 
nerve cell impulses, hydrolysis of acetylcholine (ACH) and continual removal of 
cytosolic Ca2+ by the SERCA pump (Guyton and Hall, 2000).  
Although global increases in [Ca2+]i are necessary for contraction of smooth 
muscle, local increases through the coordinated opening of Ca2+ sensitive RyRs, a 
phenomenon known as Ca2+ sparks, mediates arterial smooth muscle relaxation (Cheng et 
al., 1993, Nelson et al., 1995).  Increases in the frequency of Ca2+ spark activity, that 
could occur as a result of increased Ca2+ load in the SR following a rise in global Ca2+, 
triggers nearby plasmalemmal large conductance potassium channel (BK ) outward 
currents that lead to membrane hyperpolarization and closing of VDCCs (Nelson et al., 
1995, Wellman and Nelson, 2003). Thus, global increases in [Ca2+]i are loosely coupled 
to local Ca2+ release from the SR in smooth muscle and the phenomenon of Ca2+- induced 
Ca2+ release in smooth muscle is opposite in effect to the response observed in cardiac 
muscle (See Figure 1-1) (Nelson et al., 1995).  
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Figure  1-1  Ca2+- induced Ca2+ release produces opposite physiological responses in 
cardiac and smooth muscle. On the left, membrane depolarization and opening of 
VDCCs in cardiac myocytes are directly coupled to activation of ryanodine receptors 
(RyRs) on the sarcoplasmic reticulum (SR) that stimulate Ca2+ release from the SR, 
elevate global Ca2+ and initiate contraction. On the right, Ca2+ entry through VDCCs 
increases global and SR Ca2+ stores, leading to an increase in the frequency of Ca2+ 
sparks, activation of large conductance K+ (BK) channels and smooth muscle relaxation.  
(Adapted with permission from, Wellman & Nelson Rev (2003), “Signaling between SR 
and plasmalemma in smooth muscle: sparks and the activation of Ca2+-sensitive ion 
channels”, Cell Calcium 34:211-229).  
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SR/ER Calcium Regulation 
In all cells, important signaling events are initiated by ligand-receptor activation 
of membrane bound phospholipases that mediate the hydrolysis of phosphoinositides and 
production of the secondary messengers, inositol 1,4,5 triphophosphate (IP3) and protein 
kinase C (PKC) (Hardman et al., 2001).  IP3 binding to IP3 receptors (IP3R) on the SR/ER 
causes a 10 to 100 fold increase in the [Ca2+]i (Berridge, 1983, Berridge et al., 1983). 
Whether Ca2+ released from intracellular stores is graded, oscillatory, or released in 
response to stimuli, Ca2+ stores must be replenished by uptake from the extracellular fluid 
into the cytosol (Casteels and Droogmans, 1981, 1982) where it is pumped back into the 
SR/ER by the SERCA pump.  Thus, events causing increases in [Ca2+]i and store 
depletion are closely coupled to Ca2+ entry triggered by the emptying of stores via IP3R 
agonists.  
To define a role for SR Ca2+ in smooth muscle cell signaling and contractile 
processes, a pharmacological loss of Ca2+ stores can be used as a tool to elucidate a role 
for store Ca2+.  The SR Ca2+ ATPase pump exists in either the E1 high affinity Ca2+ 
binding conformation on the cytosolic surface of the SR or the low affinity E2 
confirmation to facilitate release of Ca2+ into the inner lumen of the SR (Lytton et al., 
1992).  For each ATP molecule hydrolysed, two Ca2+ ions are translocated from the 
cytosol into the SR (Guyton and Hall, 2000).   The SERCA pump inhibitor, thapsigargin 
(TG), binds to the E2 low affinity confirmation of the enzyme with very high affinity, 
showing little inhibition of pump activity in cardiac and skeletal muscle (Thastrup et al., 
1990).  Thus, SERCA pump inhibition by TG increases [Ca2+]i through depletion of  SR 
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Ca2+ stores as Ca2+ leaves the SR and travels down its concentration gradient into the 
cytoplasm, and subsequently leaves the cell to the extracellular milieu. Pretreatment of rat 
mesenteric arteries with TG blocks norepinephrine (NE) and caffeine stimulated 
increases in [Ca2+]i, suggesting that TG inhibits specific SR Ca2+ release channels in 
smooth muscle cells by depleting the SR Ca2+ pool (Baro and Eisner, 1992).  
Additionally, TG does not inhibit the Na+/K+ ATPase or the Ca2+-ATPase of the plasma 
membrane (Thastrup et al., 1990).  In this dissertation project, TG is used as a 
pharmacological tool to simulate increases in [Ca2+]i similar to IP3 mediated activation of 
IP3R or as a tool in elucidating the cellular responses to store depletion.  
 
Store-Operated Ca2+ Entry (SOCE) 
Ligand mediated stimulation of the IP3R causes an increase in [Ca2+]i coupled to a 
decrease in SR/ER Ca2+ stores, and activates store-operated Ca2+ entry (SOCE) across the 
plasma membrane to refill the SR/ER Ca2+ pools (Berridge et al., 1999, Casteels and 
Droogmans, 1982, Putney and Bird, 1993).  As the nomenclature implies, store operated 
Ca2+ channels (SOCCs) refill Ca2+ stores.  SOCCs carry an inwardly rectifying current 
referred to as the Ca2+ release-activated Ca2+ current (CRAC), in response to depletion of 
Ca2+ from the SR/ER (Dietl et al., 1996).  
A close correlation between store depletion and repletion of SR/ER Ca2+, and the 
initiation of DNA synthesis and proliferation has been suggested in a vas deferens 
smooth muscle cell line (Short et al., 1993).  The reversible SERCA pump inhibitor di-
tert-butyl-hydroquinone (DBHQ) and the irreversible SERCA pump inhibitor TG, both 
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depleted the same Ca2+ pool causing cells to enter a G0-like quiescent state(Short et al., 
1993).  Removal of DBHQ from the media of DBHQ store depleted cells caused cells to 
re-enter the cell cycle in an identical manner to cells removed from confluent arrest 
(Short et al., 1993).  However, when TG was removed from the media of TG treated 
cells, the cells remained in a G0-like quiescent state and did not re-enter the cell cycle 
until 6 hrs after treatment with full media (Short et al., 1993). This delay in cell cycle re-
entry suggests that irreversible inhibition of the SERCA pump following TG treatment 
requires synthesis of new pumps and that the Ca2+ pool likely is necessary for a specific 
signal that allows cells to proceed from G0 to G1 (Short et al., 1993).  Thus, data 
presented from the Short et al. study, suggests that the SR Ca2+ pool is necessary for 
normal progression of the cell cycle, and although a direct role for SOCE at the time was 
not yet elucidated, SOCE is likely relevant.  
Many theories regarding the precise mechanism for refilling SR Ca2+ pools were 
proposed before the identification of proteins that regulate SOCE. The most widely 
accepted model, known as “conformational coupling”  proved to be a likely mechanism 
based on the findings of numerous investigators (see Figure 1-2) (Putney et al., 2001).  
Conformational coupling suggests that a direct protein-protein interaction between the 
plasma membrane and the SR/ER is necessary for refilling of SR/ER Ca2+ stores 
(Fasolato and Nilius, 1998, Putney and Bird, 1993).  However, the identification of the 
proteins involved in this complex mechanism eluded the scientific community for many 
years.  Using an RNA interference (RNAi ) based screen to identify genes that modify 
TG induced Ca2+ entry in Drosophilia S2 cells,  knockdown of stim , whose gene product 
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is Stim (stromal interacting molecule), a single transmembane protein located in the ER 
membrane was found to reduce the TG response (Roos et al., 2005).  Further analysis 
identified the mammalian homologue, STIM1 in TG stimulated SOCE (Roos et al., 
2005).  RNAi mediated knockdown by other investigators confirmed the findings of Roos 
et al, that STIM1 functions as a Ca2+ sensor that translocates from the SR/ER membrane 
to the plasma membrane to activate CRAC currents through SOCCs upon depletion of 
Ca2+ from the SR/ER. (Zhang et al., 2005).  In addition to stim, the discovery of Orai1, 
whose gene product consists of 4 conserved transmembrane segments located in the 
plasma membrane is essential for the passage of CRAC currents through SOCCs (Zhang 
et al., 2006).   Functional studies measuring CRAC currents through SOCCs strongly 
suggest that co-expression of STIM1 and Orai1 are essential for optimal SOCE (Mercer 
et al., 2006, Peinelt et al., 2006, Soboloff et al., 2006, Zhang et al., 2006).  STIM1 acts as 
a Ca2+ sensor in the membrane of the SR/ER, whereas Orai1 is localized in the plasma 
membrane and is essential for CRAC currents through SOCCs (see Figure 1-3).  Thus, 
[Ca2+]i stores are important in the regulation of receptor mediated SOCE in excitable and 
non-excitable cells for short term responses like smooth muscle contraction, and long 
term responses like T-cell activation and gene expression respectively. 
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Figure  1-2  Four models proposing a mechanism for capacitative Ca2+ entry 
following IP3 mediated release of SR Ca2+ stores.  Only (D), a model of conformational 
coupling most closely resembles the mechanism of SOCE as confirmed by (Mercer et al., 
2006, Peinelt et al., 2006, Roos et al., 2005, Soboloff et al., 2006, Zhang et al., 2006, 
Zhang et al., 2005).  Ag (agonist); ER (endoplasmic reticulum); Ins (1,4,5) P3 (inositol 
triphosphate); PLC (phospholipase C); R (receptor); SP (scaffolding protein). (Adapted 
with permission from Putney, 2001, “ Mechanisms of capacitative calcium entry” J Cell 
Sci 114:Pt 12;  2223-9).  
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Figure  1-3  Depiction of protein-protein interaction between the plasma membrane 
Ca2+ entry channel Orai1, and the ER (SR when expressed in muscle) luminal Ca2+ 
sensor STIM1.  Orai1 consists of four helices with a proline-rich (P) N-terminus. 
Arginine (R) in the first transmembrane domain binds to phosphate residues of 
phospholipids in the plasma membrane whereas glutamate (E) in the third transmembrane 
is an integral part of the Ca2+ pore forming channel.  STIM1 is a single transmembrane 
segment that connects two cytoplasmic coiled-coil domains to the intraluminal Ca2+ -EF 
hand domain through the SAM motif.  (Adapted with permission from Soboloff et al 
2006, “Orai1 and STIM Reconstitute Store-operated Calcium Channel Function” J Biol 
Chem 281:Issue 30; 20661-5). 
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Ca2+ and Hypertension 
Hypertension is characterised by a chronic elevation of [Ca2+]i in VSMCs that 
likely plays a role in enhanced vascular contractility and altered gene 
expression(Wellman et al., 2001).  Data suggest that smooth muscle cells from SHRs 
have up-regulated VDCC currents and a more depolarized membrane potential than 
normotensive WKY controls (Harder et al., 1985, Wellman et al., 2001, Wilde et al., 
1994).  Additionally cerebral artery myocytes from Dahl S hypertensive animals have 
decreased voltage dependent K+ channel outward current density when compared to 
normotensive Dahl R controls, which likely enhances depolarization of the membrane 
potential (Wellman et al., 2001).  Thus, hypertensive genetic rat models are more reactive 
to excitatory stimuli than their normotensive controls.  An elevation in intravascular 
pressure in cerebral resistance arteries results in membrane depolarization, an increase in 
arterial wall Ca2+ and a reduced lumen diameter due to arterial vasoconstriction compared 
to non-pressurized resistance arteries (Knot and Nelson, 1998).  Additionally increases in 
arterial wall Ca2+ and arterial contractions elicited by high pressure were inhibited by L-
type VDCC blockers (Knot and Nelson, 1998). The results of the Knot et al. study are 
consistent with the data generated from different genetic hypertensive animal models, 
suggesting a more depolarized membrane potential increases the probably of VDCC 
opening, and smooth muscle contraction.   
In addition, Ca2+ has been coupled to activation of the transcription factor CREB 
(Ca2+ and cAMP response element binding protein) and induction of the immediate early 
gene c-fos in depolarized arterial cross sections (Cartin et al., 2000).  Furthermore, intact 
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cerebral arteries from hypertensive Dahl S animals have a higher level of arterial wall 
Ca2+, c-fos transcripts and active CREB in cerebral arterial cross sections than Dahl R 
normotensive controls (Wellman et al., 2001). These results are consistent and correlate 
well with the theory that increased levels of arterial wall Ca2+ contribute significantly to 
the contractile state and altered gene expression observed in VSMCs in genetic models of 
hypertension. 
 
Mitogen Activated Protein Kinases (MAPK) 
The mitogen activated protein kinase (MAPK) family members mediate many 
signaling events relevant for cell proliferation, gene expression, differentiation, survival, 
apoptosis, and motility through activation of transcription factors (Roux and Blenis, 
2004).  Multiple MAPK pathways exist in eukaryotes, with at least five distinct groups 
identified thus far (Roux and Blenis, 2004).  The most highly characterized and 
extensively studied groups consist of members of Extracellular Signal-Regulated Kinases 
(ERK),  p38 and c-Jun amino terminal kinase (JNK) (Roux and Blenis, 2004).  p38 
MAPK and JNK are often referred to as Stress-Activated Protein Kinases (SAPKs) 
because their activity is strongly regulated by stressful stimuli i.e. uv irradiation, osmotic 
shock, cytokine stimulation and environmental stresses (Roux and Blenis, 2004). This 
contrasts with their weak response to mitogenic stimuli.  The ERK family of MAPKs 
primarily regulate growth and proliferation of cells through growth factors,  and phorbol 
esters and are weakly activated by stressful stimuli (Roux and Blenis, 2004).  Since the 
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research presented here explores the regulation of genes by the ERK family of MAPKs, 
the ERK signal transduction pathway will be the focus of this review. 
 
Extracellular Signal Regulated Kinase (ERK) 
The ubiquitously expressed isoforms of ERK, ERK 1 and ERK 2, are 44 and 42 
KD proteins respectively with ~ 83% amino acid homology (Boulton and Cobb, 1991).  
ERK 1/2 (ERK) activity is involved in the regulation of transcription factors, cytoskeletal 
proteins, receptors, and enzymes through serine/threonine phosphorylations.  The 
discovery that activation of the epidermal growth factor receptor (EGFR) causes the same 
biochemical response observed in the transforming protein of the Rous sarcoma virus, 
pp60v-src tyrosine kinase, led to the identification of ERK as an important intermediate 
between the EGFR and downstream nuclear targets (Boulton and Cobb, 1991, Cohen et 
al., 1982).  
 
ERK Signal Transduction 
ERK has been identified as a downstream target of EGFR activation, therefore the 
EGFR will be used a model for receptor tyrosine kinase (RTK) mediated ERK signal 
transduction (Figure 1-4).  However, ERK is also activated in response to other growth 
factors i.e. platelet derived growth factor (PDGF), vascular endothelial growth factor 
(VEGF), fibroblast growth factor (FGF), and insulin although the mechanism for ligand 
receptor interactions involved in the initiation of the extracellular signal, differ.  EGF 
binding to the EGFR causes receptor dimerization and subsequent autophosphorylation of 
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tyrosine residues on the receptor.  Phospho-tyrosines act as docking sites for adaptor 
proteins (Grb2) that recruit son of sevenless (SOS) the Ras activating guanine nucleotide 
exchange factor (Bonfini et al., 1992, Bowtell et al., 1992).  Exchange of GTP for GDP 
on Ras localizes RAF to the membrane and initiates the activation of its serine-threonine 
kinase activity; RAF then phosphorylates and activates MEK (MAP kinase or ERK 
kinase) immediately upstream of ERK (Crews et al., 1992, Macdonald et al., 1993, 
Morrison et al., 1988).  Phosphorylation of ERK on threonine and tyrosine residues by 
MEK, actives ERK kinase activity (Crews et al., 1992). Once activated ERK can 
phosphorylate cytoplasmic targets on serine/threonine residues or translocate to the 
nucleus and phosphorylate transcription factor targets i.e., Elk-1, and c-Fos.  Active P-
ERK is inactivated by the dual specificity phosphatase, including the immediate early 
gene product, MAP kinase phosphatase-1 (MKP-1) (Sun et al., 1993).   
Additionally, at least three ERK kinase substrate subfamilies exists; p90 
ribosomal S-6 kinase (RSK) phosphorylates the ribosomal subunit protein 6 (S6 subunit) 
of the 40S ribosome, the mitogen and stress activated protein kinase (MSK) is dually 
regulated by both ERK1/2 and p38 MAPK and the mitogen interacting kinase (MNK) 
which activates translational enzymes necessary for protein synthesis (Roux and Blenis, 
2004).  Thus, phosphorylation by these and perhaps other yet to be identified ERK 
substrates lead to transcriptional activation or repression of target genes.  
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Figure  1-4  Growth factor receptor mediated activation of the Mitogen 
Activated Protein Kinase (MAPK)/Extracellular Regulated Protein Kinase 
(ERK) signal transduction pathway. (Linked from 
(http://www.tulane.edu/~dmsander/WWW/335/Trans23.gif) 
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MAPK activation of Transcription Factors 
Many transcription factors are regulated through covalent modification by 
phosphorylation of specific amino acid residues in their transactivating domains.  The 
MAPK signal transduction pathway couples extracellular signals to intracellular 
responses through the phosphorylation of transcription factors critical to the cell cycle 
machinery to stimulate proliferation, and transcription of genes necessary for protein 
synthesis and cell survival.  Transcription factor targets of ERK that have long been 
identified include the proto-oncogene c-Myc, the AP-1 member Fos, and CREB.   
Following mitogenic stimuli, ERK and its downstream substrate sub-family 
member p90 RSK, rapidly translocate into the nucleus to phosphorylate CREB and its 
transcriptional co-activator CREB binding protein (CBP) to initiate induction of 
immediate early genes i.e. c-fos, junB and egr1 (Nakajima et al., 1996, Roux and Blenis, 
2004, Xing et al., 1996).  Immediate early genes are genes that are activated transiently 
and rapidly in response to specific biochemical signals without the translation of any new 
proteins (Hazzalin and Mahadevan, 2002).  Phosphorylation of CREB also occurs in 
response to, MSK-1 in embryonic stem cells responding to stressful stimuli (Deak et al., 
1998).  Additionally, long term potentiation (LTP), has a short term transient phase and a 
long term phase that includes altered gene expression, and new protein synthesis (Adams 
et al., 2000).  ERK has a critical role in producing cellular changes necessary for LTP by 
phosphorylation and subsequent activation of CREB in the CA1 hippocampal region of 
the brain causing long lasting synaptic changes and long-term memory (Adams et al., 
2000, Davis et al., 2000). 
  32
In addition to CREB, MAPKs also regulate the activator protein (AP-1) 
transcription factors, which is composed primarily of Fos (c-Fos, FosB, Fra1, and Fra2) 
and Jun (c-Jun, JunB, and JunD) family members (Reddy and Mossman, 2002).  
Immediate early gene products like c-Fos undergo post-translational modification via 
phosphorylation in the carboxyl terminus by ERKs and RSKs to stabilize and amplify the 
external signal and increase their growth effects (Roux and Blenis, 2004).  As an 
environmental biosensor, AP-1 couples external stimuli to an appropriate biological 
response by binding to specific DNA sequences on target genes to activate or repress 
transcription (Reddy and Mossman, 2002).  Hence, the effects of MAPK signal 
transduction on CREB and AP-1 by ERKs are very diverse but specific in response to 
external signals. 
 
MAPK in Vascular Remodeling  
Activation of MAPKs through mechanical stretch and shear fluid stress is 
important for the transcription of genes and the synthesis of proteins necessary for 
structural remodeling.  High intraluminal pressure causes changes in glycoproteins of the 
extracellular matrix (ECM) causing increased binding of the ECM with their respective 
heterodimeric integrin receptors on the surface of cells(Lehoux et al., 2006).  Integrin 
receptors have been designated as mechanical sensors upsteam of MAPKs, and as 
activators of tyrosine kinases, i.e. focal adhesion kinase, (FAK), that phosphorylate 
intracellular proteins at focal adhesions (integrin clusters and cytoskeletal 
proteins)(Lehoux et al., 2006).  Newly formed ECM-integrin receptor interactions induce 
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focal adhesion assembly, c-Src phosphorylation, activation of focal adhesion kinase 
(FAK), docking of the adaptor protein Grb2 and subsequent activation of ERK. (LeHoux 
and Lefebvre, 2006).  The duration of the stimulus in the form of mechanical stress, 
determines if the vessel wall will undergo a short-term acute transient change or a long-
term sustained change.  Additionly, stretch of the myocytes caused by increased 
intraluminal pressure, increases [Ca2+]i, that could activate c-Src, and subsequent FAK 
activation.  
 
MAPK Inhibitors  
Inhibitors upstream of ERK have been employed to determine if ERK has a role 
in the regulation of trans-activating elements (transcription factors) necessary for gene 
transcription, cellular proliferation, or other functions important to cell survival.  
Stimulus mediated activation of ERK in cultured cells is blocked by two structurally 
unrelated non-competitive inhibitors of MEK, PD098059 and U0126 (Roux and Blenis, 
2004).  However, unlike PD098059, U0126 binds to the catalytic site of the active and 
inactive forms of MEK to block phosphorylation hence activation of ERK 1/2; PD098059 
only binds to inactive MEK to prevent phosphorylation thus activation by Raf  (Ballif and 
Blenis, 2001).  U0126 is a less toxic, more potent inhibitor of MEK than PD098059 and 
is used as the MEK inhibitor of choice in the research presented here (See Figure 1-5).  
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p38 MAPK Inhibition 
The p38 MAPK signaling pathway is capable of activating downstream kinases 
that are also regulated by ERKs, i.e. MSKs.  Therefore using a specific inhibitor of p38 
MAPK is useful in differentiating signal transduction and confirming if phosphorylation 
of  MSK is mediated specifically by ERKs(Lali et al., 2000).  The p38 inhibitor, 
SB203580, inhibits p38 MAPK through competitive inhibition of the ATP binding site 
(Young et al., 1997).  SB203580 does not alter JNK or ERK signals in many cell types 
and is therefore considered a selective inhibitor(Lali et al., 2000).  However, SB203580 
also inhibits phosphoinositide 3-kinase (PI3K) at concentrations >2µM. (Lali et al., 
2000).  For this reason SB203580 was used at concentrations below 1-2 µM in this 
project (See Figure 1-5). 
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Figure  1-5  Inhibition of MEK 1/2 and p38 using U0126 and SB203580 
respectively. Signal transduction pathways depict downstream kinase targets of 
ERK 1/2 and p38.  The RSK subfamily of ERKs is activated by ERK 1/2 whereas 
MSKs are regulated by both ERK 1/2 and p38 (Adapted with permission from 
Roux et al 2004, “ERK and p38 MAPK-activated protein kinases: a family of  
protein kinases with diverse biological functions”   Microbiol Mol Biol Rev 
68:Issue 2; 320-44).  
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Angiotensin II    
Angiotensin II (Ang II), one of the most potent vasoconstrictors on a molar basis, 
plays a central role together with renin and aldosterone in the regulation of blood 
pressure, and fluid and electrolyte homeostasis.  Thus, Ang II affects vascular smooth 
muscle and a multitude of organ systems including the kidneys, adrenal cortex, heart and 
brain(Hardman et al., 2001).  Overactivity of the renin-Ang II-aldosterone system has 
been implicated in hypertension, and fluid and electrolyte imbalance; therefore inhibition 
of Ang II synthesis and blocking receptors for Ang II are clinically effective in the 
treatment of hypertension, and heart failure (Hardman et al., 2001).  In this research, Ang 
II is used to modulate the physiologic response to hypertension in the in vitro studies. 
 
Synthesis of Angiotensin II (Ang II) 
Ang II is a multifunctional, highly characterized octapeptide hormone 
synthesized in response to renin released from the juxtaglomerular cells in the kidneys 
(see Figure 1-6).  Renin, is an aspartyl protease, whose secretion and release is triggered 
primarily by a decrease in NaCl flux across the macula densa or by CNS mediated 
norepinephrine (NE) release by sympathetic ganglia(Hardman et al., 2001).  The renin 
substrate angiotensinogen, is an α2-globulin that consists of 14 amino acids synthesized 
primarily in the liver then secreted into plasma (Hardman et al., 2001).  Cleavage of 
angiotensinogen by renin yields the decapeptide angiotensin I (Ang I) (Hardman et al., 
2001).  Ang I is then enzymatically converted to the octapeptide Ang II by angiotensin 
converting enzyme (ACE), a non-specific glycopeptide enzyme that cleaves dipeptide 
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units.  However, ACE does not cleave Ang II because of a penultimate proline in the 
carboxyl-terminal that restricts ACE activity (see Figure 1-6) (Hardman et al., 2001).  
ACE is identical to the enzyme kininase II, which converts bradykinin to inactive 
fragments.  Since bradykinin, a nonapeptide produces much of its vasodilatory effects 
through the release of NO, many of the beneficial effects observed through the use of 
ACE inhibitors in the treatment of hypertension are thought to involve bradykinin 
(Baumbach and Chillon, 2000, Hardman et al., 2001, Watanabe et al., 2005).  Once 
synthesized Ang II is converted to Ang III and Ang IV through the actions of 
aminopeptidase. While Ang II and Ang III are qualitatively similar, the potency of Ang II 
is far greater than Ang III.  The physiological effects of Ang (1-7) and Ang IV are not 
well characterized (Hardman et al., 2001). 
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Figure  1-6  The Angiotensin synthetic pathway (Adapted with permission 
from Watanabe et al 2005,  “Angiotensin II and the endothelium: diverse signals 
and effects”. Hypertension 45: Issue 2:163-9). 
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Angiotensin II Signaling  
AT1 Receptor  
The physiological effects of Ang II are mediated through the heptahelical G-
protein coupled receptor (GPCR) subtypes, AT1R and AT2R (de Gasparo et al., 1990).  In 
vascular smooth muscle, Ang II interactions with AT1R (Murphy et al., 1991) couples to 
the guanine nucleotide binding protein, Gq to cause rapid enzymatic hydrolysis of 
phosphatidylinositol 4,5 bisphosphate by phospholipase C (PLC) to generate the second 
messengers IP3 and 1,2-diacylglycerol (DAG) (Alexander et al., 1985, Smith, 1986).   
AT1R mediated increases in IP3 and Ca2+ release from SR stores in smooth 
muscle are both transient and acute in nature.  In order to produce a proliferative and or a 
hypertrophic response, a more sustained elevation of [Ca2+]i and DAG is required 
(Assender et al., 1997).  An important function of DAG involves recruiting PKC to the 
plasma membrane, where Ca2+ along with phosphatidylserine and DAG activate PKC to 
phosphorylate targets promoting cellular growth and proliferation.  In addition AT1R 
mediated hydrolysis of phosphotidylcholine (PC) through the activity of phospholipase D  
(PLD) (Lassegue et al., 1991) also generates DAG from the hydrolysis of phosphatidic 
acid (PA); hence PLD presents a major pathway that generates further production of 
DAG to stabilize and prolong the PKC signal (Griendling et al., 1997).   
Ang II interacting with the AT1R also causes the production of ligand molecules 
capable of amplifying the Ang II signal.  For example, a close examination of the Ang II 
signaling pathway suggests that PLD mediated production of PA from PC can also 
generate lysophophatidic acid (LPA) through the actions of phospholipase A2 (PLA2) on 
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PA (Hardman et al., 2001).  LPA is a natural phospholipid that activates ERK signal 
transduction and induces proliferation and growth of VSMCs (Seewald et al., 1997).  
Thus, the production of other ligands generated through AT1R interactions could lead to a 
convergence of signals on the ERK pathway, thus causing an amplified Ang II response 
with resultant long term cellular changes i.e. proliferation, and hypertrophy of the vessel 
wall (Campbell-Boswell and Robertson, 1981).   
In addition to Ang II’s systemic effects, data from the literature suggest a role for 
AT1R in mediating Ang II growth factor-like effects on VSMCs (Berk et al., 1989).  
AT1R interactions and subsequent tyrosine kinase phosphorylation of PLCγ1 suggests that  
GPCRs are capable of mediating growth factor like effects similar to that of growth factor 
receptors (Marrero et al., 1994).  A role for tyrosine kinase activity in AT1R signaling is 
implicated in the activation of ERKs in cultured VSMCs, since pretreatment of cells with 
genistein, a tyrosine kinase inhibitor, reverses ERK activation (Berk and Corson, 1997, 
Eguchi et al., 1996, Marrero et al., 1994).  Furthermore Ang II mediated c-Src dependent 
activation of ERK, which led to increases in [3H] thymidine and [3H] leucine 
incorporation were reversed by AT1R blockers, PD098059, and the selective Src 
inhibitor, protein phosphatase 2 (PP2)  (Touyz et al., 2001).  
Finally, Ang II induces extracellular matrix (ECM) interactions with the actin 
cytoskeleton involving a pathway that includes AT1R mediated increases in [Ca2+]i,  
activation of c-Src which phosphorylates and activates the focal adhesion tyrosine kinase 
(FAK) (Ishida et al., 1999).  In this manner Ang II mediates focal adhesion complex 
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formation and actin bundling (Ishida et al., 1999).  Hence, a role for Ang II is suggested 
in vascular remodeling through its induction of c-Src and FAK. 
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Figure  1-7  Ang II, growth factor and mechanical stress mediated signal 
transduction, in small arteries. Symbols are represented as follows; AII- Ang II; 
AT1-R- Ang II type I receptor; ERK- extracellular signal regulated kinase; FAK-
focal adhesion kinase; MEK-ERK 1/2 kinase; PDGF- platelet derived growth 
factor; PKC-protein kinase C;PLC-phospholipase C; TK-tyrosine kinase (Adapted 
with permission from Mulvany et al 2002, “Small artery remodeling and 
significance in the development of hypertension” News Physiol Sci 17:105-109). 
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AT2 Receptor 
Ang II interactions with the Ang II type 2 receptors (AT2R) suggest that AT1R 
and AT2R are physiological antagonists (Hardman et al., 2001). The AT2R is not as 
highly characterized as AT1R.  However like AT1R, AT2R is a serpentine receptor, but it 
differs in its coupling primarily to the Pertussis toxin sensitive G protein Gi (Hansen et 
al., 2000).  AT2R signaling causes K+ channel activation, production of NO and 
bradykinin, and activation of the MAPK phosphatase-1 (MKP-1) to terminate AT1R 
receptor mediated ERK signal transduction (Fischer et al., 1998, Hansen et al., 2000, 
Horiuchi et al., 1998).  
AT2R expression is highly expressed during fetal development but levels decline 
significantly after birth (Aguilera et al., 1994, Watanabe et al., 2005). Low levels are 
expressed in the aorta and coronary arteries in adult humans, and expression is 
upregulated in vascular injury (Watanabe et al., 2005).  
AT2R signaling has a protective effect in both endothelial and VSMCs and is 
closely associated with the release of bradykinin, superoxide dismutase (SOD) and NO 
(Watanabe et al., 2005). Thus signaling through AT2R could lead to vasodilation, anti-
hypertensive, anti-proliferative, and pro- apoptotic activity (Mehta and Griendling, 2007, 
Watanabe et al., 2005). 
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Ang II and Reactive Oxygen Species 
Ang II mediates activation of membrane bound NADH/NADPH oxidase in 
cultured VSMCs generating superoxide species that causes an increase in vascular tone 
and induction of long term cellular changes, i.e. hypertrophy or hyperplasia (Griendling 
et al., 1994).  Furthermore, smooth muscle relaxation using acetylcholine (ACH)  as well 
as those induced by the Ca2+ ionophore A23187, or the NO donor nitroglycerin, are 
antagonized by Ang II suggesting a loss of the ability of smooth muscle to produce 
endothelial derived NO following ACH and A23187 treatments, and the inability of 
smooth muscle to utilize NO to relax even in the presence of NO donors i.e. nitroglycerin 
(Rajagopalan et al., 1996).  Pretreating animals with the AT1R blocker, losartan or use of 
SOD to reduce superoxide levels attenuates the effects of Ang II on VSM relaxation 
(Rajagopalan et al., 1996).  These data strongly suggest that Ang II increases superoxide 
(·O2-) production using the AT1R, and that NO mediated vascular smooth muscle 
relaxations are reduced by the oxidation of NO likely to peroxynitrite. Additionally, long 
term treatment of cells with Ang II causes the rapid conversion of ·O2- by SOD to 
hydrogen peroxide (H2O2), which plays an important role in proliferation, and altered 
gene expression, not only in VSMCs, but in lung epithelial cells as well (Barlow et al., 
2006b, Griendling et al., 1997). 
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Angiotensin II and Hypertension  
A role for Ang II has been confirmed in various animal models of hypertension 
including the SHR, Dahl S model, and through systemic infusion of Ang II.  Since my 
research entails using Dahl S animals, most of the data discussed here are from research 
generated using the Dahl S rat model.  Dahl S rats have significantly higher systolic 
blood pressure, increased aortic ·O2- production, and reduced endothelial derived 
relaxation (EDR) of smooth muscle in response to ACH when compared to normotensive 
Dahl R controls (Zhou et al., 2003).  Lowering of blood pressure and restoration of ACH 
induced EDR occurs upon removal of HS from the diet and the addition of an AT1R 
blocker (Zhou et al., 2003).  Because Ang II and NO are physiological antagonists in the 
regulation of arterial tone, increased production of ·O2-  in the vessels of hypertensive 
Dahl S animals could reduce NO bioavailability, thus cause a functional increase in the 
effects of Ang II in the vasculature (Zhou et al., 2003, Zhou et al., 2006).  Furthermore 
inhibition of nitric oxide synthase (NOS) using L-NG- Nitro-arginine methyl ester (L-
NAME) abrogates salt sensitive hypertension, whereas the AT1R blocker losartan, 
reverses the effects of NOS inhibition (Hodge et al., 2002). Clearly, these data suggest a 
role for Ang II and the AT1R in salt sensitive hypertension, which supports the initial 
hypothesis of this research. 
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Angiotensin II and Remodeling 
A role for Ang II is confirmed in hypertension through the use of Ang II 
converting enzyme (ACE) inhibitors and Ang II type 1 receptor (AT1R) blockers (ARBs).  
The advantage of inhibitors of Ang II over other anti-hypertensive agents (i.e. beta-
adrenergic receptor blockers, Ca2+ channel blockers, and direct acting vasodilators),  is 
that in addition to lowering the mean blood pressure these drugs also prevent structural 
remodeling in small resistance and cerebral arteries (Baumbach and Heistad, 1989, 
Dupuis et al., 2005, Mulvany, 1991).  For example, measurements in lumen diameter, 
medial thickness and the media:lumen ratio of peripheral resistance arteries in SHR 
animals treated with the ACE inhibitor perindopril were normalized to that of the WKY 
control group (Mulvany, 1991).  Additionally, following withdrawal of antihypertensive 
agents, hypertension redeveloped except in SHR rats treated with ACE inhibitors 
(Mulvany, 2002b).  
In addition to the benefits of ACE inhibitors in the periphery, these agents shift 
the autoregulatory curve to the left, thus maintaining cerebral blood flow (CBF) at lower 
blood pressure limits (Paulson and Waldemar, 1991).  Therfore, the ability of an 
antihypertensive agent (i.e. Ang II inhibitors) to prevent vascular remodeling and cause a 
leftward shift in the autoregulatory curve prevents iatrogenic cerebral hypoperfusion and 
restores vasodilatory functions (Dupuis et al., 2005). Finally, low doses of the ACE 
inhibitors given to SHRs that do not reduce blood pressure reverse cerebral vascular 
eutrophic remodeling; similar doses given to SHRs with hypertrophy of cerebral 
arterioles showed no change in hypertrophy (Baumbach and Chillon, 2000). However, a 
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reversal of hypertrophy is observed only when the higher blood pressure lowering dose of 
the ACE inhibitor is administered; these data strongly suggest that increased arterial 
pressure observed in hypertension contributes to the hypertrophy, whereas remodeling of 
the cerebral arterioles is associated with Ang II signaling (Baumbach and Chillon, 2000).     
 
Transcription Factors 
cAMP response element binding protein (CREB)  
Vast arrays of physiological stimuli elicit changes in gene expression through the 
phosphorylation of transcription factors.  CREB, is a well-characterized member of the 
basic leucine zipper (b-ZIP) superfamily of transcription factors composed of CREB, 
CREM, and ATF-1 (Mayr and Montminy, 2001).  Alternative splicing of the human and 
mouse CREB gene expresses at least  3 isoforms designated α, β, and δ (Shaywitz and 
Greenberg, 1999).  Structurally all CREB family members contain DNA binding and 
dimerization domains in the carboxy terminal bZIP region; two hydrophobic glutamine 
rich regions designated Q1 and Q2 (constitutive activation domain, CAD) that confer 
basal transcriptional activity; and the kinase inducible domain (KID) which contains the 
activation domain (Mayr and Montminy, 2001).  CREB is activated in a stimulus 
inducible manner by phosphorylation of serine-133 in its KID by cAMP dependent 
protein kinase (PKA) (see Figure 8) (Gonzalez and Montminy, 1989, Montminy and 
Bilezikjian, 1987).  P-CREB then interacts with the kinase interacting domain (KIX) of 
CREB binding protein (CBP) a transcriptional co-activator and its paralogue p300; CBP 
in turn interacts with RNA polymerase II on the promoter to facilitate CRE (cAMP-
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responsive element) driven gene expression (Kee et al., 1996, Lonze and Ginty, 2002, 
Parker et al., 1996).  The CRE, is a highly conserved 8 base palindromic sequence, (5’-
TGACGTCA-3’) first identified in the promoter region of the somatostatin gene 
following forskolin mediated gene activation (Montminy et al., 1986).  There are 
conflicting data regarding whether CREB binds to the CRE as a dimer or if it binds as a 
monomer to the CRE and then dimerizes in a “scanning mode” (Mayr and Montminy, 
2001).  Nevertheless, CREB binding to the CRE in the promoter region of target genes is 
critical for the mediation of transcription of genes important in cell proliferation, survival, 
and differentiation. Termination of CREB target gene transcription is mediated by 
dephosphorylation of Ser-133 by the serine/threonine phosphatases, protein phosphatase 
1 (PP1), and protein phosphatase 2 (PP2) (Hagiwara et al., 1992, Wadzinski et al., 1993). 
CREB phosphorylation was initially observed in response to cAMP, but CREB is 
also activated in a Ca2+- inducible manner (Cartin et al., 2000, Pulver-Kaste et al., 2006, 
Pulver et al., 2004, Sheng et al., 1991).  In neurons, a rise in intracellular Ca2+  mediated 
by VDCCs or receptor operated cation channels leads to interactions with the Ca2+ 
binding protein calmodulin (CaM) (Greenberg et al., 1992).  Data suggest that Ca2+-CaM 
translocates into the nucleus where it interacts with and activates calmodulin dependent 
kinases (CaMKs) to facilitate phosphorylation of CREB on serine-133 (Deisseroth et al., 
1998).  Furthermore, following stimulation by a depolarizing stimulus, expression of c-
fos, a CRE driven gene, is significantly reduced by KN-93, a CaMK inhibitor and 
calimidazolium, a calmodulin inihibitor (Cartin et al., 2000).  These data strongly suggest 
a link between Ca2+-CaM interactions to CaMKs capable of phosphorylating CREB 
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(Cartin et al., 2000).  A role for Ca2+ in CREB activation is confirmed in both 
hippocampal neurons (Bito et al., 1996), and intact cerebral arteries (Cartin et al., 2000, 
Pulver et al., 2004, Wellman et al., 2001).   
The level of CREB phosphorylation can also be modulated by the mechanism of 
Ca2+ entry into the cytoplasm.  For example, Ca2+ dependent activation of CREB using 
Ca2+ influx mediated through the activation of VDCC by membrane depolarization (high 
K+) is well characterized (Cartin et al., 2000, Pulver et al., 2004).  However, other 
sources of Ca2+ entry besides voltage dependent Ca2+ influx influence CREB activity as 
well (Pulver et al., 2004).  Additionally, membrane depolarization using high K+ activates 
a different subset of CRE driven genes in comparison to those activated following store 
depletion induced by TG (Pulver-Kaste et al., 2006).  Although high K+ and TG induced 
c-fos transcription, a much higher level of c-fos induction was observed following 
membrane depolarization (Pulver-Kaste et al., 2006).  CREB is associated with 
proliferation due to induction of genes containing the CRE motif in the promoter i.e. c-
fos, an immediate early gene and cyclin D, a regulator of the cell cycle (Montminy et al., 
1986).  Thus, Ca2+ mediated gene expression, correlates well with the increases in the 
level of P-CREB and c-fos mRNA levels detected in the arterial wall of genetically 
hypertensive animals, confirming a distinctive role for Ca2+ and CREB in altered gene 
expression in the vasculature (Wellman et al., 2001).    
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Figure  1-8  Structure of CREB α.  The hydrophobic glutamine rich domains (Q1/Q2) 
are separated by the kinase inducible domain (KID) containing the serine 133 
phosphorylation site, necessary to mediate activation.  Q2 also contains a constitutively 
active domain designated CAD.  bZIP represents the basic leucine zipper domain that 
contains sites for DNA binding (basic site) and dimerization (leucine heptad repeat) 
respectively, bZIP also contains the nuclear localization signal (NLS). Amino acid 
residues are numbered accordingly.  (Adapted with permission from Ichiki et al 2006, 
“Role of cAMP response element binding protein in cardiovascular remodeling: good, 
bad, or both?” Arterioscler. Throm. Vasc. Biol. 26:Issue 3: 449-55). 
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Figure  1-9  Schematic showing activation of transcription factor CREB. Numerous 
kinases phosphorylate CREB on Ser-133 to activate gene transcription. For simplification 
of signal transductions cross talks are not indicated; signal transduction pathways are 
initiated by an external stimulus that activates protein kinases in the cytoplasm. 
Translocation of active kinases into the nucleus increase the level of P-CREB to trigger 
binding of transcriptional co-activators (not shown) which activate transcription of CRE 
driven genes, fos and mkp1. Figure depicts regulation of CREB by receptor mediated 
signal transduction pathways discussed in the literature.  AP-1 (activator protein-1); 
CaM, calmodulin; CaMK (calmodulin dependent protein kinase); CRAC (Ca2+ release-
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activated Ca2+ current; Gq ( subtype of G-protein coupled receptor); CREB, (cAMP 
response element binding protein); CRE (cAMP responsive element); ERK, (extracellular 
signal-regulated protein kinase);  IP3 (inositol triphosphate); MEK, (MAPK/ERK 
Kinase); MKP1 (MAPK phosphatase 1); PDGFR, (platelet derived growth factor 
receptor); PLC, phospholipase C; RSK (ribosomal S-6 kinase); SRE (serum responsive 
element); STIM (stromal interacting molecule). 
 
CREB and Disease  
Abnormal expression and or regulation of transcription factors and their gene 
targets are implicated in the pathogenesis of diseases i.e. restenosis following balloon 
angioplasty, atherosclerosis, and diabetes. Since CREB is activated in response to a wide 
range of extracellular stimuli, investigators have focused their attention on CREB activity 
and signal transduction pathways that could alter CREB regulated gene expression.  
Functional studies suggest that CREB is necessary for differentiation of neurons, 
VSMCs, cardiac myocytes, and adipocytes (Reusch and Klemm, 2003); and that CREB 
mediated induction of bcl-2 an anti-apoptotic CRE driven gene, implicates CREB in cell 
survival (Ji et al., 1996, Reusch and Klemm, 2003).  Normally when CREB is 
phosphorylated, its activity is rapid and transient in nature; CRE driven genes, i.e. the 
immediate early gene c-fos and genes that are important for cell differentiation and cell 
survival are activated.  However, chronic signals like those initiated by growth factor 
receptors and Ang II in an injured artery reduce endogenous CREB expression, lower 
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CREB activity and promote dedifferentiation and apoptosis of VSMCs  (Reusch and 
Klemm, 2003).   
Although data have been published suggesting a loss of nuclear CREB following 
ischemia, data published from our lab suggest that blocking nuclear import prior to 
membrane depolarization results in nuclear export of CREB into the cytoplasm; thus, the 
level of nuclear CREB would decrease because of nuclear export (Klemm et al., 2001, 
Stevenson et al., 2001).  Nevertheless, the transition of VSMCs from a differentiated 
contractile to a  de-differentiated proliferative phenotype is one of the hallmark changes 
observed in vascular disease and is suggestive of altered gene regulation (Somlyo and 
Somlyo, 1994). Evidence of increased P-CREB and the proliferative marker PCNA 
(proliferative cell nuclear antigen) following arterial injury have been reported in chronic 
exposure to nicotine, Ang II induced hypertension and oxidative endothelial injury 
(Barlow et al., 2006a, Gerzanich et al., 2003).  Since c-fos is a CRE driven gene that 
induces cyclin D1, thus cell cycle activity, a role for CREB is suggested in proliferation 
(Montminy et al., 1986).  The current perception is that CREB and CRE driven genes are 
robustly activated in response to acute vascular injury like that observed in balloon injury 
post angioplasty, and acute neuronal injury, i.e. ischemic stroke; in this capacity CREB 
activity is protective  (Reusch and Klemm, 2003).   In this manner an initial increase in P-
CREB in the nuclei of hypertensive genetic rats (Wellman et al., 2001), could suggest a 
protective role for CREB since it is a positive regulator of the anti-apoptotic gene bcl-2 
(Zhao et al., 2003).  However, CREB activity if not turned off could lead to proliferation 
and the induction of genes that could induce damage to the arterial wall.  
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Finally, our lab has provided evidence that peroxide mediated oxidant stress in 
lung epithelial cells increases the level of P-CREB in a Ca2+ and ERK dependent 
manner(Barlow et al., 2006b).  However, in contrast to data presented in injured neurons, 
loss of CREB led to a reduction in the percentage of cells undergoing apoptosis following 
exposure to peroxide, suggesting a role for CREB as a pro-apoptotic transcription factor 
(Barlow et al., 2006b). These findings suggest a differential effect of CREB signaling that 
varies depending on the type of stimulus and the cell type. 
 
Activator protein -1 (AP-1) 
The activator protein 1 (AP-1) family of transcription factors regulate gene 
transcription in response to a broad range of stimuli including growth factors, 
inflammatory cytokines, tumor promoters and other stress signals(Reddy and Mossman, 
2002).  AP-1’s activity is associated with proliferation, differentiation, apoptosis and 
cellular transformation, and was amongst the first transcription factors identified in 
mammals (Angel and Karin, 1991).   
Structurally, AP-1 exists as either a homo- or heterodimer, belonging to the basic 
leucine zipper (bZIP) superfamily referred to as immediate early genes.  AP-1 is 
primarily composed of the Fos (c-Fos, FosB, Fra-1, and Fra-2),  and Jun (c-Jun, JunB, 
JunD) subfamilies, but ATF (ATFa, ATF-2,ATF-3) and JDP (JDP-1, JDP-2) are 
structurally related and primarily form heterodimers with Jun family members (Angel 
and Karin, 1991).  AP-1 proteins recognize the 7 bp-palindromic DNA sequence (5’-
TGAGTCA-3’) referred to as the 12-O-tetradecanoylphorbol-13-acetate response 
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element (TRE) and when stimulated bind to these sites on targeted genes (Mayr and 
Montminy, 2001, Reddy and Mossman, 2002).  Additionally, AP-1 can form 
heterodimers with other bZIP family proteins i.e. ATFs/CREB and interact with the 8-bp 
CRE, which is nearly identical to the TRE except for the insertion of an additional 
nucleotide (Reddy and Mossman, 2002).  
Like CREB, the AP-1 proteins have positively charged basic amino acid residues 
in their carboxy-terminus designated DBD (DNA binding domain), they also contain a 
hydrophobic region contsisting of a heptad repeat of leucine referred to as the leucine 
zipper domain (LZD) for dimerization (Reddy and Mossman, 2002).  Unlike Jun family 
members, Fos proteins differ in amino acid composition in their LZD domains, thus, Fos 
proteins do not form homodimers (Jochum et al., 2001).  Additionally the TAD 
(transcription activating domain) is located in the amino terminus of JUN proteins 
whereas Fos proteins, with the exception of FRA-1 and FRA-2 have TADs on the amino- 
and carboxy terminals (see Figure 1-10) (Shaulian and Karin, 2002). 
Both Fos and Jun sub-families are the most highly characterized and recognized 
members of AP-1, with the induction of c-fos, c-jun, junB, and junD mRNA transcipts 
occurring within 15 to 30 minutes in response to extracellular mitogenic stimuli or toxins.  
Maximum induction of mRNA following mitogenic stimulation causes several fold 
changes in transcript that return to basal levels within a few hours upon removal of the 
stimulus (observed by myself and others).  The transcriptional regulation of c-fos by 
serum or growth factors requires the phosphorylation of specific ERK substrates i.e. 
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ELK-1 which translocates into the nucleus where it binds to the c-fos promoter to activate 
transcription(Roux and Blenis, 2004).   
Although AP-1 members are quite similar structurally, Fos and Jun proteins are 
differentially regulated by ERKs and JNKs respectively (Reddy and Mossman, 2002).  
Fos has the capacity to act as a sensor to differentiate the type of biological response 
based on the nature of the ERK signal(Murphy et al., 2002).  Upon transient activation of 
ERK, signal duration is not sufficient for stability of newly formed Fos protein, thus Fos 
does not accumulate(Murphy et al., 2002).  However, sustained signal duration of ERK 
and downstream ERK subfamily kinases i.e. p90 RSK leads to phosphorylation of Fos in 
the carboxy terminal which stabilizes FOS and exposes a docking site, defined as the 
‘DEF’ domain, for further phosphorylation by ERKs (Murphy et al., 2002).   
In contrast to Fos, c-Jun is phosphorylated by activated c-Jun NH2-terminal kinase 
on a docking site located on the amino terminus.  JunB lacks the amino terminus although 
a docking site does exist, and JunD contains an amino terminus but lacks a functional 
docking site (Reddy and Mossman, 2002).   
While a role for AP-1 in cellular proliferation has been confirmed through the 
upregulation of the cyclin D1 promoter, data suggest a redundant role for Fos proteins 
while inhibition of any of the Jun proteins inhibit cell cycle progession suggesting that 
Jun proteins have different roles functionally at different phases of the cell cycle 
(Shaulian and Karin, 2002).  Additionally, JunB is a negative regulator of c-Jun and will 
inhibit proliferation if it replaces c-Jun on a single AP-1 site bound to a single TRE in the 
presence of c-Jun(Chiu et al., 1989).  However in the absence of c-Jun, JunB can 
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dimerize and bind multiple TREs on promoters to activate transcription and can restore 
expression of genes normally regulated by Jun and Fos (Chiu et al., 1989) (Passegue et 
al., 2002).   
A commonality that exists in Jun and Fos proteins is that neither family member 
is directly activated by p38 MAPKs; however, both are indirectly regulated through the 
phosphorylation of ATF-2, Elk1 and other transcription factors that bind to jun and fos 
promoter elements to induce transcription(Reddy and Mossman, 2002).  Hence 
differential activation of AP-1 through different MAPKs (i.e. ERK, JNK, p38/SAPK) is a 
means to selectively regulate extracellular signals into the appropriate biological 
responses i.e. proliferation, apoptosis, and normal cellular differentiation or 
transformation (Reddy and Mossman, 2002).  In this fashion, activation of various 
MAPKs by different extracellular mediators stimulates AP-1, which in turn regulates 
gene expression of cellular targets and autoregulates their own expression (Angel and 
Karin, 1991, Hill et al., 1994).     
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Figure  1-10  Schematic representation of diagram showing :  (A) Sites on Jun 
and Fos proteins depicting TAD, DBD, LZD (B) Dimerization and DNA binding 
of Jun as a homo- and heterodimer on the TRE (left); Jun and Fos heterodimers 
with the CREB family member ATF on the CRE (right). Abbreviations; A: TAD, 
transcription-activating domain; LZD, leucine-zipper domain; DBD, DNA 
binding domain; N, amino terminus; C, carboxyl terminus. B: Dimerization of 
proteins mediated in LZD brings two DBDs into juxtaposition, which optimizes 
the interaction of protein dimers with DNA. ATF, activation transcription factor; 
TRE, 12-O-tetradecanoylphorbol-13-acetate (TPA)-responsive element; CRE, 
cyclic AMP-responsive element. Note the extra base (underlined) insertion on the 
CRE compared with TRE. (Adapted with permission from Reddy et al 2002, 
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“Role and regulation of activator protein-1 in toxicant-induced responses of the 
lung” Am J Physiol Lung Cell Mol Physiol 283:Issue 6:L1161-78). 
 
AP-1 and Disease 
AP-1 activity is regulated by growth factors and tumor promoters that stimulate 
proliferation by regulating the expression of components of the cell cycle, hence, a role 
for AP-1 has been linked to neoplastic transformation and the control of cell growth 
(Shaulian and Karin, 2002).  Data suggest that an oligodeoxynucleotide decoy (ODN) 
that blocks  transactivation of AP-1 reduces proliferation and migration of VSMCs in 
arteries following carotid balloon catheter injury, thus reducing neointimal formation 
(Ahn et al., 2002). ODN decoys have also established a role for AP-1 as an activator of 
PAI-1 transcription following Ang II and glucose stimulation of VSMCs (Ahn et al., 
2001).   
The Jun and Fos AP-1 family members have conserved cysteine residues in their 
DNA binding and dimerization domains that are sensitive to the effects of oxidant 
stress(Reddy and Mossman, 2002).  The effects of inducers of oxidative stress can 
increase or inhibit DNA binding and dimerization of AP-1 depending on the cell 
type(Reddy and Mossman, 2002).  For example, many cell types exhibit reduced DNA 
binding activity and dimerization of AP-1 when exposed to oxidants(Reddy and 
Mossman, 2002).  In contrast, exposure of  lung epithelial cells to inducers of oxidative 
stress, i.e. asbestos, and peroxides, increase AP-1 DNA binding and transcription of AP-1 
oncogenes (Reddy and Mossman, 2002).   
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In conclusion, although AP-1 is necessary for the transcription of many genes, 
increased expression through abnormal extracellular signals could lead to neoplastic 
transformation, neointima formation post-vascular injury, and vascular changes like those 
observed in diabetes mellitus and hypertension.  The overall conclusions within this 
dissertation are based on an integration of the findings of others as described here, and 
the results of experiments that expand these concepts towards a further understanding of 
gene regulation in response to hypertension. 
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Excerpts from Abstract 
Ca2+-regulated gene transcription is a critical component of arterial responses to 
injury, hypertension, and tumor-stimulated angiogenesis.  The Ca2+/cAMP response 
element binding protein (CREB), a transcription factor that regulates expression of many 
genes, is activated by Ca2+-induced phosphorylation.  Multiple Ca2+ entry pathways may 
contribute to CREB activation in vascular smooth muscle including voltage-dependent 
Ca2+ channels and store-operated Ca2+ entry (SOCE).  To investigate a role for SOCE in 
CREB activation, we measured CREB phosphorylation in intact arteries using 
immunofluorescence.  Here we report that SOCE activates CREB in intact arteries.  
Depletion of intracellular Ca2+ stores with thapsigargin increased nuclear phospho-CREB 
levels.  These effects were abolished by inhibiting SOCE through lowering extracellular 
Ca2+ concentration or by application of 2-aminoethoxydiphenylborate and Ni2+.  
Inhibition of Ca2+ influx through voltage-dependent Ca2+ channels using nimodipine 
partially blocked intact artery responses.  Our findings indicate that Ca2+ entry through 
store-operated Ca2+ channels leads to CREB activation, suggesting that SOCE contributes 
to the regulation of gene expression in vascular smooth muscle. 
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Excerpts from the Introduction 
Vascular smooth muscle cells (VSMCs) possess an ability to transition between 
differentiated and proliferative phenotypes in response to environmental cues (Schwartz 
et al., 1995).  Although the proliferative phenotype is essential for vasculogenesis, 
uncontrolled proliferation and migration caused by changes in VSMC gene transcription 
are associated with the development of vascular pathologies such as atherosclerosis, 
hypertension, postangioplasty restenosis, and tumor-stimulated angiogenesis 
(Delafontaine, 1998, Owens, 1995).  Disease-related variations in VSMC phenotype 
correlate with atypical Ca2+ signaling, elevated intracellular Ca2+, and gene transcription 
(Lindqvist et al., 1999, Nayler, 1999, Wellman et al., 2001).  As yet, the 
interrelationships between Ca2+ signaling and transcriptional control of gene expression 
in VSMCs remain unresolved. 
Regulation of gene expression by Ca2+ can be mediated by Ca2+-dependent 
phosphorylation of the transcription factor CREB (Ca2+/cyclic AMP-response element 
binding protein).  Regulation of c-fos and other immediate early genes is in part Ca2+-
dependent and requires CREB (Cartin et al., 2000, Lonze and Ginty, 2002).  CREB 
activation requires phosphorylation at 133Serine to facilitate formation of an active 
transcriptional complex including recruitment of CREB binding protein (CBP300) and 
other co-factors to the Ca2+/cyclic AMP-response element (CRE) in the promoter of 
many genes (Gonzalez et al., 1989, Mayr and Montminy, 2001, Shaywitz and Greenberg, 
1999).  CREB phosphorylation can be mediated by multiple kinases including cAMP-
dependent protein kinase, ribosomal S6 kinase, mitogen- and stress-activated protein 
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kinases, and calmodulin-dependent protein kinase (CaMK) (Shaywitz and Greenberg, 
1999).  We have previously determined that membrane depolarization increases 
phosphorylated CREB (P-CREB) levels and c-fos transcription in VSMCs (Stevenson et 
al., 2001).  This effect is dependent on Ca2+ influx through L-type voltage dependent Ca2+ 
channels (VDCCs) and CaMK activation (Cartin et al., 2000, Stevenson et al., 2001).  In 
addition, cerebral arteries from hypertensive rat’s exhibit elevated intracellular Ca2+ and 
an increased level of basal P-CREB and c-fos transcription (Wellman et al., 2001). 
Multiple sources of Ca2+ may participate in regulation of gene expression in 
VSMCs.  Elevation of Ca2+ in smooth muscle cells can result from entry of extracellular 
Ca2+ as well as release from Ca2+ sequestered within organelles such as the sarcoplasmic 
reticulum (SR) (Dreja et al., 2001, McFadzean and Gibson, 2002, Sanders, 2001).  Ca2+ 
influx across the plasma membrane is mediated by voltage-dependent Ca2+ channels, and 
voltage-independent cation channels including store-operated Ca2+ channels.  Store-
operated calcium entry (SOCE), also known as capacititative Ca2+ entry, has been 
detected in VSMCs (Casteels and Droogmans, 1981, Putney, 1986) and is thought to play 
an essential role in the regulation of contraction, cell proliferation and apoptosis 
(Trepakova et al., 2001, Venkatachalam et al., 2002).  Activation of Ca2+ influx through 
store-operated Ca2+ channels is triggered by a reduction in SR Ca2+ concentration 
(Putney, 1986, Trepakova et al., 2001).  Transient discharge of SR Ca2+ occurs during the 
course of signaling events that activate inositol 1,4,5-trisphosphate receptors (IP3R) or 
ryanodine receptors in the SR membrane (Dreja et al., 2001, Wellman and Nelson, 2003).  
SR Ca2+ stores also can be depleted by inhibiting sarcoendoplasmic reticulum Ca2+ 
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ATPases (SERCA) with thapsigargin or cyclopiazonic acid (Seidler et al., 1989, Thastrup 
et al., 1990). 
A role for SOCE in the regulation of gene expression in VSMCs is unclear.  In the 
current study, we examined the signaling pathway linking SR Ca2+ store depletion to 
CREB phosphorylation in intact arteries.  Our findings indicate that Ca2+ entry through 
SOCE contributes to Ca2+ homeostasis and induces CREB activation, suggesting a novel 
mechanism for the regulation of gene expression by Ca2+ in VSMCs. 
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Materials and Methods 
Animals and Reagents 
Experiments were conducted in accordance with the Guide for the Care and Use 
of Laboratory Animals (NIH PUBLICATION 85-23, 1985) following protocols approved 
by the University of Vermont IACUC.  Female Sprague-Dawley rats (Harlan) (~12 wks, 
200 g) were euthanized (pentobarbital 150 mg/kg intraperitoneal), and the, middle and 
posterior cerebral arteries were dissected in cold HBS (HEPES buffered saline).   
Thapsigargin (TG), and nimodipine (Nim), were purchased from Calbiochem, and 
2-aminoethoxydiphenylborate (2-APB) was from Tocris Cookson, Inc.  All other 
chemicals were purchased from Sigma. 
 
P-CREB Immunofluorescence  
Immunofluorescence was performed using anti-P-CREB antibodies (Cell Signaling 
Technology, Beverly, MA) [1:250] and Cy5-anti-rabbit IgG secondary antibody (Jackson 
ImmunoResearch Labs) [1:500] as described (Stevenson et al., 2001), with the following 
exceptions.  For immunolabeling, intact arteries were fixed with 4% formaldehyde, and 
0.2% Triton X-100 was added to blocking and antibody dilution solutions.  YOYO-1 
(Molecular Probes) [1:10,000] containing 250 μg/ml RNase was added for 30 min at 
37˚C to counterstain the cell nuclei.  Images were captured using a Bio-Rad 1000 laser 
scanning confocal microscope with a 40X objective.  Fluorescence intensities from 30-90 
nuclei were determined per condition from at least 3 independent experiments as 
described (Wellman et al., 2004).  
  86
Statistical Analysis 
Student’s t-test and Student-Neuman-Keuls multiple comparisons test were used to 
determine statistical significance between treatment groups. 
 
Results 
Store-operated Ca2+ entry leads to CREB phosphorylation in intact arteries 
VSMCs maintained in culture undergo multiple phenotypic changes (Londqvist). 
It is therefore possible that SOCE and Ca2+ signaling responses may be different in 
smooth muscle cells present in intact arteries.  To measure the effect of SR Ca2+ store 
depletion on CREB phosphorylation in arterial myocytes, rat cerebral arteries were 
isolated and treated in vitro with thapsigargin, followed by detection of P-CREB using 
immunofluorescence.  Thapsigargin induced an increase in P-CREB fluorescence that co-
localized with nuclei (see figure 1).  In agreement with our previous findings (Cartin et 
al., 2000), induction of CREB phosphorylation following membrane depolarization by 
elevated K+ was prevented by nimodipine or reducing extracellular Ca2+. The 
thapsigargin-induced CREB phosphorylation was partially inhibited by nimodipine, but 
was ablated by reducing extracellular Ca2+ (Figures 2-1A and 2-1B).  Furthermore, the 
nimodipine-insensitive CREB phosphorylation was eliminated by treatment with 2-APB 
or Ni2+ (figure 1C), suggesting that thapsigargin-mediated CREB activation is 
accomplished by Ca2+ signaling through voltage dependent Ca2+ channels and SOCE in 
intact arteries.  
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(Excerpts from the Discussion) 
The gene expression profile of arterial smooth muscle cells is a critical 
determinant of the differentiated versus proliferative phenotype.  CREB is implicated in 
both promoting VSMC proliferation and conversely in the protection of arteries from 
smooth muscle cell dedifferentiation.  P-CREB levels and c-fos transcription are 
increased in smooth muscle cells of hypertensive arteries, and inhibition of CREB 
activity through expression of dominant negative CREB prevents apoptosis and augments 
mitogenesis of VSMCs (Cartin et al., 2000, Tokunou et al., 2003).   However, CREB 
content of vascular tissues inversely correlates with VSMC proliferation and migration 
(Klemm et al., 2001, Reusch and Klemm, 2003, Watson et al., 2001).  In light of its 
regulation by multiple pathways, CREB likely has pleiotropic effects on smooth muscle 
cell functions that may explain its regulation of opposing events, depending on the signal 
source and duration.   
The underlying Ca2+-dependent signaling mechanisms involved in CREB 
activation and VSMC gene transcription are not completely understood.  Here we used 
pharmacological tools and measurements of intracellular Ca2+ to establish a role for 
SOCE in the activation of CREB in VSMCs.  We report that influx of Ca2+, caused by 
thapsigargin-induced depletion of SR Ca2+, results in transient phosphorylation of CREB 
and transcription of c-fos.  Ca2+ influx through VDCCs did not affect thapsigargin-
induced CREB phosphorylation or c-fos transcription in cultured VSMCs derived from 
vascular explants, but did contribute to P-CREB formation in intact arteries.  The effect 
of SOCE on CREB activation suggests that SR Ca2+ store homeostasis is important in 
  88
regulating gene expression in vivo and supports the hypothesis that store-operated Ca2+ 
influx pathways are involved in CREB-mediated transcriptional events in both 
physiological arterial signaling and in pathological growth changes associated with the 
development of hypertension and atherosclerosis (Cartin et al., 2000, Page et al., 2000). 
Although Ca2+ is a ubiquitous signaling ion affecting many aspects of VSMC 
physiology, the relative contribution of different modes of Ca2+ entry or intracellular Ca2+ 
release in the induction of gene transcription is uncertain.  Coupling of Ca2+ influx and 
intracellular Ca2+ mobilization pathways to CREB activation has been observed in 
neurons (West et al., 2001).  Our work suggests that similar mechanisms are present in 
VSMCs.  Results in intact arteries indicate that influx of Ca2+ through either VDCCs or 
store-operated Ca2+ channels can contribute to regulation of CREB, and suggest that P-
CREB formation occurs following global increases in Ca2+.  The simplest explanation for 
the discrepancy between VSMCs from aortic explants and intact arterial myocytes is the 
reduction in L-type VDCC expression in the cultured cells and indirect effects of 
thapsigargin on membrane potential (Lindqvist et al., 1999, Owens, 1995).  The VDCC-
independent component of CREB phosphorylation was sensitive to inhibition of SOCE, 
supporting the hypothesis that SR Ca2+ and SOCE regulate Ca2+-dependent gene 
expression in intact arterial myocytes.  Consistent with SOCE playing a role in the 
change between the differentiated and proliferative VSMC phenotypes, previous studies 
have demonstrated up-regulation of store-operated channels in vascular smooth muscle 
during proliferation (Golovina et al., 2001) and growth arrest of smooth muscle cells 
following loss of SERCA expression (Ufret-Vincenty et al., 1995). 
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The kinases activated downstream of SOCE were not identified in this study.  In 
neurons, CaM kinases have been implicated in the immediate phase of Ca2+-activated 
CREB phosphorylation, whereas the Ras/MAP kinase pathway has been linked to 
sustained CREB phosphorylation (Wu et al., 2001) CaM kinase activity has also been 
shown to play an important role in CREB phosphorylation following membrane 
depolarization in vascular smooth muscle (Cartin et al., 2000)The transient nature of 
CREB phosphorylation following SERCA inhibition that we observed in the present 
study suggests that SOCE activates the immediate pathway involving CaM kinases. 
CREB phosphorylation has been established as an important molecular switch to 
control gene transcription driven by CREs.  Here we have identified changes in c-fos 
transcription that correlate with SOCE-induced CREB phosphorylation.  It is likely that 
the interplay between SR Ca2+ homeostasis and SOCE contributes to transcriptional 
regulation of multiple genes through CREB phosphorylation and interactions with other 
proteins in transcriptional complexes (Bito et al., 1996, Deisseroth and Tsien, 2002, 
Lindqvist et al., 1999).  Moreover, different spatial and temporal patterns of Ca2+ 
gradients in VSMCs may add another level of transcriptional regulation. 
In summary, we have established that SOCE stimulates phosphorylation of 
CREB, an essential step in the activation of this transcription factor.  Future studies that 
determine the relative contributions of Ca2+ signals arising from multiple sources to the 
diverse patterns of CRE-mediated gene expression will contribute greater understanding 
of Ca2+ regulation of VSMC phenotype and development of vascular pathologies.  
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Figure  2-1  SOCE plays a role in CREB phosphorylation in intact arteries.  Rat 
cerebral arteries were isolated and incubated in HBS with normal Ca2+ (2 mmol/L), 100 
nmol/L Ca2+, or 100 nmol/L nimodipine (Nim)  for 15 min.  Arteries were then exposed 
to 100 nmol/L TG for 15 min or 60 mM K+ for 10 min.  CREB phosphorylation was 
detected by anti-P-CREB immunofluorescence.  A, Confocal images representing P-
CREB (red), YOYO nuclear stain (green) and overlap of P-CREB and YOYO (white).  
Bar represents 100 µm. B, Histograms of nuclear P-CREB immunofluorescence 
intensities normalized to untreated control (± SEM, n = 3);  * p<0.05, *** p<0.001, when 
compared to the TG-induced response; # p<0.05, ## p<0.01, when compared to the 60 
K+-induced response.  C, TG-induced P-CREB is sensitive to 2-APB and Ni2+.  Arteries 
were treated with TG after pre-incubation with 100 nmol/L Nim and, where indicated, 
100 µmol/L 2-APB or 500 µmol/L Ni2+ was included for 15 min (± SEM, n = 3); *** 
p<0.001. 
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Abstract 
Although changes in gene expression are necessary for arterial remodeling during 
hypertension, the genes altered and their mechanisms of regulation remain uncertain.  
The goal of this study was to identify cerebral artery genes altered by hypertension and 
define signaling pathways important in their regulation.  Intact cerebral arteries from 
Dahl salt-sensitive normotensive (LS) and chronic hypertensive (HS) rats were examined 
by immunostaining, revealing increased phosphorylation of extracellular signal-regulated 
kinase 1/2 (ERK) and expression of the proliferative marker, Ki-67 in arteries from 
hypertensive animals.  Arterial RNA analyzed by microarray and validated with RT-
qPCR revealed that jun-family member, junB, and matricellular genes, plasminogen 
activator inhibitor-1 (PAI-1) and osteopontin (OPN), were significantly over-expressed in 
HS arteries.  Fisher’s exact test and annotation-based gene subsets showed that genes 
upregulated by Jun and Ca2+/cAMP-response element binding protein (CREB) were over-
represented.  To test the hypothesis that JunB and CREB are important in the regulation 
of genes identified in the Dahl rat hypertension model, Angiotensin II (Ang II) was in 
vitro used to treat cultured rat cerebrovascular smooth muscle cells to modulate the 
changes in target genes observed in the hypertensive rat model.  Ang II induced transient 
induction of junB and delayed induction of PAI-1 and OPN mRNA levels that were 
reduced by ERK inhibition with U0126.  Silencing junB using siRNA reduced mRNA 
levels of OPN, but not PAI-1.  Silencing of CREB reduced PAI-1 induction by Ang II, 
but enhanced transcription of OPN.  Together these results suggest that salt induced 
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hypertensive disease promotes changes in matricellular genes that are universally 
regulated by ERK, and selectively regulated by JunB and CREB. 
Key words: microarray, Dahl rat, brain arteries, map kinase signaling, transcription 
factors 
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Introduction 
 Hypertension is a multifactorial disease linked to both genetic and 
environmental origins, that ultimately cause direct alterations on the vasculature 
including smooth muscle cell proliferation and vascular remodeling (Baumbach and 
Heistad, 1989, Oparil et al., 2003, Somlyo and Somlyo, 1994).  Rats selectively bred for 
hypertension studies have been useful models to study the complexity of human essential 
hypertension (Rapp, 2000).  The Dahl salt sensitive (Dahl S) genetic model of 
hypertension is a paradigm of low renin hypertension observed in humans. Two genetic 
defects have been identified in the Dahl S strain including a mutation of the α1 Na+-K+ 
ATPase gene, affecting the renal basolateral epithelia throughout the nephron, and a 
restriction fragment length polymorphism in the renin gene, affecting the proximal tubule 
(Herrera and Ruiz-Opazo, 1990, Rapp et al., 1989).  In response to the Na+ challenge of a 
high salt diet, Angiotensin II (Ang II) is not down-regulated in the proximal tubules of 
Dahl S rats, and the resulting dysregulation of Ang II likely contributes to the 
pathological findings seen in salt-sensitive hypertensive disease (Hodge et al., 2002, Tank 
et al., 1998).  Ultimately, the Dahl S genetic rat strain develops a sustained elevation in 
systolic blood pressure that may exceed 200 mm Hg when given a high salt (HS) diet, 
with evidence of compensatory hypertrophy and congestive heart failure (Iwanaga et al., 
1998, Kameyama et al., 1998).  A loss of cerebral blood flow autoregulation followed by 
blood-brain barrier disruption and hypertensive encephalopathy has also been observed in 
these animals (Smeda and Payne, 2003).   
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The arterial effects of Ang II are primarily mediated through G-protein coupling 
of Ang II type 1 receptors (AT1R) on vascular smooth muscle cells (VSMCs) to 
phospholipases C, D and A2 (de Gasparo et al., 1990, Whitebread et al., 1989).  These 
signals mediate acute vasoconstriction and blood pressure regulation, and also regulate 
VSMC proliferation, oxidant signaling, and extracellular matrix interactions (Mehta and 
Griendling, 2007).  Angiotensin converting enzyme (ACE) inhibitors and AT1R blockers, 
are beneficial in the treatment of hypertension not only because they reduce blood 
pressure through improvement of endothelial function and NO bioavailability by 
reducing Ang II mediated oxidative stress, but they also reverse vascular remodeling 
(Baumbach and Chillon, 2000, Mulvany, 1991, Rajagopalan et al., 1996, Zhou et al., 
2003).  Ang II is considered a mitogen because of its ability to stimulate VSMC 
hypertrophy and hyperplasia, and its capacity to activate mitogen-activated protein 
kinases such as p38 and extracellular signal-regulated kinase1/2 (ERK) (Berk et al., 1989, 
Campbell-Boswell and Robertson, 1981, Pulver-Kaste et al., 2006).   
 Cerebral vascular smooth muscle from arteries of Dahl S hypertensive rats 
exhibit a significant decrease in membrane potential, smooth muscle cell Ca2+, c-fos 
transcription, and Ca2+/cAMP-response element binding protein (CREB) phosphorylation 
when compared to their normotensive resistant (Dahl R) controls (Wellman et al., 2001).  
In this study, data are presented that support the hypothesis that salt-induced hypertensive 
disease in Dahl S rats induces expression of specific ERK- and CREB-regulated genes in 
cerebral arteries.  Oligonucleotide array analysis was utilized to identify the range of 
genes affected by hypertensive disease, and these results were complemented by an 
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investigation of ERK activation, cell proliferation, and validation using techniques to 
quantify mRNA and detect protein expression.  Ang II stimulation of cultured 
cerebrovascular smooth muscle cells (cVSMCs) was further employed to modulate 
changes in target gene expression observed in hypertensive disease to define selective 
roles for ERK, JunB and CREB in the signaling mechanisms leading to upregulation of 
gene targets. 
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Materials and Methods 
Animal protocol, cerebral artery isolation, and cVSMC explants 
 All experiments were conducted in accordance with the Guide for the Care and 
Use of Laboratory Animals and followed protocols approved by the Institutional Animal 
Use and Care Committee of the University of Vermont.  All arteries were obtained 
through tissue sharing from University of Vermont investigators Martin LeWinter, 
Joseph Brayden, Victor May and Natalia Gokina (IACUC 06-100AP), thus no animals 
were sacrificed exclusively for this study.   
 For intact studies, male Dahl salt sensitive (Dahl S) rats, weighing ~300-500 g 
and approximately 6 weeks old, were obtained from a colony supported by Merck 
Pharmaceuticals and maintained by Taconic (Germantown, NY).  At 7 weeks of age (time 
0), rats were divided into 2 groups receiving either an 8% NaCl (high salt, HS) or 0.4 % 
NaCl (low salt, LS) diet.  For animals used in the blood pressure study, systolic blood 
pressures (SBP) were measured weekly using a tail cuff plethysmograph.  For study 
group animals, beginning at 6 weeks on the diet, echocardiography was performed 
weekly, and animals were euthanized when left ventricular dysfunction was detected as 
previously described (Kameyama et al., 1998).  The LS animals were euthanized at times 
that corresponded approximately with the HS animals (see Table 1).  After euthanasia, 
brains were removed and primary branch resistance arteries projecting from the Circle of 
Willis were dissected (middle and posterior cerebral and posterior cerebellar) in cold 
HEPES buffered solution (HBS) composed of (mmol/L):  10 HEPES (pH 7.4), 140 NaCl, 
6 KCl, 2 CaCl2, 1 MgCl2, and 10 glucose.  For immunocytochemistry, isolated arteries 
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were fixed in 4% formaldehyde and processed as described below.  For oligonucleotide 
array and RT-qPCR, arteries were either snap frozen in liquid N2 and stored at -80°C or 
submerged in RNAlater™ (Qiagen, Valencia, CA) and stored at -20°C until processed for 
RNA extraction.  
 To generate cultured cerebrovascular smooth muscle cells (cVSMCs), middle 
and posterior cerebral arteries were isolated from female Sprague Dawley rats (~12 
weeks, 200 g), cut into rings, and placed in 60 mm culture dishes containing SMGM2 
media (Cambrex, Palo Alto, CA).  VSMCs that migrated within 7 to 10 days were 
transferred to 100 mm plates, passaged with trypsin/EDTA, and cells were used between 
passages 2 and 4.  cVSMCs were grown to approximately 70-75% confluence and serum 
starved in DMEM containing 0.5% fetal bovine serum, 2 mmol/L L-glutamine, 1000 
units/ml penicillin, and 1 mg/ml streptomycin for 48 h prior to treatment.   
 Angiotensin II (Ang II, used at 100 nmol/L) and U0126 (used at 10 μmol/L), 
were purchased from Calbiochem (San Diego, CA).  SB203580 (used at 700 nmol/L) was 
obtained from Biosource International, Inc (Camarillo, CA), and cell culture reagents 
were from Gibco (Grand Island, NY).   All other reagents were obtained from Sigma (St. 
Louis, MO).    
 
Intact artery immunofluorescence (IMF) 
Intact artery immunofluorescence was performed as described previously (Pulver 
et al., 2004).  Briefly, formaldehyde-fixed intact cerebral arteries, secured to sylgard 
dishes, were sequentially incubated in blocking solution containing 2% BSA and 0.2% 
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Triton -X-100 in PBS (Sigma-Aldrich, St. Louis, MO) followed by rabbit anti-p42/p44-
phospho-ERK (anti-P-ERK1/2; Cell Signaling Technologies, Beverly MA) diluted 1:250 
in blocking solution.  Arteries were then incubated with Cy5 goat anti-rabbit IgG 
(Jackson ImmunoResearch, Westgrove, PA) diluted 1:500 in blocking solution.  YOYO-
1 (Molecular Probes, Eugene, OR) diluted 1:10,000, and containing 24 U/ml RNase A, 
was used to counterstain the nuclei.  Arteries were mounted on microscope slides and 
images were captured using a Bio-Rad 1000 laser scanning confocal microscope at 400X 
magnification.  Fluorescence intensity was quantified using mean-pixel intensity analysis 
as described previously (Pulver et al., 2004).  For nuclear intensities, a mask of 25 nuclei 
was generated from the YOYO images and intensity of P-ERK1/2 was determined within 
the mask regions. 
 
Intact artery immunohistochemistry (IHC) 
 Formaldehyde-fixed arteries were paraffin embedded, cut in 5 μm sections, and 
applied to microscope slides.  Tissue sections were deparaffinized using standard 
techniques (Wong et al., 2003) and exposed to antigen retrieval buffer containing 10 
mmol/L sodium citrate, pH 6.0 for 15 min at 95°C.  Immunohistochemistry was 
performed using the EnVision + Dual Link Peroxidase and Substrate systems according 
to the manufacturer’s protocol (DakoCytomation, Carpinteria, CA).  Rabbit anti-Ki-67 
and rabbit anti-OPN primary antibodies were obtained from Abcam, Cambridge MA and 
used at 1:50 dilution.  Sections were counterstained with Mayer’s hematoxylin.  Digital 
images were captured using an Olympus BX50 upright light microscope (Olympus 
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America, Inc., Lake Success, NY) with an attached Optronics MagnaFire digital camera 
and software. 
 
RNA Isolation from Intact Arteries 
 Each starting sample (n) consisted of arteries pooled from 3 brains 
(approximately 2 mg wet tissue weight) with an average yield of 340 ng total RNA.  
Total RNA was extracted from intact cerebral arteries that had been stored at -80°C or at 
-20°C in RNAlater™ using a modified RNeasy™ protocol for isolation from animal 
tissues with a DNase I digestion step (Qiagen).  To improve tissue disruption and 
increase RNA yield, the protocol for tissue homogenization was modified to include 
approximately 25 mg of 200 μm silicon carbide abrasive beads (MoBio labs, Carlsbad, 
CA) in the homogenizing buffer and use of a Pellet Pestle™ system (Kontes, Vineland, 
NJ).  RNA was eluted with 25 μl RNAse-free H20.  RNA concentrations were determined 
using a Nanodrop™ spectrophotometer and RNA quality was assessed by an Agilent 
2100 bioanalyzer (Agilent Technologies, Palo Alto, California).   
 
Intact Artery RNA Amplification and Microarray  
 Each sample (n) consisted of RNA pooled from 3 different rats on their 
respective diets (9 total rats/group) as described above.  RNA samples (n=3) per group 
were analyzed to achieve an estimated statistical power of 0.8.  RNA amplification and 
microarray analysis were performed by the University of Vermont Microarray Facility.  
RNA samples were double amplified to generate cRNA from the reverse transcribed 
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cDNA using the method outlined in the Affymetrix Technical Manual (Park et al., 2004).  
Following second cycle, second strand cDNA synthesis and cleanup, biotinylated-cRNA 
was prepared by in vitro transcription, fragmented and stained using a streptavadin-
phycoerythrin conjugate before application to Affymetrix GeneChip™  Rat Expression 
Set 230A (RAE230A) (Affymetrix, Santa Clara, CA).  Biotinylated anti-streptavidin 
antibodies were used to amplify the signal.  A total of 10 µg of amplified cRNA was 
applied to each gene chip.  
 
Intact Artery Real Time Quantitative PCR (RT qPCR) 
 For validation experiments, cDNA was reverse transcribed from different 
sample pools of RNA than those used in the array analysis.  Reverse transcription of 160 
ng total RNA from intact cerebral arteries was carried out using an Omniscript™ Reverse 
Transcriptase, RNase free DNase kit (Qiagen), with an oligo dT primer, according to the 
manufacturer’s protocol.  RT qPCR primers and probes were obtained as Assays-on-
Demand™ kits from Applied Biosystems ( Foster City, CA).  PCR products were 
detected by TaqMan qPCR, as previously described (Pulver-Kaste et al., 2006, Pulver et 
al., 2004).  Expression levels of target genes were determined using hypoxanthine-
guanine phosphoribosyl transferase (hprt) as the internal standard.  All samples were run 
in duplicate from at least 3 independent experiments and the comparative Ct (cycle 
threshold) method for relative quantity (RQ value) was used to calculate relative mRNA 
expression among samples.   
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cVSMC Transient Transfections with Small Interfering RNA (siRNA) 
 siRNAs were obtained from Dharmacon (Lafayette, CO) and included a non-
targeting pool (ON-TARGETplus siCONTROL; Catalog #D-001810-10-05), a positive 
control cyclophilin B (CypB; 116HsiSTABLE Cyclophilin B siRNA), and pools targeting junB 
or CREB (ON-TARGETplus SMARTpool siRNAs; Catalog #L-087675-00, Catalog #L-
092995-00).  Transfections were performed following the manufacturers instructions. 
Briefly, 100 mm plates of cVSMCs were grown to ~75% confluence in SMGM2 media 
without antibiotics.  Cells were transfected with siRNAs (100 nmol/L) complexed with 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) for 4h, transferred back to SMGM2 for 
24 h, and then placed in serum-starving media for a total of 48 h including treatment 
time. 
 
cVSMC Real Time Quantitative PCR (RT qPCR) 
 Total RNA was extracted from cultured cVSMCs using the RNeasy™ PLUS 
protocol for total RNA isolation from animal cells (Qiagen,Valencia, CA).  cDNA was 
reverse transcribed from a total of 500 ng total RNA and qPCR was performed as 
described for intact arteries.  All samples were run in duplicate with at least 3 
independent experiments and the comparative Ct (cycle threshold) method for relative 
quantity was used to calculate relative mRNA levels among samples. 
cVSMC Western Blot 
 Following treatments cell plates were transferred to ice, media was aspirated, 
and the cells were washed first with cold PBS followed by cold hypotonic lysis buffer 
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(HLB; in mmol/L: 25 Tris, pH 8.0, 2 MgCl2, 5 KCl).   Cells were collected by scraping in 
60 µl of cold HLB supplemented with a protease/phosphatase inhibitor cocktail 
containing 1 mmol/L phenyl-methyl-sulfonamide, 20 µg/ml aprotinin, 4 µg/ml leupeptin, 
2 mmol/L Na+ orthovanadate, 2 mmol/L Na+ pyrophosphate. Cell lysates were 
homogenized and DNA was sheared by passing the extract through a 26 gauge needle 20 
times.  Protein concentration was determined using a Bradford protein assay (Bio-Rad, 
Hercules, CA), and 10 μg of protein was separated by 10% SDS-PAGE and transferred to 
nitrocellulose.  Western blots were performed using antibodies specific to CREB (mouse 
anti-CREB, Cell Signaling Technologies, Beverly, MA; 1:1000), OPN (rabbit polyclonal 
anti-OPN (AB8448), Abcam, Cambridge, MA; 1:1000), JunB (rabbit polyclonal anti-
JunB, (Santa Cruz Biotechnology, Santa Cruz, CA) ; 1:500), β-actin (rabbit polyclonal 
anti- β-actin, Cell Signaling Technologies, Beverly, MA; 1:1000.  All antibodies were 
diluted in 3% bovine serum albumin in Tris-buffered saline/0.1% Tween-20 (TBST) and 
blocked in 3% non-fat dry milk dissolved in TBST. Binding of primary antibody to 
nitrocellulose blots was detected with HRP-conjugated anti-rabbit IgG (Santa Cruz 
Biotechnology, Santa Cruz, CA); 1:5000) or HRP-conjugated anti-mouse IgG  (Santa 
Cruz Biotechnology, Santa Cruz, CA; 1:5000), followed by chemiluminescence using 
Lumiglo (Kirkgaard and Perry Laboratories, Gaithersburg, MD).   
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Statistical Analysis 
 For immunofluorescence, immunohistochemistry, and RT qPCR data, statistical 
significance between groups was determined using a 2-tailed unpaired Student’s t-test 
(significance at p<0.05).  Results are presented as means ±SEM.   
 For statistical analysis of microarray data, signal intensities were assigned to 
probes in each sample using Affymetrix software (GCOS). Using BioConductor software 
( 117Hwww.bioconductor.org), probe-level expression data was normalized using the qspline 
method of Workman et al. (Workman et al., 2002), and the Robust Multichip Average 
(RMA) expression statistics were calculated for each probe set and sample using the 
method of Speed et al. (Bolstad et al., 2003, Irizarry et al., 2003).  The complete GEO 
data set is available under accession #GSE5488.  
 Two dimensional histograms (volcano plots) and density contours were 
calculated for the permuted data using R-project software (www.r-project.org).  The log2 
fold-change in the means of LS and HS treatment group (M) and a p-value (p) from the 
two-sided t-test (assuming equal variance) were calculated for each probe set and each of 
10 distinct permutations of the sample labels.   
 Sets of genes associated with disease were identified using the Disease Portal of 
the Rat Genome Database (RGD) (de la Cruz et al., 2005).  Sets of target genes 
associated with transcription factors CREB and Jun were identified using the 
Transcription Regulatory Element Database (TRED) (Zhao et al., 2005).  Association of 
annotation-based partitions with differential expression-based partitions was evaluated 
using Fisher’s exact test. 
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Results 
 
Dahl S Animal Study Group  
 The Dahl S model of hypertensive disease is characterized by elevated blood 
pressure and the development of heart failure in response to a high-salt diet (Iwanaga et 
al., 1998, Kameyama et al., 1998).  Systolic blood pressure measurements in Dahl S 
animals confirmed an early onset and sustained increase in blood pressure in animals fed 
an 8% NaCl diet (HS) (data not shown), and previous experiments found no significant 
difference in blood pressures between 6 and 12 weeks on the HS diet (Kameyama et al., 
1998).  Animals in the study group were evaluated by echocardiography and HS animals 
with their LS controls were euthanized when left ventricular dysfunction was detected, 
after an average of 11 weeks on the HS diet.  As shown in Table 1, when compared with 
LS controls, animals receiving HS diet exhibited a significant decrease in body weight 
and an increase in lung:body weight ratio, indicating development of heart failure as a 
result of malignant hypertension. 
 
Cerebral Arteries from Salt-Induced Hypertensive Rats Have Significantly Higher 
ERK activity than LS controls. 
 To determine if hypertensive disease is associated with an upregulation of 
cerebral artery ERK activity, cerebral arteries from HS and LS animals were dissected 
and analyzed by immunofluorescence to detect phospho-ERK (P-ERK1/2).  As 
represented in Fig. 1, arteries from HS animals exhibited a significantly elevated level of 
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phospho-ERK in both the nucleus and cytoplasm when compared with LS controls.  
Based on the known involvement of ERK in proliferation and remodeling, these data 
support a role for ERK in the altered signaling pathways that result from chronic 
hypertension. 
  
Cerebrovascular Smooth Muscle Cells of HS Chronically Hypertensive Rats Show 
Marked Proliferation Compared to LS Normotensive Controls. 
 The impact of hypertensive disease on vascular smooth muscle cell proliferation 
in cerebral arteries was measured directly using immunohistochemical detection of the 
nuclear proliferation marker, Ki-67 (Gerdes et al., 1984), and by quantifying 
nuclei/arterial section.  Arteries from HS animals displayed a significantly higher number 
of Ki-67 positive nuclei (Fig. 2), suggesting that the elevated ERK activity corresponds 
with increased smooth muscle cell proliferation in cerebral arteries from hypertensive 
animals.  
 
Genes Important for Hypertrophy are Upregulated in Cerebral Arteries from 
Hypertensive Animals. 
 The effect of hypertensive disease on cerebral artery gene expression was 
determined by oligonucleotide array analysis using an Affymetrix RAE230A GeneChip 
array.  Of the 15,923 genes represented on the microarray, 133 exhibited a significant 1.5 
fold or greater change in expression (99 genes were up-regulated and 34 down-regulated 
in HS compared to LS rats, GEO accession #GSE5488).  Rather than rank genes 
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independently based on the log ratio change (M) or the p-value (p), differential 
expression statistics were represented as a joint distribution using a two-dimensional 
histogram (log2(M), -log10(p)) (volcano plot).  This representation of the data allowed 
assignment of volcano plot-motivated statistics to each probe set (pv).  Contours of pv that 
exclude 10% and 1% of the probe set were then used to define differential expression-
based binary partitions.  The pv threshold was supplemented with the condition │log2M
│>0.5 and p<0.2 to eliminate small values from the analysis.     
 Standouts in a volcano plot analysis of the array data were several genes related 
to extracellular matrix and tissue remodeling including osteopontin (OPN, Spp1), 
plasminogen activator inhibitor-1 (PAI-1, Serpine1), bone expressed sequence tag 5 
(Best5) and periostin (Postn) (Fig. 3A, Table 2).  Of note was the finding that guanylyl 
cyclase (Guacy1a3), a major substrate for NO-mediated vasodilation was down-regulated 
in the cerebral arteries from HS rats.  Several other forms of guanylyl cyclase were also 
significantly reduced, although to a lesser degree.     
 Fisher’s exact test was used to examine the prospective hypothesis that genes 
specified by the TRED and RGD databases as related to hypertension and selected 
transcription factors are upregulated in arteries from Dahl HS animals (Fig. 3B-D).  
Differential expression-based partitions of the probe sets at 1% and 10% revealed over-
representation of Jun-regulated genes and changes in CREB-regulated genes that 
approached significance (Table 3).  Using the hypertension data set, the resulting volcano 
plot also revealed increases in apolipoprotein E (ApoE) and adducin3, that were not 
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initially significant when analyzed amongst the entire data set,  providing a potential link 
to genes involved in the pathological course of hypertensive disease (Fig. 3B).   
   Seven genes were selected for validation and further study based on their 
regulation by ERK signaling and evidence for their transcriptional regulation by Ang II 
(Campos et al., 2003).  Of these, three were confirmed by RT qPCR (OPN, PAI-1 and 
junB), and the reduction in guanylyl cyclase approached significance (Table 4).  
Although the other selected genes were not validated, the trends in the data suggest that 
variability between samples precluded significance.  The confidence in the changes 
associated with genes that did validate is strengthened by the fact that RT qPCR was 
performed using RNA sample pools that were distinct from samples used in the array 
analysis.   
 
Osteopontin Protein Expression is Increased in Cerebral Arteries from 
Hypertensive Animals. 
 The confirmed extent of induction of osteopontin (OPN) mRNA levels in 
response to hypertensive disease was particularly intriguing due to the previous 
implications that OPN regulates vascular smooth muscle cell proliferation and migration 
and is overexpressed during post-angioplasty restenosis (Gadeau et al., 1993, Panda et al., 
1997, Weissberg et al., 1995).  In addition, OPN is a matricellular gene that is known to 
be transcriptionally regulated by Ang II and ERK signaling (Campos et al., 2003).  To 
determine if the induction of OPN mRNA levels correlated with an increase in OPN 
protein expression, immunohistochemistry was used to detect OPN in cerebral artery 
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cross-sections from HS and LS animals.  Arteries from HS animals exhibited a 
significantly higher level of OPN protein staining throughout the cytoplasm of the 
smooth muscle cell layers (Fig. 4), suggesting that the induction of OPN at the mRNA 
level is translated to an induction of protein expression.  Together these data suggest that 
hypertensive disease affects cerebral arteries through enhanced ERK signaling and 
smooth muscle cell proliferation which correlates with induction of 
matricellular/proliferation-related genes, particularly OPN.     
 
Angiotensin II Exposure of Cultured cVSMCs Mimics Induction of Hypertension 
Target Genes   
 The genes of focus, junB, PAI-1 and OPN have been linked to ERK activation in 
other systems and have inducible AP-1 and/or CRE sites within their promoters.  In 
addition, Ang II signaling has been linked to pathologies in the Dahl S hypertensive 
model and to ERK activation.  A culture model of low-passage explanted cerebral 
vascular smooth muscle cells (cVSMCs) was thus utilized to define the importance of 
ERK, JunB induction, and CREB activation in the regulation of junB, PAI-1 and OPN 
expression.  A time-course of Ang II treatment established an early transient induction of 
junB mRNA level and protein expression in cVSMCs (Fig. 5A).  Delayed induction of 
PAI-1 and OPN by Ang II was also observed, with significant increases in mRNA levels 
at 3 and 6 h (Fig. 5B).  Of note, the induction of OPN mRNA level was less than that 
observed in the Dahl S hypertensive model, likely reflective of higher basal OPN in the 
cVSMC model.  Overall, these data show that Ang II signaling leads to induction of the 
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same target genes that are upregulated in the Dahl hypertensive model, and that JunB 
upregulation by Ang II precedes the elevation of PAI-1 and OPN mRNA levels.    
 
Angiotensin II Induction of junB, PAI-1 and OPN mRNA Levels is Reduced by 
MAPK Inhibition  
 To determine a specific role for MAP kinases in the Ang II mediated response 
on gene targets, cVSMCs were pretreated with the selective MEK inhibitor, U0126 or the 
selective p38 inhibitor, SB203580 prior to Ang II treatments.  MEK inhibition reduced 
basal expression of junB mRNA and caused a significant inhibition of Ang II induction of 
both junB and PAI-1 mRNA levels (Fig. 6).  In these experiments, Ang II caused an 
increase, although not significant, in OPN mRNA that was reduced by U0126 and 
SB203580 (Fig. 6C).  Closer interpretation of the RT qPCR data revealed high basal 
expression of OPN in the presence of the DMSO vehicle, which has been observed 
previously in smooth muscle cells (Gadeau et al., 1993).  Inhibition of p38 resulted in a 
trend towards reducing the level of Ang II induction of mRNA for all gene targets.  MAP 
kinases are thus important in Ang II signaling to gene targets related to hypertension, 
with a prominent role for ERK.   
 
 
Silencing junB and CREB in cVSMCs using siRNA  
 To elucidate a role for JunB and CREB in the Ang II transcriptional regulation 
of gene targets (junB, PAI-1, OPN), an siRNA transfection technique was developed for 
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cVSMCs.  Optimum transfection conditions were first determined using a positive 
control siRNA, targeting cyclophilin B (CypB), which achieved 70% knockdown of 
CypB mRNA (Fig. 7A).  These conditions were used to selectively silence junB or 
CREB, using a non-targeting siRNA (si Control) as a control for transfection.   As shown 
in Fig. 7B, transfection with siRNA targeting junB resulted in a significant 50% reduction 
in the Ang II-mediated junB transcriptional response at 30 min, which corresponded with 
a loss of JunB protein expression (Fig. 7C).  CREB expression was not affected by Ang II 
treatment, but transfection with si CREB resulted in a considerable reduction in 
detectable CREB protein.  The si CREB did not significantly inhibit the junB 
transcription or its corresponding protein expression, although a slight decrease was 
consistently observed.  Thus, efficient and selective knockdown of junB and CREB can 
be achieved using transfection with siRNAs, and this experimental template was used to 
explore the effects of junB and CREB knockdown on the regulation of PAI-1 and OPN 
expression. 
 
JunB and CREB have Selective Roles in the Angiotensin II-mediated Regulation of 
PAI-1 and OPN Gene Expression 
 Whereas silencing of junB transcript had no effect on the induction of PAI-1 by 
Ang II, silencing CREB transcript prevented the PAI-1 response.  Thus, CREB is 
important in the Ang II-mediated signaling that results in PAI-1 transcription (Fig. 8A).  
PAI-1 protein levels were not assessed due to lack of suitable Western blot antibodies.  
Conversely, si junB significantly reduced both the basal and Ang II-stimulated 
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transcription of OPN, whereas knockdown of CREB resulted in an unexpected induction 
of OPN mRNA and protein (Fig. 8B,C).  Although both JunB and CREB are regulated 
through ERK signaling, the data presented here suggest that they have opposing roles 
related to PAI-1 and OPN gene expression, which may be important with respect to 
signaling during the development of vascular pathologies as a result of hypertension.    
 
Discussion 
Chronic hypertensive disease leads to hypertrophic changes in the arterial wall, 
and the goal of this study was to better define the underlying mechanisms that alter 
signaling pathways and gene expression in cerebral arteries (Baumbach and Chillon, 
2000).  Here we present the first evidence that salt-induced hypertensive disease in Dahl 
S animals results in chronic activation of ERK and increased proliferation of cerebral 
artery smooth muscle cells.  These changes correlate with increased mRNA levels of 
multiple genes known to be regulated by ERK signaling, most notably the AP-1 
transcript, junB and the matricellular genes, OPN and PAI-1.  These findings were 
extended using a culture model of cerebrovascular smooth muscle cells revealing 
parallels between altered genes observed in chronic hypertension and modulation of these 
same genes through Ang II signaling and establishing, for the first time, selective roles 
for JunB and CREB in the induction of OPN and PAI-1.     
ERK has been implicated as a mediator of hypertension in both Dahl S rats and 
other models of hypertension (Campos et al., 2003, Pulver-Kaste et al., 2006).  Our data 
showing elevated ERK activation in cerebral arteries from Dahl S hypertensive animals 
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corroborates an earlier study in the same model linking chronic activation of ERK with 
glomerular injury (Hamaguchi et al., 2000).  In cultured VSMCs, ERK phosphorylation 
induced by mechanical injury leads to over-expression of OPN protein, and Ang II 
induces PAI-1 expression in an ERK-dependent manner (Chen and Feener, 2004, Moses 
et al., 2001).  Furthermore, OPN and PAI-1 were identified in a matricellular gene cluster 
as highly Ang II responsive (Campos et al., 2003).  Our data thus support the findings of 
others implicating an important role for altered signaling between Ang II, ERK, and 
expression of OPN and PAI-1.   
Both OPN and PAI-1 have been previously implicated as participants in vascular 
remodeling.  OPN is a marker of proliferation in rat VSMCs and its expression in 
cultured VSMCs correlates with down-regulation of contractile proteins suggesting a 
switch from the contractile to the proliferative phenotype (Gadeau et al., 1993, Giachelli 
et al., 1993, Weissberg et al., 1995, Yamamoto et al., 1997).  OPN plays a role in 
coronary artery post-angioplasty restenosis through its chemotactic properties, where it 
mediates smooth muscle cell extracellular matrix invasion of the intimal layer (Panda et 
al., 1997).  Moreover, OPN has been referred to as a “delayed early gene” because of its 
role in cell proliferation following mitogenic stimulation in arterial smooth muscle cells 
(Gadeau et al., 1993).   
PAI-1  is a potent chemotactic molecule and promotes migration through its 
interactions with LDL receptor-related protein and is the primary physiological 
antagonist to both tissue and urokinase plasminogen activators (Degryse et al., 2004).  
Increased levels of PAI-1 have also been detected in vascular lesions induced by 
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atherosclerosis or balloon catheter injury (Coban and Ozdogan, 2004, Sawa et al., 1994).  
PAI-1 promotes proliferation and protects arterial smooth muscle cells from apoptosis, 
thus there is an increased likelihood of hyperplasia following angioplasty when PAI-1 
expression is abnormally elevated (Chen et al., 2006a).  Our findings extend these 
conclusions to cerebral arteries, supporting a role for OPN and PAI-1 in the proliferative 
changes observed in cerebral arteries of hypertensive rats. 
While not observed previously in cerebral arteries, induction of OPN and PAI-1 
has been observed in other models of hypertensive disease.  An array analysis to detect 
changes in genes from the left ventricle of the heart in the spontaneously hypertensive rat 
(SHR) model found over-expression of OPN, PAI-1, fibronectin-1, ApoE and cathepsin 
K (Rysa et al., 2005).  Up-regulation of OPN and PAI-1 was also detected in kidneys 
from stroke-prone SHR rats with malignant hypertension (Nerurkar et al., 2007).  PAI-1 
is elevated in the plasma of chronically hypertensive patients, and populations expressing 
the 4G/4G PAI-1 promoter polymorphism, which confers increased basal PAI-1 
transcription, exhibit an increased risk of developing arterial hypertension (Martinez-
Calatrava et al., 2007).  These data suggest that our observed changes in cerebral artery 
gene expression are not restricted to the etiology of the hypertensive disease or to arterial 
tissue and that the Dahl model may be useful for deciphering the consequences of 
hypertension on cerebral artery function in human disease.   
In this study, several AP-1 family member transcripts were variably elevated in 
cerebral arteries from hypertensive animals including c-jun and c-fos, however junB 
transcript was consistently upregulated.   JunB has been shown to dimerize and 
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transactivate AP-1 genes but can also act as a negative regulator of c-Jun for some genes 
(Chiu et al., 1989, Passegue et al., 2002). In cultured VSMCs, JunB has been detected in 
active AP-1 complexes in cells responding to receptor tyrosine kinase and G protein-
coupled receptor agonists, and its induction is related to the production of reactive oxygen 
species (Rao et al., 1999).  These findings together with our findings that Jun- and 
CREB-regulated genes are overrepresented in cerebral arteries from hypertensive animals 
indicate that signaling through AP-1 and CRE promoter elements may be particularly 
relevant in the arterial remodeling response.   
The early-onset and transient nature of JunB induction by Ang II in cultured 
VSMCs is consistent with activation of other AP-1 family members responding to 
mitogen stimulation (Kim and Iwao, 2003).  The delayed stable induction of OPN and 
PAI-1 transcript by Ang II also agrees with previous findings that prolonged ERK leads 
to their induction (Chen and Feener, 2004, Gadeau et al., 1993).  Persistent upregulation 
of junB in malignant hypertension may thus indicate a defect in the regulation of junB 
that contributes to remodeling and involves OPN and PAI-1 expression.  
Our RNA silencing experiments indicate that JunB is important for the Ang II-
mediated upregulation of OPN, and that CREB is not required for junB induction but acts 
as a negative regulator of OPN expression.  Although the junB promoter contains a half-
site CRE, it also contains both AP-1 and SRE sites that likely compensate for the CRE 
through their stimulation by Ang II in our model (Lu et al., 1996, Whitmarsh and Davis, 
1996).   Two AP-1 sites and a CRE have been identified within the OPN promoter, and 
mutational analysis suggests that the AP-1 sites are the most critical (Jalvy et al., 2007).  
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The CREB findings were at first unexpected since others have found that dominant 
negative CREB reduces OPN expression, and CREB has been associated with c-Fos 
binding to AP-1 sites on the OPN promoter (Jalvy et al., 2007).  The differences may be 
agonist specific, and because Ang II initiates transactivation through both CREB and AP-
1, our data suggest that AP-1 activity not only predominates in induction of OPN, but that 
CREB activity interferes with the AP-1 induction.            
Contrary to the OPN results, silencing of junB had no effect on Ang II-mediated 
induction of PAI-1 mRNA levels, whereas silencing of CREB prevented PAI-1 
induction.  The PAI-1 promoter contains at least two AP-1 sites and the CREB target 
database identifies two half-site CREs.  AP-1 has been shown previously in fibroblasts to 
be important in PAI-1 induction through ERK (Keeton et al., 1991), thus the lack of 
effect of silencing junB in our studies suggests an alternate AP-1 member may be 
important for PAI-1 induction by Ang II or that the AP-1 effect is cell type-specific.  
Although implicated by promoter elements, our data are the first to define a specific role 
for CREB in PAI-1 induction by Ang II.  Taken together, our data support a model for 
gene expression in cerebral arteries following salt-induced hypertensive disease that 
includes upregulation of matricellular genes that are universally regulated by Ang II and 
ERK, and selectively regulated by JunB and CREB (Fig. 9). 
This study is the first to use microarray analysis to examine gene expression in 
intact cerebral vessels from Dahl S hypertensive animals.  Our results substantiate 
previous data and offer new findings related to changes in gene expression induced by 
hypertension.  These data also illustrate how array analyses, especially when evaluated 
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using the Fisher’s exact test, can be useful tools for assessing sets of genes altered in 
disease.  Our data using cultured VSMCs to elucidate a role for JunB and CREB in the 
regulation of PAI-1 and OPN gives us greater insight into the molecular mechanisms that 
underlie over-expression of these genes.  In addition to revealing a role for JunB and 
CREB in the development of hypertensive disease, these results will serve as a 
springboard of information to explore other sets of genes that contribute to the 
manifestations of cardiovascular disease in the Dahl S and other models of hypertension.   
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Figure  3-1  Dahl S rats with hypertensive disease have increased phospho-ERK in 
intact cerebral arteries.  A, Cerebral arteries were isolated from animals fed a low-salt 
(LS) or high-salt (HS) diet and then analyzed by whole artery immunofluorescence to 
detect P-ERK1/2 (red).  YOYO was used to stain nuclei (green).  Co-localization 
(Overlay) of P-ERK1/2 and YOYO appears white.  Images were collected by confocal 
fluorescence microscopy as described in Methods; Bar=100 µm.  B, Quantification of P-
ERK1/2 immunofluorescence was measured by mean pixel intensity over equal areas 
(Total) or within masked nuclear regions (Nuclear); n=4, *p<0.05.   
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Figure  3-2  Cerebral arteries from Dahl S rats with hypertensive disease have 
increased smooth muscle cell proliferation.  A  Cerebral arteries were isolated from 
animals fed either a low-salt (LS) or high-salt (HS) diet, and then cross-sections were 
analyzed by immunohistochemistry to detect the proliferation marker, Ki-67 (brown 
nuclear stain). Left panels represent staining in the absence of primary antibody (No 1° 
Ab).  All other panels depict Ki-67-specific staining.  Left and middle panel images were 
collected using a 20X objective, and right panels were collected using a 60X objective.  
B, Ki-67-positive nuclei graphically depicted as a percent of total nuclei ±SEM;  n=4 
animals/group, 2-3 arteries/animal; **p<0.005. 
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Figure  3-3  Identification of Genes of Interest using Database Subsets.  Volcano 
plots were created expressing –log10 of the p-value (p) on the y-axis versus the log2 fold-
change (M) on the x-axis to reveal genes of interest in the upper quadrants.  Plots 
represent A, the complete probe set, B, a subset from the RGD database of genes 
associated with hypertension, and C,D, a subset from the TRED database of genes 
regulated by Jun or CREB.  Contours represent the probability density derived from 
permutation of sample labels to exclude 10% (inner contour) and 1% (outer contour) of 
the probe sets (See Methods section for details).  Genes of interest are identified and 
designated by circles. 
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Figure  3-4  Osteopontin (OPN) protein expression is elevated in Dahl S rats with 
hypertensive disease.  Cerebral arteries were isolated from animals fed either a low-salt 
(LS) or high-salt (HS) diet, and then cross-sections were analyzed by 
immunohistochemistry to detect OPN.  A, OPN (brown cytoplasmic stain) detected in a 
representative arterial section from a LS and HS animal.   B, Histogram of relative OPN 
staining intensity ±SEM from experiments shown in A, quantified using MetaMorph 
software; n=4 animals/group, 2-3 arteries/animal, *p<0.05.
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Figure  3-5  Ang II induces transient expression of JunB and delayed expression of 
PAI-1 and OPN in cVSMCs.  A, cVSMCs were treated with 100 nM Ang II for the 
indicated times and mRNA levels for junB were determined by RT qPCR.  Inset:  
Representative Western blot showing time-course for JunB protein expression following 
100 nM Ang II treatments.  Blots were probed for β-Actin to confirm equal protein 
loading.  B, Cells were treated as in A, and mRNA levels for junB (red), PAI-1 (green), 
and OPN (blue) were determined by RT qPCR.  RNA concentration was corrected using 
hprt as the endogenous control and values were normalized to time 0.  Results are 
expressed as mean RQ value ±SEM (n=4-7), *p < 0.05.   
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Figure  3-6  Inhibition of MAP kinases reduces Ang II transcriptional activation of 
junB and PAI-1.  Following 30 min of pre-treatment with either DMSO (vehicle 
control),10 µmol/L U0126 or 700 nmol/L SB203580, cVSMCs were treated with 100 nM 
Ang II for A, 30 min or B,C, 3h, followed by measurement of mRNA for A, junB, B, 
PAI-1 or C, OPN using RT qPCR.  RNA concentration was corrected using hprt as the 
endogenous control and values were normalized to the DMSO untreated control.  
Histograms represent mean RQ value ± SEM, *p< 0.05 compared to DMSO, # p< 0.05 
compared to DMSO+Ang II; n=4 independent experiments.  
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Figure  3-7  Efficient knockdown of CREB and JunB in cVSMCs using siRNA.  A, 
cVSMCs were transfected with 100 nmol/L of either non-targeting siRNA pool (si 
Control) or siRNA targeting cyclophilin B (si CypB).  Cells that were not transfected (No 
Trfx) were used as the endogenous control for transfection.  RNA was isolated and 
mRNA levels were detected by RT qPCR using hprt as the endogenous control.  Values 
were normalized to the untreated control.  Results are expressed as mean RQ value 
±SEM; *p< 0.05 when compared to si Control, n=4.  B, Cells were transfected as in A, 
with siRNAs targeting junB (si junB) or CREB (si CREB).  Following treatments with 
100 nmol/L Ang II for the indicated times, mRNA levels were detected by RT qPCR and 
expressed as in A; *p< 0.05 when compared to untreated si Control, #p< 0.05 when 
compared to Ang II treated si Control using Holm-Sidak method for multiple 
comparisons; n= 4-7 independent experiments.  C, cVSMCs were transfected and treated 
with Ang II as in B, followed by analysis of protein extracts by Western blot using 
antibodies specific to JunB (top panel), CREB (middle panel) and β-actin (bottom panel) 
as a standard for protein loading.  Blots are representative of 3 independent experiments. 
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Figure  3-8  CREB Silencing Prevents Ang II Induction of PAI-1 mRNA and junB 
Silencing Inhibits OPN Expression.  cVSMCs were transfected with 100 nmol/L of 
either non-targeting siRNA pool (si Control) or siRNAs targeting junB (si junB) or 
CREB (si CREB) and then treated with 100 nmol/L Ang II for the times indicated.  A, B, 
PAI-1 and OPN mRNA levels were detected using RTqPCR, using hprt as the 
endogenous control and untreated groups as baseline control.  Histogram shows results 
expressed as mean RQ value ±SEM, *p< 0.05 when compared to untreated si Control, 
#p<0.05 when compared to corresponding Ang II si Control (PAI-1 is NS, p= 0.071) 
using Holm-Sidak method for multiple comparisons; n = 4-7 independent experiments.  
C, Western blots of cVSMC protein extracts using antibodies specific for OPN and β-
Actin (loading control).  Blots are representative of 5 independent experiments.  
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Figure  3-9  Proposed model for regulation of gene expression in cerebral arteries 
responding to hypertension.  Hypertension leads to dysregulated Ang II signaling which 
activates a signaling cascade that includes activation of ERK and selective regulation of 
gene expression through JunB and CREB.   
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Table  3-1  Dahl S Rat Study Group 
 
 n Mean Age 
(wks) 
Age Range 
(wks) 
Time on 
Diet (wks) 
Body Wt. 
(g) 
Lung wt./BWt. 
(g/kg) 
LS 26 19 14-24 12 481±8.0   3.66±0.39 
HS 27 18 14-22 11  415±9.9**  5.60±2.17* 
 
LS, low salt diet; HS, high salt diet; *p<0.05, **p<0.005 when compared to LS.  
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Table  3-2  Microarray analysis using Rat Expression Set 230A 
(Affymetrix®) to compare gene transcripts between LS (normotensive control) 
and HS (hypertensive) Dahl S rats. 
Cluster I.D. Gene ID Gene Name HS:LS Ratio p-value 
Rn.8871 Spp1 Osteopontin +6.27 0.0142 
Rn.29367 Serpine1 PAI-1 +4.31 0.0184 
Rn.93714 Jun jun +2.50 0.0249 
Rn.4166 Calm1 Calmodulin1 +1.98 0.0328 
Rn.11200 Edg2 LPA1R +1.92 0.0196 
Rn.15806 Junb junb +1.87 0.0360 
Rn.13882 Best5 Best5 +3.50 0.047 
Rn.1974 
 
Gucy1a3 
 
Guanylate 
cyclase 1a3 
-2.32 
 
0.0190 
 
Rn.30516 Postn Periostin +5.23 0.058 
Rn.76589 Add3 Adducin3 +2.16 0.159 
Rn.32351 Apoe ApoE +1.91 0.099 
Rn.103750 Fos fos +1.27 0.683 
HS:LS ratio changes and p-value based on t-test as described in Methods. The threshold 
was 1.5 fold change and p<0.05; n=3 independent assays using arteries from 3 
rats/sample.  Lower section, notable genes p>0.05. 
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Table  3-3  Association of gene expression statistics using Fisher’s exact 
test. 
 p-value 
  Database  10% 1% 
  CREB  0.089 0.11 
  Jun  0.67 0.040 
  Elk1  0.16 1.0 
  Arteriosclerosis 1.0 1.0 
  Cardiovascular Accident 0.20 1.0 
  Hypertension 1.0 1.0 
 
Evaluation was based on annotation-based partitions of the RAE230A probe sets using 
gene identities from the TRED and RGD databases as described in the Methods.  
Contoured p-values were determined using Fisher’s exact test. 
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Table  3-4  Validation of array results for selected genes altered in cerebral 
arteries of Dahl S hypertensive rats using RT qPCR 
Gene Name Fold change p-value 
Osteopontin 43.13 0.000125 
PAI-1 12.14 0.00978 
jun 1.254 >0.1 
Calmodulin1 1.268 >0.1 
LPA1R 1.914 >0.1 
junB 1.471 0.00952 
Guanylate cyclase -1.634 0.0704 
 
 
 
HS:LS fold change and p-value based on t-test as described, using hprt as the endogenous 
control; based on duplicate samples, n=3 (arteries from 2-3 animals/sample). 
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Abstract 
Microarray analysis used to identify genes altered in a Dahl salt sensitive (Dahl S) 
genetic model of hypertension revealed significant increases in osteopontin (OPN), 
plasminogen activator inhibitor 1 (PAI-1) and junB mRNA transcripts with a near 
significant reduction in guanylate cyclase 1a3 isoform (Gucy1a3) compared to controls 
(data submitted for publication). In the present study Wistar Kyoto hypertensive  rats 
(WKHT) were used to determine if genes altered in salt induced hypertensive disease 
(OPN, PAI-1, junB, and Gucy1a3) in Dahl S animals were also modified in this genetic 
rat strain.  Of the 4 target genes only Gucy1a3 showed a significant change in expression 
compared to Wistar Kyoto (WKY) controls.  Expression of Gucy1a3 in WKHT was 
significantly reduced by 62% similar to the reduction observed in hypertensive Dahl S 
animals.  Our study suggests that downregulation of Gucy1a3 expression is present in 
different genetic models of hypertension.  Overexpression of the matricellular gene 
products OPN, and PAI-1 may thus be due to the effects of chronic hypertension, age and 
or the 8% NaCl (high salt, HS) diet (long term events) that eventually alters signal 
transduction pathways regulating their expression.  Data presented here also suggests that 
downregulation of Gucy1a3 mRNA may serve as an early biomarker of hypertension.  
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Introduction 
Animal models of hypertension allow researchers to study the patho/physiological 
changes that occur in human forms of the disease.  Thus, enabling investigators to 
examine specific hereditary genetic traits or gene mutations that increase the 
susceptibility to hypertension.  The spontaneously hypertensive rat (SHR) is a genetic 
model of hypertension that closely simulates essential hypertension observed in humans 
(Bing et al., 2002).  Like humans, heart failure occurs as part of the aging process (Bing 
et al., 2002), thus the shorter life span in the rat model enables investigators to examine 
disease related changes in a timely and reproducible manner.  One major drawback is that 
the development of left ventricular hypertrophy (LVH) and subsequent heart failure as a 
consequence of severe hypertension (non age related) in the SHR is associated with a 
behavioral component that contributes to the pathological phenotype (Bing et al., 2002).  
Hyperactive behavioral patterns caused by environmental stress are linked to 
cardiovascular reactivity in hypertensive SHRs (Knardahl and Hendley, 1990).  Since 
behavioral hyperactivity is not observed in the WKY strain, hypertensive SHR males 
were crossbred with normotensive WKY females (Hendley et al., 1983).  Subsequent 
recombinant selected inbreeding produced two strains of rats with dominant traits for 
either hyperactivity (HA) or hypertension (HT) (Hendley et al., 1983, Hendley and 
Ohlsson, 1991).  Increased circulating levels of norepinephrine and epinephrine along 
with pressor renal and mesenteric responses to stress were observed in the SHR and 
WKHA strains only (Hendley et al., 1988, Knardahl and Hendley, 1990).  The expression 
of a purely hypertensive phenotype (WKHT) without hyperactivity enables investigators 
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to better interpret data gathered from hypertension studies.  Here we measured effects of 
genetically-induced hypertension on the expression of genes identified in the Dahl model 
of hypertension.  Results show a significant decrease in Gucy1a3 suggesting that loss of 
guanylyl cyclase activity is an early effect of hypertension. 
 
Materials and Methods 
Animals and RNA Isolation 
Experiments were conducted in accordance with the Guide for the Care and Use 
of Laboratory Animals and followed protocols approved by the Institutional Animal Use 
and Care Committee of the University of Vermont. All arteries were obtained through 
tissue sharing from the University of Vermont investigators, Edith Hendley and Brad 
Palmer.   Male WKY and WKHT (F50 generation) rats weighing ~200g, and ~10 weeks 
of age, were maintained on a 12:12 h light:dark cycle in a temperature-controlled 
environment on rat chow diet. Blood pressure measurements were taken using the tail 
cuff plethysmograph.  Animal euthanization was by isoflurane anesthesia followed by 
decapitation.  Middle and posterior cerebral, and posterior cerebellar arteries were 
dissected, and vessels were immediately transferred to RNA Later™ and stored at -20°C 
prior to RNA isolations.  Total RNA was extracted using a modification of Qiagens 
RNeasy Plus Kit ™ and measured on a nanospec similar to methods described in (Rose et 
al ’07, newly submitted).  Following reverse transcription of equal amounts of total RNA 
(average RNA concentrations ~ 20 ng/µl) from WKY and WKHT animals, RT qPCR was 
used to measure relative expression of OPN (SPP1), PAI-1 (Serpine), junB, and Gucy1a3 
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using Assays on Demand™ supplied by Applied Biosystems™ (Pulver-Kaste et al., 
2006) . 
 
Results 
WKHT rats have downregulated Gucy1a3 mRNA compared to normotensive WKY 
control. 
To examine whether changes in gene expression in the Dahl model is 
representative of hypertension rather than effects of a high salt diet, expression of target 
genes OPN, PAI-1, junB, and Gucy1a3 were examined in a spontaneously hypertensive 
rat strain (WKHT).  The parent strain (WKY) was used as control.  Young WKHT rats 
have a significantly lower level of Gucy1a3 mRNA when compared to normotensive 
controls (see Figure 4-1); whereas no significant change was observed in OPN, PAI-1 or 
junB (data not shown).  Paradoxically OPN and PAI-1 expression trended towards higher 
levels in control animals. Data from the Dahl S animal study suggests much lower 
threshold cycles (Ct values) for both OPN and PAI-1 transcripts than those of WKY and 
WKHT suggesting an increase in transcriptional regulation of these genes in chronic 
hypertensive disease. 
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                           WKY vs WKHT 
 
  Figure  4-1  Guanylyl cyclase 1a3 mRNA is downregulated in WKHT rats. 
Histogram depicts Gucy1a3 mRNA levels detected using RT-qPCR.  Expression 
levels of target genes were determined using hprt as the endogenous control and 
were normalized to WKY, data compares levels of transcripts from WKY and 
WKHT animals at ~10 weeks of age.  Results are expressed as means ± SEM, 
n=3, * p<0.05. 
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Discussion 
In this study, data obtained from WKHT animals, a purely hypertensive genetic 
rat model that lacks the behavioral hyperactivity demonstrated in SHR and WKHA 
strains, suggest that Gucy1a3 is downregulated in the early stages of hypertension. 
However, in contrast to data from Dahl S hypertensive rats, WKHTs did not show 
significant differences in the matricellular genes PAI-1 and OPN.  This difference in 
expression of PAI-1 and OPN transcripts in WKHTs compared to the Dahl S group may 
be due to long term changes that could result from chronic hypertensive disease, HS diet 
or the age of the animal.  
WKHT rats used in this study had mean systolic blood pressure measurements of 
~155 mmHg, which is actually considered the threshold for hypertension (Smeda and 
Payne, 2003).  The apparently slow onset of hypertension in WKHTs compared to the 
hypertensive Dahl rats allow the blood vessel arteries to adjust to the small incremental 
changes in pressure.  Unlike the WKHT strain, the Dahl S group develops a rapid and 
significant increase in blood pressure within 7 days of a HS diet.  This acute change in 
blood pressure, with steady increases in pressure as the diet continues, does not allow 
compensatory mechanisms to normalize the blood pressure back to baseline, with 
subsequent altered transcription of OPN and PAI-1 (data submitted for publication).   
Soluble guanylyl cyclase catalyses the conversion of guanosine triphosphate 
(GTP) to cyclic guanosine monophosphate (cGMP) in vascular smooth muscle in 
response to nitric oxide (NO).  cGMP activation of cGMP dependent protein kinase 
(PKG) mediates VSMC relaxation.  It is important to note that endothelial derived NO 
  156
and Ang II act as physiological antagonists in the regulation of arterial tone. Vascular 
injury observed in chronic hypertensive disease leads to the functional up-regulation of 
Angiotensin II because of increased superoxide production, causing loss of endothelial-
derived NO and induction of inducible nitric oxide synthase (iNOS) in Dahl S rats (Zhou, 
MS ’03) (Zhou et al., 2003).  Our array data indicate that soluble Gucy1a3 is significantly 
down-regulated in chronically hypertensive Dahl S rats, with validation of this data using 
RT qPCR.  Down-regulation of PKG has also been observed in VSMCs responding to 
proinflammatory cytokines, and coordination of guanylyl cyclase and PKG expression 
has been suggested as an adaptation mechanism.  (Browner et al., 2004a, Browner et al., 
2004b).  It is possible that downregulation of Gucy1a3 and other guanylyl cyclase 
isoforms reduce PKG activity in cerebral arteries that may directly contribute to the 
hypertension or may alternatively serve to compensate for the induction of iNOS that 
may occur in response to arterial injury. Data presented in this study supports the 
suggestion that down regulated isoforms of guanylyl cyclase may be an important early 
marker of hypertensive disease (Ruetten et al ’99, Kagota et al ’01). 
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Discussion and Future Directions  
 
Transition of VSMCs from a contractile to a proliferative phenotype is one of the 
hallmark changes in arteries following post-angioplasty balloon injury, hypertension, 
diabetes and other diseases affecting the arterial wall.  Ca2+ is central in the mediation of 
many cellular and physiological processes including muscle contraction and the 
regulation of gene transcription.  The role of Ca2+ in contraction of muscle is well 
characterized, however, research involving Ca2+ regulated gene expression particularly in 
diseased arteries is still being pursued.  The impetus for my dissertation research project 
is a result of the efforts of many investigators before me.  Data gathered from their 
research provided me with the insight to move forward with my project.  
 
Aim 1:  SOCE plays a role in CREB phosphorylation in intact tissue 
The CREB transcription factor, initially characterized for its response to cAMP, 
was confirmed as a highly Ca2+ dependent transcription factor (Cartin et al., 2000, 
Pulver-Kaste et al., 2006, Pulver et al., 2004, Sheng et al., 1991).  Several investigators 
before me have confirmed that CREB activation, initiated by phosphorylation of Ser-133 
is increased in response to influx of Ca2+ through VDCCs leading to the activation of the 
CRE driven immediate early gene c-fos in cultured and intact tissue (Cartin et al., 2000, 
Pulver-Kaste et al., 2006, Pulver et al., 2004, Stevenson et al., 2001).   
In addition to using VDCCs as a Ca2+ source to mediate CREB phosphorylation, a 
role for SOCE was confirmed by depleting the SR Ca2+ stores in intact cerebral arteries 
using TG as described in Chapter 2 (Pulver et al., 2004).  In the Pulver et al study, the 
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VDCC blocker nimodipine revealed a partial inhibition of the TG response in intact 
arteries only, with no effect observed in cultured VSMCs suggesting either a loss of 
expression of VDCCs or loss of VDCC signaling in cultured cells.  Data generated from a 
microarray study using cultured VSMCs suggest that increases in P-CREB in response to 
influx of Ca2+ from both VDCCs or SOCE differentially activate distinct subsets of CRE 
driven genes (Pulver-Kaste et al., 2006).  
Recently the discovery of the genes whose products are essential to the function 
of store operated Ca2+ channels (Orai1 and STIM1) were revealed (Mercer et al., 2006, 
Peinelt et al., 2006, Soboloff et al., 2006, Zhang et al., 2006). Thus, a future direction for 
studies focused on the role of SOCE in gene expression could involve using reverse 
permeabilization to expose cells to inhibitors of Orai1 and STIM1 expression to analyse 
gene expression following stimulation with Ang II.  It is expected that Ang II induced 
IP3R mediated store depletion would be uncoupled from gene expression in the absence 
of SOCE (Pulver-Kaste et al., 2006).  Additionally, this study could also be used to 
determine if the differential expression of CRE driven genes involving different modes of 
Ca2+ entry in an intact model (VDCC versus SOCE) differ from the data obtained from 
cultured cells.  
 
Aim 2:  Dahl S genetic model of hypertension exhibits elevated ERK activity and 
over-expression of ERK regulated genes 
Thus far, data described from Chapter 2 were obtained from cultured VSMCs and 
intact arteries from normotensive animals.  Similar changes in the level of CREB 
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phosphorylation and c-fos induction coupled to a more depolarized membrane potential 
was observed in a genetically hypertensive rat model (Dahl S) suggesting that stimulated 
Ca2+ influx mimics the vascular changes observed in hypertension (Wellman et al., 
2001).   
Data presented in Chapter 3 were generated from studies using immunostaining 
followed by microarray analysis to examine the level of P-ERK and the expression of 
ERK regulated genes respectively in intact cerebral arteries from normotensive (LS) and 
hypertensive (HS) Dahl S rats.  Data generated from these methods revealed excessive 
ERK activity and over representation of ERK regulated genes in the hypertensive group 
only.  In addition, the hypertensive group showed a significant increase in subsets of 
genes regulated by CREB and Jun as determined by the TRED database utilizing 
Fischer’s exact test.  A tissue culture model was developed using Ang II to stimulate 
cultured VSMCs explanted from normotensive rat arteries to modulate changes in genes 
observed in the hypertensive response.  Ang II was chosen to stimulate VSMCs because 
the matricellular genes OPN and PAI-1 were identified as Ang II responsive genes, the 
Dahl S rats have a dysregulated renin angiotensin system, and Ang II activates ERK and 
increases [Ca2+]i.    Figure 5-1 depicts a working hypothesis for the role of ERK in Ang II 
mediated transcription of target genes.  Data suggests that Ang II induction of junB, OPN 
and PAI-1 require ERK activity (Campos et al., 2003, Hodge et al., 2002, Liao et al., 
1997). 
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Figure  5-1  Does Ang II regulate transcription of OPN, PAI-1 and junB through 
MAPK pathways? 
 
Aim 3: Ang II can be used in vitro on VSMCs to modulate changes in ERK 
regulated genes observed in chronic hypertensive disease and elucidate a role for 
AP-1 and CREB in target gene transcription.  Because genes regulated by CREB and 
AP-1 were significantly over expressed in the HS group, a role for CREB and JunB in the 
transcriptional regulation of PAI-1 and OPN respectively was investigated.  Gene 
silencing was used to reduce CREB and junB transcripts necessary for the synthesis of 
ERK1/2 
U0126/SB203580 
Transcription 
Ang II 
junB PAI-1 OPN 
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their respective transcription factors prior to Ang II treatments.  Figure 5-2  is a depiction 
of the working hypothesis.  Data obtained from these experiments suggest that Ang II 
induction of OPN and PAI-1 require JunB and CREB respectively. 
 
 
Figure 5-2  Does Ang II Induction of gene targets require junB and CREB? 
Finally, although OPN and PAI-1 are Ang II responsive matricellular genes 
whose expression is upregulated in response to vascular injury, data generated from gene 
knockdown studies indicate a reciprocal regulation of these genes.  A final working 
hypothesis is shown in Figure 5-3, suggesting that CREB is a negative regulator of OPN 
and that CREB induces PAI-1, while JunB activates basal and Ang II mediated induction 
of OPN having no effect on induction of PAI-1 by Ang II.  CREB down regulation of 
AP-1 
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OPN supports data suggesting that OPN over expression is observed in VSMC that have 
lost the contractile phenotype.  Hence, CREB knockdown reveals that CREB 
downregulates OPN as a mechanism to block VSMC dedifferentiation.   
A future direction for this project could include setting up different time points to 
determine when transcriptional changes in the expression of matricellular genes occur in 
hypertension, and if the observed differences are due to high salt, hypertensive disease or 
both.  I suspect a role for hypertension, and that high salt diet may have an additive effect 
on altered gene expression.  
 
Figure  5-3  Schematic of final working hypothesis  representing Ang II and ERK 
regulated genes 
PAI-1 OPN 
ERK1/2 
Ang II 
CREB AP-1 
junB, c-fos? 
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Down regulation of soluble guanylyl cyclase is observed in different genetic rat 
models of hypertension 
Expression of soluble guanylyl cyclase isoforms is critical for NO mediated 
activation of cGMP dependent protein kinase.  Data presented in Chapter 4 was generated 
from a genetically hypertensive animal model produced by cross breeding SHR and 
WKY rats.  The resultant WKHT strain used in this study is considered purely 
hypertensive, thus, a good model to determine if the altered gene transcription observed 
in Dahl S rats would also be observed in the WKHT strain.  Data suggests no significant 
differences in OPN, PAI-1 and junB transcripts between the hypertensive and 
normotensive groups.  However, there was a significant down regulation of the guanylyl 
cyclase isoform Gucy1a3, in the hypertensive strain compared to the control group.  Data 
from this study suggests that down regulation of Gucy1a3 as observed in these young 
purely hypertensive animals follows a similar trend to that seen in the Dahl S rat possibly 
linking this gene to a hypertensive phenotype.  Observed differences in the pattern of 
gene expression for OPN, PAI-1 and junB could be linked to different end points used in 
the study.  Dahl S rats had acute significant increases in blood pressure by 8 weeks of age 
that remained elevated throughout the study suggesting the observed changes represent 
chronic hypertensive disease.  Thus, guanylyl cyclase downregulation may be an early 
event, whereas upregulated transcription of matricellular genes may occur following 
chronic hypertension.   
A future direction for the WKHT study would be to include control groups for age 
and diet.  Thus, a working model would include the determination of blood pressure and 
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the expression of target gene transcript levels observed at 0, 10 and 15 weeks of age 
using 4 different groups i.e. control, and hypertensive groups with or without a HS diet.  
A comparison of this data suggests that follow up experiments for the Dahl genetic 
strains could further confirm if the observed changes in matricellular gene expression and 
their respective transcriptional activators are linked to hypertension, diet or both. 
 
Overall Significance of the Study 
Data obtained from the experiments completed thus far has increased our 
understanding of Ca2+ regulated signal transduction mechanisms in arterial smooth 
muscle that lead to changes in gene expression and smooth muscle cell proliferation.  
Importantly, although our findings are supported by the research of others, many of the 
signaling pathways examined and techniques developed during this research to our 
knowledge were not studied previously using intact arterial tissue.  These experiments 
have thus set the groundwork for future studies of gene expression in intact arteries.    
The incidence of hypertension has risen steadily over the last few decades leading 
to increases in the incidence of heart failure, renal disease, and strokes.  Data obtained 
from experiments outlined in this dissertation suggest, that hypertension in salt-sensitive 
individuals may lead to changes in Ang II-mediated gene expression that promote arterial 
remodeling and atherosclerosis.  Clinical research obtained from human studies suggests 
that inhibition of Ang II signaling using ACE inhibitors (ACEIs) either alone or 
combined with AT1R blockers is beneficial in the treatment of hypertension and, if used 
early, could prevent heart failure.  Close examination of Ang II synthesis and Ang II 
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receptor-mediated signaling outlined in Chapter 1 supports this therapeutic intervention.  
The conclusions of this research predict that the beneficial use of these drugs may lie in 
their ability to inhibit down stream signaling through Ang II, ERK, JunB, and CREB.  
Thus, the results presented here will be used for further study of these pathways in hopes 
of defining additional targets for preventative therapies in patients suffering from 
hypertensive disease. 
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Abstract 
Ca2+-regulated gene transcription is a critical component of arterial responses to 
injury, hypertension, and tumor-stimulated angiogenesis.  The Ca2+/cAMP response 
element binding protein (CREB), a transcription factor that regulates expression of many 
genes, is activated by Ca2+-induced phosphorylation.  Multiple Ca2+ entry pathways may 
contribute to CREB activation in vascular smooth muscle including voltage-dependent 
Ca2+ channels and store-operated Ca2+ entry (SOCE).  To investigate a role for SOCE in 
CREB activation, we measured CREB phosphorylation using immunofluorescence, 
intracellular Ca2+ levels using a fluorescence resonance energy transfer (FRET)-based 
cameleon indicator, and c-fos transcription using RT-PCR.  Here we report that SOCE 
activates CREB in both cultured smooth muscle cells and intact arteries.  Depletion of 
intracellular Ca2+ stores with thapsigargin increased nuclear phospho-CREB levels, 
intracellular Ca2+ concentration and transcription of c-fos.  These effects were abolished 
by inhibiting SOCE through lowering extracellular Ca2+ concentration or by application 
of 2-aminoethoxydiphenylborate and Ni2+.  Inhibition of Ca2+ influx through voltage-
dependent Ca2+ channels using nimodipine partially blocked intact artery responses, but 
was without effect in cultured smooth muscle cells.  Our findings indicate that Ca2+ entry 
through store-operated Ca2+ channels leads to CREB activation, suggesting that SOCE 
contributes to the regulation of gene expression in vascular smooth muscle. 
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 Introduction 
Vascular smooth muscle cells (VSMCs) possess an ability to transition between 
differentiated and proliferative phenotypes in response to environmental cues1.  Although 
the proliferative phenotype is essential for vasculogenesis, uncontrolled proliferation and 
migration caused by changes in VSMC gene transcription are associated with the 
development of vascular pathologies such as atherosclerosis, hypertension, 
postangioplasty restenosis, and tumor-stimulated angiogenesis2;3.  Disease-related 
variations in VSMC phenotype correlate with atypical Ca2+ signaling, elevated 
intracellular Ca2+, and gene transcription4-6.  As yet, the interrelationships between Ca2+ 
signaling and transcriptional control of gene expression in VSMCs remain unresolved. 
Regulation of gene expression by Ca2+ can be mediated by Ca2+-dependent 
phosphorylation of the transcription factor CREB (Ca2+/cyclic AMP-response element 
binding protein).  Regulation of c-fos and other immediate early genes is in part Ca2+-
dependent and requires CREB7;8.  CREB activation requires phosphorylation at 133Serine 
to facilitate formation of an active transcriptional complex including recruitment of 
CREB binding protein (CBP300) and other co-factors to the Ca2+/cyclic AMP-response 
element (CRE) in the promoter of many genes9-11.  CREB phosphorylation can be 
mediated by multiple kinases including cAMP-dependent protein kinase, ribosomal S6 
kinase, mitogen- and stress-activated protein kinases, and calmodulin-dependent protein 
kinase (CaMK)9.  We have previously determined that membrane depolarization 
increases phosphorylated CREB (P-CREB) levels and c-fos transcription in VSMCs12.  
This effect is dependent on Ca2+ influx through L-type voltage dependent Ca2+ channels 
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(VDCCs) and CaMK activation13;14.  In addition, cerebral arteries from hypertensive rats 
exhibit elevated intracellular Ca2+ and an increased level of basal P-CREB and c-fos 
transcription15. 
Multiple sources of Ca2+ may participate in regulation of gene expression in 
VSMCs.  Elevation of Ca2+ in smooth muscle cells can result from entry of extracellular 
Ca2+ as well as release from Ca2+ sequestered within organelles such as the sarcoplasmic 
reticulum (SR)16-18.  Ca2+ influx across the plasma membrane is mediated by voltage-
dependent Ca2+ channels, and voltage-independent cation channels including store-
operated Ca2+ channels.  Store-operated calcium entry (SOCE), also known as 
capacititative Ca2+ entry, has been detected in VSMCs19;20 and is thought to play an 
essential role in the regulation of contraction, cell proliferation and apoptosis21;22.  
Activation of Ca2+ influx through store-operated Ca2+ channels is triggered by a reduction 
in SR Ca2+ concentration23;24.  Transient discharge of SR Ca2+ occurs during the course of 
signaling events that activate inositol 1,4,5-trisphosphate receptors (IP3R) or ryanodine 
receptors in the SR membrane25;26.  SR Ca2+ stores also can be depleted by inhibiting 
sarcoendoplasmic reticulum Ca2+ ATPases (SERCA) with thapsigargin or cyclopiazonic 
acid27;28. 
A role for SOCE in the regulation of gene expression in VSMCs is unclear.  In the 
current study, we examined the signaling pathway linking SR Ca2+ store depletion to 
CREB phosphorylation in cultured VSMCs and intact arterial myocytes.  Our findings 
indicate that Ca2+ entry through SOCE contributes to Ca2+ homeostasis and induces 
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CREB activation, suggesting a novel mechanism for the regulation of gene expression by 
Ca2+ in VSMCs. 
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Materials and Methods 
 
Cell culture, animals, reagents, and solutions 
All experiments were conducted in accordance with the Guide for the Care and 
Use of Laboratory Animals (NIH PUBLICATION 85-23, 1985) following protocols 
approved by the Institutional Animal Use and Care Committee of the University of 
Vermont.  Female Sprague Dawley rats (~12 weeks, 200 g) were euthanized 
(pentobarbital 150 mg/kg intraperitoneal) and the middle cerebral artery, posterior 
cerebral artery and descending aorta were dissected in cold HBS (HEPES buffered saline) 
or 100 nmol/L Ca2+ HBS.  Cerebral arteries were used for intact artery 
immunofluorescence, and the aorta was used to generate explants of cultured VSMCs as 
described previously29.  Briefly, rat explants were cultured in DMEM containing 10% 
fetal bovine serum (FBS), 2 mmol/L L-glutamine, 1000 units/ml penicillin, and 1 mg/ml 
streptomycin.  VSMCs that migrated within 3 to 5 days were passaged with 
trypsin/EDTA and cells were used between passages 2 and 4.   
Early passage hc VSMCs (passages 2-4) were obtained from human cerebral 
artery explants and used for RNA isolation.  2 mm slices of human cerebral artery (IRB# 
CHRMS 01-195; informed consent) were applied to scored 60 mm culture dishes, 
cultered in SMGM2 media (Cambrex) and passaged with trypsin/EDTA. 
Thapsigargin (TG), cyclopiazonic acid (CPA), BAPTA (1,2-bis(o-
Aminophenoxy)ethane-N,N,N′,N′-tetraacetic Acid), Nimodipine (Nim), and ionomycin 
were purchased from CalBiochem, San Diego, CA.  2-APB (2-
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aminoethoxydiphenylborate) and levcromakalim (Lev) were purchased from Tocris 
Cookson, Inc., Ellisville, MO.  Cell culture reagents were obtained from Gibco, Grand 
Island, NY.  All other chemicals were obtained from Sigma, St. Louis, MO. The 
composition of PSS was (in mmol/L): 119 NaCl, 4.7 KCL, 1.2 KH2PO4, 1.2 MgSO4, 1.6 
CaCl2, 1.2 MgCl2, 0.023 EDTA, 11 glucose and 24 NaHCO3 (pH = 7.4 with NaOH).  The 
composition of HBS was (in mmol/L):  10 HEPES, pH 7.4, 6 KCl, 140 NaCl, 2 CaCl2, 1 
MgCl2, and 10 glucose and the composition of 100 nmol/L Ca2+ HBS was (in mmol/L):  
10 HEPES, pH 7.4, 6 KCl, 140 NaCl, 0.1 CaCl2 (effectively 100 nmol/L due to EGTA), 1 
MgCl2, 10 glucose, and 1.1 mmol/L EGTA.  60 mmol/L K+ HBS consisted of HBS with 
isotonic replacement of NaCl by KCl (final composition in mmol/L: 60 KCl and 86 
NaCl).   
 
Immunofluorescence of cultured VSMCs   
VSMCs were grown to approximately 60% confluence on glass coverslips in 6-
well culture dishes and serum starved in media containing 0.1% FBS 24-48 hr prior to 
treatment.  Following treatment the cells were washed with ice-cold phosphate-buffered 
saline (PBS), fixed with 4% formaldehyde, and blocked in PBS containing 2% milk and 
0.1% Triton X-100.  Coverslips were incubated consecutively for 1 hr at 37˚C with rabbit 
anti-P-CREB antibody (Cell Signaling Technology, Beverly, MA) [1:250] and Cy3 goat 
anti-rabbit IgG (Jackson ImmunoResearch Labs) [1:500] in PBS containing 2% bovine 
serum albumin (BSA) and 0.1% Triton X-100.  YOYO-1 (Molecular Probes) [1:10,000] 
containing 250 μg/ml RNase was then added for 30 min at 37˚C to counterstain the cell 
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nuclei.  Coverslips were washed with PBS and mounted with Aqua Poly/Mount 
(Polysciences, Inc.).  Images were captured using a Bio-Rad 1000 laser scanning 
confocal microscope with a 40X objective.  For statistical analysis, at least 30 cells were 
quantified from at least 3 independent experiments.  P-CREB nuclear fluorescence 
intensity was quantified using Corel Photopaint™ by calculating mean nuclear pixel 
intensity after background subtraction1.  Data were plotted in histograms as mean values 
±SEM and a Student’s Neuman-Keuls test for multiple comparisons was used to 
determine statistical significance. Means were considered significantly different at * p < 
0.05, ** p < 0.01, and ***p<0.001.   
 
RNA Isolation, RT-PCR, and Quantitative RT-PCR 
Total RNA was extracted from treated hc VSMCs using TriZol reagent and 
chloroform.  RNA was precipitated using isoproponol with glycoblue (Ambion) as a 
carrier, washed with 75% ethanol, dissolved in RNAse free water and quantified using 
the NanoDrop® spectrophotometer.   
For c-fos mRNA analysis using RT-PCR, RNA (25 ng) was reverse-transcribed 
using a Sensiscript™ RT kit (Qiagen) according to the manufacturer’s instructions and 
cDNA was amplified using c-fos (5’-TTATCTGTGCGTGAAACACACC; 3’-
CCATGCGTTTTGCTACATCTC, 104 bp product, Sigma Genosys) and β-actin (5’-
ATGATATCGCCGCGCTCGTCGTC; 3’-CCGCTCGGCCGTGGTGGTGAA, 611 bp 
product, Operon) primers.  PCR products were separated by agarose gel electrophoresis 
and quantified using Quantity OneTM software.  The c-fos product level was corrected by 
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levels of β-actin amplified by the same procedure.  Data were plotted in histograms as 
mean values ±SEM and a Student’s Neuman-Keuls test for multiple comparisons was 
used to determine statistical significance. Means were considered significantly different 
at ** p < 0.01 and ***p<0.001. 
For c-fos mRNA analysis by quantitative RT-PCR, RNA (2 µg) was reverse-
transcribed using Omniscript™ RT kit (Qiagen) according to the manufacturer’s 
instructions.  cDNA was amplified by real time RT-PCR using Assays-on-Demand™ 
gene expression product kits (Applied Biosystems) and a 7900HT Sequence Detection 
System (TaqMan, Applied Biosystems).  HPRT was used as the internal standard.  Data 
analysis was fully automated and carried out using Sequence Detection 2.1 software 
(Applied Biosystems).  Standard curves were run to validate comparing the threshold 
cycle (CT) between c-fos and HPRT for data analysis.  RNA was isolated from at least 
two independent experiments and duplicate assays were performed.  Data were plotted in 
histograms as mean values ±SEM and a Student’s Neuman-Keuls test for multiple 
comparisons was used to determine statistical significance. Means were considered 
significantly different at * p < 0.05.       
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Ca2+ imaging using a FRET-based Cameleon Ca2+ indicator    
VSMCs were grown on coverslips in 60 mm dishes and maintained in DMEM 
containing 0.1% fetal bovine serum.  Cells were transiently transfected with 1 µg/ml of 
yellow cameleon2.1 (YC2.1), a fluorescence resonance energy transfer (FRET)-based 
calcium biosensor30 using Lipofectamine 2000™ (Invitrogen).  After 2 hr, the media was 
replaced and cells were maintained in a humidified incubator 24 hr before use.   
Coverslips were placed into a SA-NIK chamber (Warner Instruments) mounted 
on a Nikon Diaphot 200 inverted microscope equipped for epifluorescence.  Cells were 
superfused with HBS at room temperature.  YC2.1 excitation was 440 nm and emission 
recorded with an ORCA-ER™ charge-coupled device (Hamamatsu) at 480 nm (FRET 
donor, enhanced cyan fluorescent protein, ECFP) and 535 nm (FRET acceptor, enhanced 
yellow fluorescent protein, EYFP).   FRET emission ratio (Ratio 535/480) was recorded 
every 10 sec with an acquisition time of 200 msec and was used as a measure of 
intracellular Ca2+ concentration Ca2+.  Normalized ratio was obtained by dividing the 
Ratio 535/480 by the starting baseline ratio value.  The data were converted to a range of 
100% using maximum and minimum values for each experiment to calculate the percent 
maximal FRET ratio change.  Ionomycin (10 µmol/L) and EGTA (2 mmol/L) were used 
to determine the maximal and minimal values, respectively.  Data were analyzed using 
Metafluor 3.0 Imaging Software (Universal Imaging Corporation, West Chester, PA).  
Area under the curve (AUC) ± SEM was calculated using Sigma PlotTM.  Student’s t test 
and Student-Neuman-Keuls multiple comparisons test were used where appropriate to 
determine statistical significance.   
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Immunofluorescence of intact arteries 
Following dissection, arteries were immobilized with insect pins in sylgard-coated 
dishes and bathed in cold HBS for 15 min before exposure to treatments.  Treatments 
were performed at room temperature then arteries were fixed in 4% formaldehyde.  
Immunofluorescence was performed following the same protocol as for cultured VSMCs 
with the following exceptions.  Triton X-100 was increased to 0.2% in the blocking and 
antibody dilution solutions.  Cy5 goat anti-rabbit IgG (Jackson ImmunoResearch Labs) 
[1:500] was used as the secondary antibody to reduce background auto-fluorescence from 
the elastic lamina.  Following the final wash, arteries were transferred to slides and 
mounted using Aqua Poly/Mount.  Specificity of the P-CREB fluorescence was 
confirmed by loss of signal in the presence of a P-CREB blocking peptide (Cell Signaling 
Technology) (not shown).  Images were captured using a Bio-Rad 1000 laser scanning 
confocal microscope with a 40X objective.  P-CREB nuclear fluorescence intensity was 
quantified as for cultured VSMCs measuring fluorescence in at least 90 cells per 
condition from at least 3 independent experiments.  Data were plotted in histograms as 
mean values ±SEM and a Student-Neuman-Keuls test for multiple comparisons was used 
to determine statistical significance.  Means were considered significantly different at * 
or # p < 0.05, ** or ## p < 0.01, and *** or ### p<0.001.   
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Results 
 
SERCA inhibition promotes CREB phosphorylation and c-fos transcription 
independent of L-type Ca2+ channel activity in cultured vascular smooth muscle cells 
Ca2+ entry through L-type VDCCs has been shown to increase phosphorylation 
and activation of the transcription factor CREB31;32.  To determine whether elevations in 
Ca2+ triggered by depletion of SR Ca2+ stores can also initiate CREB phosphorylation, 
SERCA was irreversibly inhibited with thapsigargin.  CREB phosphorylation at 133Ser 
was detected by immunofluorescence using P-CREB antibodies and quantified using 
nuclear pixel intensity.  P-CREB nuclear fluorescence increased in response to 
thapsigargin in a concentration-dependent manner (Figure 1A).  The EC50 (28.2 +/- 10.7 
nmol/L, n=3) was similar to the EC50 for thapsigargin-induced arterial contraction 
(Wellman and Phillips, unpublished observation) and is consistent with SERCA 
inhibition33.  Cyclopiazonic acid (CPA), a reversible inhibitor of SERCA, also stimulated 
CREB phosphorylation (not shown).  Elevation of P-CREB was evident 1 min after 
thapsigargin addition, peaked at 5 min, and returned to baseline within 30 min of 
treatment (Figure 1B).  These results suggest that SERCA inhibition can induce transient 
CREB activation in VSMCs. 
As SERCA inhibition depletes SR Ca2+ stores and consequently stimulates 
SOCE34, we explored a role for Ca2+ influx through store-operated Ca2+ channels in the 
observed thapsigargin -induced CREB phosphorylation.  Reducing extracellular Ca2+ or 
chelating extracellular Ca2+ with BAPTA significantly decreased thapsigargin-induced P-
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CREB levels (Figure 2A).  Nimodipine, an L-type VDCC blocker, was without effect, 
whereas Nickel (Ni2+), a divalent blocker of cation channels35, and 2-
aminoethoxydiphenylborate (2-APB), a blocker of SOCE36, significantly reduced 
thapsigargin-mediated CREB phosphorylation (Figure 2B).   
To confirm that the observed effects on P-CREB correlated with changes in its 
transcriptional activity, we measured the effect of thapsigargin on transcription of the 
CRE-regulated gene, c-fos, using both standard and quantitative RT-PCR.  Transcription 
of c-fos was induced by thapsigargin, and this effect was insensitive to nimodipine, but 
blocked by 2-APB, closely paralleling the data profile for CREB phosphorylation 
(Figure 3).  Together, these results provide evidence that depletion of SR Ca2+ using 
thapsigargin leads to CREB activation through a mechanism requiring Ca2+ influx and 
functional store-operated Ca2+ channels. 
 
Thapsigargin-induced Ca2+ signaling involves store-operated Ca2+ channels   
The mechanism of CREB activation by thapsigargin was consistent with Ca2+ 
entry through store-operated Ca2+ channels.  To support these data using single cell 
measurements of Ca2+, we expressed the cameleon YC2.1, a calmodulin-based FRET 
biosensor in VSMCs37.  Because this indicator has not been previously characterized in 
VSMCs, we first examined FRET ratio changes over a range of Ca2+ concentrations.  
Cells were incubated with buffers of known Ca2+ concentration38 in the presence of the 
Ca2+ ionophore, ionomycin.  A 20% FRET ratio change occurred at 200 nmol/L Ca2+ and 
the indicator appeared saturated at concentrations above 10 µmol/L (Figure 4A). 
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Administration of serum, known to stimulate IP3-mediated Ca2+ release from 
thapsigargin-sensitive stores39-41, resulted in a transient rise in Ca2+.  Thapsigargin caused 
a rapid and more sustained increase in Ca2+ and its administration inhibited subsequent 
serum responses, indicating that it effectively diminished SR Ca2+ (Figures 4B-D).  
Similar to our results related to CREB phosphorylation, the increase in Ca2+ initiated by 
thapsigargin was significantly attenuated by BAPTA or 2-APB (Figure 5).  These 
findings indicate that the source of Ca2+ leading to CREB activation by thapsigargin is 
likely through SOCE. 
 
Store-operated Ca2+ entry leads to CREB phosphorylation in intact arteries 
VSMCs maintained in culture undergo multiple phenotypic changes42.  It is 
therefore possible that SOCE and Ca2+ signaling responses may be different in smooth 
muscle cells present in intact arteries.  To measure the effect of SR Ca2+ store depletion 
on CREB phosphorylation in arterial myocytes, rat cerebral arteries were isolated and 
treated in vitro with thapsigargin, followed by detection of P-CREB using 
immunofluorescence.  Thapsigargin induced an increase in P-CREB fluorescence that co-
localized with nuclei (Figure 6A).  In agreement with our previous findings43, induction 
of CREB phosphorylation following membrane depolarization by elevated K+ was 
prevented by nimodipine or reducing extracellular Ca2+. The thapsigargin-induced CREB 
phosphorylation was partially inhibited by nimodipine, but was ablated by reducing 
extracellular Ca2+ (Figure 6A,B).  Furthermore, the nimodipine-insensitive CREB 
phosphorylation was eliminated by treatment with 2-APB or Ni2+ (Figure 6C), 
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suggesting that thapsigargin-mediated CREB activation is accomplished by Ca2+ 
signaling through voltage dependent Ca2+ channels and SOCE in intact arteries.  
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Discussion 
 The gene expression profile of arterial smooth muscle cells is a critical 
determinant of the differentiated versus proliferative phenotype.  CREB is implicated in 
both promoting VSMC proliferation and conversely in the protection of arteries from 
smooth muscle cell dedifferentiation.  P-CREB levels and c-fos transcription are 
increased in smooth muscle cells of hypertensive arteries, and inhibition of CREB 
activity through expression of dominant negative CREB prevents apoptosis and augments 
mitogenesis of VSMCs44;45.   However, CREB content of vascular tissues inversely 
correlates with VSMC proliferation and migration46-48.  In light of its regulation by 
multiple pathways, CREB likely has pleiotropic effects on smooth muscle cell functions 
that may explain its regulation of opposing events, depending on the signal source and 
duration.   
The underlying Ca2+-dependent signaling mechanisms involved in CREB 
activation and VSMC gene transcription are not completely understood.  Here we used 
pharmacological tools and measurements of intracellular Ca2+ to establish a role for 
SOCE in the activation of CREB in VSMCs.  We report that influx of Ca2+, caused by 
thapsigargin-induced depletion of SR Ca2+, results in transient phosphorylation of CREB 
and transcription of c-fos.  Ca2+ influx through VDCCs did not affect thapsigargin-
induced CREB phosphorylation or c-fos transcription in cultured VSMCs derived from 
vascular explants, but did contribute to P-CREB formation in intact arteries.  The effect 
of SOCE on CREB activation suggests that SR Ca2+ store homeostasis is important in 
regulating gene expression in vivo and supports the hypothesis that store-operated Ca2+ 
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influx pathways are involved in CREB-mediated transcriptional events in both 
physiological arterial signaling and in pathological growth changes associated with the 
development of hypertension and atherosclerosis49;50. 
Although Ca2+ is a ubiquitous signaling ion affecting many aspects of VSMC 
physiology, the relative contribution of different modes of Ca2+ entry or intracellular Ca2+ 
release in the induction of gene transcription is uncertain.  Coupling of Ca2+ influx and 
intracellular Ca2+ mobilization pathways to CREB activation has been observed in 
neurons51.  Our work suggests that similar mechanisms are present in VSMCs.  Results in 
intact arteries indicate that influx of Ca2+ through either VDCCs or store-operated Ca2+ 
channels can contribute to regulation of CREB, and suggest that P-CREB formation 
occurs following global increases in Ca2+.  The simplest explanation for the discrepancy 
between VSMC from aortic explants and intact arterial myocytes is the reduction in L-
type VDCC expression in the cultured cells and indirect effects of thapsigargin on 
membrane potential52;53.  The VDCC-independent component of CREB phosphorylation 
was sensitive to inhibition of SOCE, supporting the hypothesis that SR Ca2+ and SOCE 
regulate Ca2+-dependent gene expression in intact arterial myocytes.  Consistent with 
SOCE playing a role in the change between the differentiated and proliferative VSMC 
phenotypes, previous studies have demonstrated up-regulation of store-operated channels 
in vascular smooth muscle during proliferation54 and growth arrest of smooth muscle 
cells following loss of SERCA expression55.   
The kinases activated downstream of SOCE were not identified in this study.  In 
neurons, CaM kinases have been implicated in the immediate phase of Ca2+-activated 
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CREB phosphorylation, whereas the Ras/MAP kinase pathway has been linked to 
sustained CREB phosphorylation56.  CaM kinase activity has also been shown to play an 
important role in CREB phosphorylation following membrane depolarization in vascular 
smooth muscle57. The transient nature of CREB phosphorylation following SERCA 
inhibition that we observed in the present study suggests that SOCE activates the 
immediate pathway involving CaM kinases. 
 CREB phosphorylation has been established as an important molecular switch to 
control gene transcription driven by CREs.  Here we have identified changes in c-fos 
transcription that correlate with SOCE-induced CREB phosphorylation.  It is likely that 
the interplay between SR Ca2+ homeostasis and SOCE contributes to transcriptional 
regulation of multiple genes through CREB phosphorylation and interactions with other 
proteins in transcriptional complexes58-60.  Moreover, different spatial and temporal 
patterns of Ca2+ gradients in VSMCs may add another level of transcriptional regulation. 
In summary, we have established that SOCE stimulates phosphorylation of 
CREB, an essential step in the activation of this transcription factor.  Future studies that 
determine the relative contributions of Ca2+ signals arising from multiple sources to the 
diverse patterns of CRE-mediated gene expression will contribute greater understanding 
of Ca2+ regulation of VSMC phenotype and development of vascular pathologies. 
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Figure  A-1A  Thapsigargin induces a dose-dependent transient increase in CREB 
phosphorylation in cultured VSMCs.  A, Cells were incubated with increasing 
concentrations of thapsigargin (TG) for 5 min, and P-CREB was detected by 
immunofluorescence.  Upper panels are representative images of P-CREB 
immunofluorescence in nuclei of VSMCs, and the graph represents quantification of 
nuclear P-CREB immunofluorescence intensities (± SEM, n = 3).  Bar represents 100 
µm.  B, Cells were incubated with 100 nmol/L TG over a time period of 1 min to 24 hr 
followed by detection of P-CREB by immunofluorescence.  Time points for TG addition 
were staggered such that all cells were simultaneously fixed at 24 hr.  Upper panels are 
representative images of P-CREB for untreated control, 5 min, and 120 min time points, 
and the graph represents quantification of nuclear P-CREB immunofluorescence 
intensities normalized by the untreated control P-CREB intensity (± SEM, n = 3) (lower).    
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Figure  A-2A  Thapsigargin-mediated CREB phosphorylation requires Ca2+ influx 
and is reduced by blockers of SOCE in cultured VSMCs.  A, VSMCs were incubated 
in HBS with normal Ca2+ (2 mmol/L), 100 nmol/L Ca2+, or pre-incubated with 5 mmol/L 
BAPTA for 30 min then treated with 100 nmol/L thapsigargin (TG) for 5 min.  P-CREB 
was detected by immunofluorescence, and shown are histograms of nuclear P-CREB 
intensities normalized by the untreated control P-CREB intensity (± SEM, n=3); *** 
p<0.001 when compared to 2 mmol/L Ca2+.  B, Where indicated, VSMCs were pre-
incubated 100 nmol/L nimodipine (Nim) for 15 min (n = 3), 100 µmol/L 2-APB for 10 
min (n = 4), or 500 µmol/L Nickel for 10 min (n = 4) then treated with 100 nmol/L TG 
for 5 min.  Detection and quantification of P-CREB was performed as in A, *** p<0.001 
when compared to TG alone.   
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Figure  A-3A  Thapsigargin promotes transcription of c-fos that is insensitive to 
nimodipine and inhibited by the SOCE blocker, 2-APB, in cultured VSMCs.  A,B, 
hcVSMCs were incubated in HBS containing 100 nmol/L thapsigargin (TG) or with 
isotonic elevation of K+ to 120 mM for 30 min followed by extraction of RNA and RT-
PCR using primers recognizing c-fos.  Shown are A, a representative agarose gel of the 
resulting PCR products and B, a histogram of c-fos band intensities relative to β-actin (± 
SEM, n=5); ** p<0.01, *** p<0.001.  C, hcVSMCs were treated as above and, where 
indicated, cells were pre-incubated with 100 nmol/L nimodipine (Nim) for 15 min or 100 
µmol/L 2-APB for 10 min.  RNA was isolated and c-fos transcript levels were determined 
using quantitative RT-PCR.  Histograms represent data normalized to the TG response 
(average ± SEM) of duplicate determinations from 2 independent experiments; * p<0.05.   
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Figure  A-4A  Thapsigargin elicits a transient rise in cytoplasmic Ca2+ levels and 
depletes SR Ca2+ stores as measured using a Cameleon FRET Ca2+ indicator.  A, 
Cultured VSMCs were transfected with the YC2.1 Cameleon then incubated with buffers 
of known Ca2+ concentration containing 10 µmol/L ionomycin and images of 535 nm 
(YFP) and 480 nm (CFP) emissions were recorded and plotted as change in ratio using a 
log-linear scale (± SEM, n = 3).  B, Pseudocolor images of the FRET emission ratio of a 
single VSMC transfected with the Ca2+ indicator YC2.1.  The color range represents ratio 
of YFP/CFP from 1.0-1.5.  Time 0 represents the addition of the reagent, either 1% serum 
or 100 nmol/L TG.  C, Normalized FRET ratio (535/480 nm) plot of fluorescence 
emission from a representative single VSMC transfected with YC2.1.  Treatments were 
added as a bolus to the bath as indicated by the horizontal lines on the plot.  Maximum 
and minimum values were determined by addition of 10 µmol/L ionomycin and 2 
mmol/L EGTA.  D, Area under the curve [integration of normalized FRET ratio x time 
(min)] was calculated for serum-induced FRET responses before and after the addition of 
100 nmol/L TG (± SEM, n=6); ** p<0.01. 
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Figure A-5A  Blockers of store-operated Ca2+ channels significantly reduce 
thapsigargin-induced Ca2+ signals.  Cultured VSMCs expressing YC2.1 were treated 
with 100 nmol/L TG and, where indicated, cells were pre-incubated with 5 mmol/L 
BAPTA for 30 min or 100 µmol/L 2-APB for 10 min.  A, Shown is a representative plot 
of percent maximal FRET ratio change of emissions at 535/480 nm based on 10 µmol/L 
ionomycin (max) and 2 mmol/L EGTA (min). B, Area under the curve [integration of 
percent maximal FRET ratio change x time (min)] was calculated for the responses 
shown in A (± SEM, n=5); ** p<0.01 when compared to TG alone.    
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Figure  A-6A  SOCE plays a role in CREB phosphorylation in intact arteries.  Rat 
cerebral arteries were isolated and incubated in HBS with normal Ca2+ (2 mmol/L), 100 
nmol/L Ca2+, or 100 nmol/L nimodipine (Nim)  for 15 min.  Arteries were then exposed 
to 100 nmol/L TG for 15 min or 60 mM K+ for 10 min.  CREB phosphorylation was 
detected by anti-P-CREB immunofluorescence.  A, Confocal images representing P-
CREB (red), YOYO nuclear stain (green) and overlap of P-CREB and YOYO (white).  
Bar represents 100 μm. B, Histograms of nuclear P-CREB immunofluorescence 
intensities normalized to untreated control (± SEM, n = 3);  * p<0.05, *** p<0.001, when 
compared to the TG-induced response; # p<0.05, ## p<0.01, when compared to the 60 
K+-induced response.  C, TG-induced P-CREB is sensitive to 2-APB and Ni2+.  Arteries 
were treated with TG after pre-incubation with 100 nmol/L Nim and, where indicated, 
100 µmol/L 2-APB or 500 µmol/L Ni2+ was included for 15 min (± SEM, n = 3); *** 
p<0.001. 
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Abstract 
 Calcium (Ca2+) signals affect virtually every biological process, including both 
contraction and gene transcription in smooth muscle.  Ca2+-regulated gene transcription is 
known to be important for both physiological and pathological responses in smooth 
muscle.  The aim of this review is to discuss the current understanding of gene 
transcription regulated by excitation through Ca2+ signaling using a comparison of the 
two most characterized Ca2+-regulated transcription factors in smooth muscle, Ca2+/cyclic 
AMP response element binding protein (CREB) and nuclear factor of activated T-cells 
(NFAT).  Recent studies have shown commonalities and differences in the regulation of 
CREB and NFAT through both voltage- and non-voltage-gated Ca2+ channels that lead to 
expression of smooth muscle cell specific differentiation markers as well as markers of 
proliferation.  New insights into the regulation of specific genes through companion 
elements on the promoters of Ca2+-regulated genes have led to new models for 
transcriptional regulation by Ca2+ that are defined both by the source and duration of the 
Ca2+ signal and the composition of enhancer elements found within the regulatory regions 
of specific genes.  Thus the combination of signaling pathways elicited by particular Ca2+ 
signals affect selective promoter elements that are key to the ultimate pattern of gene 
transcription.  
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Introduction 
 Excitation-contraction coupling in smooth muscle cells (SMCs) is tightly 
controlled by spatio-temporal Ca2+ events that involve both influx of extracellular Ca2+ 
and release from selective intracellular Ca2+ stores (reviewed in (Bolton et al., 2004)).  
Recent findings have revealed that the Ca2+-regulated transcription factors CREB and 
NFAT have selective Ca2+ source requirements and are influenced  by transcriptional co-
activators and cofactors for CREB and NFAT.  Excitation-transcription coupling is thus 
clearly relevant to both normal physiological responses and to the pathogenesis of 
vascular diseases that are known to include altered Ca2+ handling and changes in gene 
expression.  
 
Ca2+ regulation of CREB and Gene Transcription in Smooth Muscle 
 CREB (Ca2+/cyclic AMP response element binding protein) regulates 
transcription through recognition and binding to Ca2+/cyclic AMP (cAMP)-response 
elements (CREs) in the promoter of many genes (Shaywitz & Greenberg, 1999).  
Stimulus-induced CREB activation requires phosphorylation of 133Serine to promote 
recruitment of CREB binding protein (CBP300) and other cofactors to form an active 
transcriptional complex (Gonzalez et al., 1989; Mayr & Montminy, 2001).  Ca2+ from 
many sources can activate CREB-induced transcription through the CaMK, growth 
factor/MAPK, and cAMP-dependent protein kinase pathways (Shaywitz & Greenberg, 
1999) (Figure 1).  Inactivation of CREB through phosphatase activity can also be 
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regulated by Ca2+ through Ca2+/CaM activation of the protein phosphatase calcineurin 
which indirectly leads to dephosphorylation of CREB (Alberts et al., 1994). 
 CREB activation elicited by membrane depolarization and Ca2+ entry through 
VDCCs has been confirmed in both cultured SMCs and intact cerebral arteries (Cartin et 
al., 2000; Stevenson et al., 2001a).  Depolarization-mediated CREB phosphorylation 
correlates with an increase in transcription of the CRE-containing immediate early gene, 
c-fos, and is sensitive to inhibitors of VDCCs.   
Although CREB is predominantly nuclear, it has been shown to accumulate in the 
cytoplasm of vascular SMCs when nuclear import is blocked prior to membrane 
depolarization (Stevenson et al., 2001a).  While the relevance of nuclear shuttling of 
CREB has not been established, it could explain CREB interactions with multiple kinases 
that do not cross the nuclear membrane and the perceived loss of CREB from the nucleus 
following ischemia (Klemm et al., 2001).   
 A role for SR Ca2+ in signaling to CREB in SMCs has been demonstrated both 
in response to Ca2+ release from inositol 1,4,5-trisphosphate (IP3) receptors and through 
store-operated Ca2+ entry.  Endothelin-1, platelet-derived growth factor (PDGF), 
sphingosine-1-phosphate, aldosterone, LDL and ischemia have all been shown to induce 
CREB phosphorylation in SMCs through an IP3-dependent mechanism (Christ et al., 
1999; Stevenson et al., 2001a; Coussin et al., 2003; Egan & Nixon, 2004; Rius et al., 
2004; Meller et al., 2005).  The majority of these pathways are also influenced by MAPK 
signaling, and a link between Ca2+ and MAPK signaling to CREB has been observed for 
norepinephrine-induced CREB signaling (Hu et al., 1999).  SOCE, in response to SR 
  234
Ca2+ depletion, has also been shown to stimulate CREB phosphorylation in both cultured 
and intact vascular SMCs (Figure 2), and a role for SOCE has been reported in CREB 
activation stimulated by Angiotensin II (Pulver et al., 2004).  Determinations of the 
relevance of SOCE activation by other IP3 mediators and its importance in MAPK 
signaling are important targets of future investigations related to CREB signaling.   
Not all Ca2+ signals lead to activation of CREB.  Release of Ca2+ from ryanodine 
receptors (RyR) in the form of Ca2+ sparks has been shown to have an inhibitory effect on 
CREB activation, likely through membrane hyperpolarization (Cartin et al., 2000).  
These results stress the importance that the nature of the Ca2+ signal has on the 
downstream changes in gene transcription mediated by CREB.    
 
Ca2+ regulation of NFAT in Smooth Muscle 
 Nuclear factor of activated T cells (NFAT) has recently been shown to play an 
important role in regulating Ca2+-dependent gene transcription in SMCs.  The activation 
of NFAT is regulated through its subcellular localization, which reflects the intensity of 
Ca2+/calcineurin signaling and the activities of several nuclear protein kinases (Figure 3) 
(Hogan et al., 2003).  Upon elevation of intracellular Ca2+ levels, the Ca2+/CaM-
dependent phosphatase, calcineurin, dephosphorylates NFAT, allowing for the 
translocation of the NFAT/ calcineurin complex into the nucleus.  Because of its 
dependence on Ca2+/calcineurin signaling, NFAT has the ability to sense dynamic 
changes in [Ca2+]i  and frequencies of Ca2+ oscillations (Dolmetsch et al., 1997; Li et al., 
1998).   
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 NFAT translocation and transcriptional activity has been clearly demonstrated in 
both cultured and native SMCs (Boss et al., 1998; Stevenson et al., 2001b).  In cerebral 
SMCs, the vasoconstrictor, UTP, and other Gq/11-coupled receptor agonists induce 
NFAT4 nuclear accumulation.  This induction is dependent on release of Ca2+ from 
intracellular stores and requires function of VDCCs (Stevenson et al., 2001b; Gomez et 
al., 2002).  However, counter to expectations, a sustained increase in [Ca2+]i  induced by 
membrane depolarization is not sufficient to achieve NFAT4 nuclear accumulation in 
vascular SMCs (Stevenson et al., 2001b).   
 One possibility for this finding is that NFAT nuclear accumulation is further 
regulated by serine/threonine protein kinases, which promote the nuclear export of 
NFAT.  Recent work examining the role of c-Jun amino-terminal kinase  (JNK) using 
JNK knockout animals suggest that although elevated Ca2+ levels are sufficient to 
promote NFAT nuclear import, suppression of NFAT nuclear export activity is also 
required.  Specifically, nuclear JNK2 has been shown to selectively promote the nuclear 
export of NFAT4 in both transfection studies (Chow et al., 1997) and native isolated 
cerebral arteries (Gomez et al., 2003).  These data suggest that although Ca2+ elevation is 
necessary, it may not be the rate-limiting step in NFAT nuclear accumulation in SMCs. 
 In intact arteries, NFAT translocates to the nucleus in response to physiological 
intraluminal pressure.  Translocation is dependent on Ca2+ influx through VDCCs, 
requires the nitric oxide/protein kinase G pathway, and correlates with an inhibition of 
JNK-dependent nuclear export (Gonzalez Bosc et al., 2004).  These results implicate an 
potential role for endothelial-derived nitric oxide in the regulation of NFAT activity and 
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suggest that physiological pressure changes are sufficient to induce transcriptional 
activity through NFAT.   
 
Ca2+ and Smooth Muscle-Specific Gene Expression 
Many vascular disease states are characterized by changes in gene expression that 
inhibit differentiation and promote the proliferative phenotype.  The serum response 
factor (SRF) DNA binding site or CArG box (CC[A/T]6GG) plays an important role in 
regulating SMC-specific genes (Kumar & Owens, 2003).  Evidence is now emerging that 
suggests a complex interaction between Ca2+ signaling, regulatory elements and co-
factors that affect SRF binding and/or transcriptional activity.  Wamhoff et al. found that 
Ca2+ influx through VDCCs stimulates expression of SRF-dependent SMC differentiation 
markers through a mechanism requiring Rho kinase and the SRF co-activator myocardin 
(Wamhoff et al., 2004).  In addition, Ca2+-dependent CRE elements have been found 
adjacent to CArG elements in several SRF-regulated SMC genes (Sekiguchi et al., 2001; 
Najwer & Lilly, 2005).  Furthermore, Ca2+-dependent NFAT activation has been shown 
to cooperatively regulate the activity of an intronic CArG enhancer of smooth muscle α-
actin (Gonzalez Bosc et al., 2005).  Thus, co-activators as well as CREB and NFAT have 
the capacity to direct expression of SRF-regulated genes in response to Ca2+ signaling in 
SMCs.   
The paradox that remains is the existence of CArG elements in genes that 
promote de-differentiation as well as differentiation.  What mechanisms underlie this 
distinction?  New evidence supports the hypothesis that growth and developmental 
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signals modulate SRF-dependent gene expression by regulating repressive cofactors that 
compete for SRF binding (Wamhoff et al., 2004; Wang et al., 2004).  In light of the 
complexities regulating SRF function, future experiments are warranted to explore these 
and other potential requirements for SRF-dependent progression to distinct SMC 
phenotypes.  
 
CREB and NFAT in Smooth Muscle Pathologies 
 The pathogenesis of vascular diseases such as hypertension includes altered Ca2+ 
handling that triggers changes in gene expression, and these changes are likely attributed 
to the ability of mature smooth muscle cells to de-differentiate and proliferate (Somlyo & 
Somlyo, 1994).  Although proliferation is important in recovering from vascular injury, 
arterial intervention procedures such as angioplasty result in abnormal proliferation and 
restenosis.   
Cerebral arteries from hypertensive animals exhibit elevated SMC Ca2+, phospho-
CREB and c-fos mRNA (Wellman et al., 2001).  Interestingly, these effects are readily 
reversed by in situ inhibition of VDCCs, suggesting a defect in the “off” mechanism of 
CREB activation.  These findings provide an important link between altered gene 
regulation through CREB and deregulation of Ca2+ signaling in a disease state.  In 
pulmonary artery SMCs CREB is necessary and sufficient for induction of transient 
receptor potential cation channel 4 (TRPC4), that has been linked to the development of 
pulmonary hypertension (Landsberg & Yuan, 2004; Zhang et al., 2004).   
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Increased levels of phospho-CREB have also been correlated with the 
proliferative response associated with arteriolar injury including angiotensin II-induced 
hypertension, chronic nicotine administration and oxidative endothelial injury (Gerzanich 
et al., 2003).  In addition, expression of dominant negative CREB constructs suppresses 
neointimal formation and increases apoptosis following balloon injury (Tokunou et al., 
2003).  Transient ischemia also leads to CREB phosphorylation and increased CRE-
mediated Bcl-2 expression (Meller et al., 2005).  Together, these results suggest a role for 
CREB in both survival and proliferation of SMCs following injury.  The role of CREB in 
the proliferative response to disease is clearly complex however, in that SMC 
proliferation induced by in vivo hypoxia correlates with a reduction in CREB content 
(Klemm et al., 2001). 
Although NFAT has also been shown to regulate genes related to cell cycle 
progression and cell differentiation in T cells and neurons, the functions of NFAT in 
SMCs are largely unknown.  In aortic SMCs, NFAT2 nuclear translocation has been 
correlated with differentiation and found to be important for driving transcription of the 
smooth muscle-specific Sm-MHC promoter in a Ca2+ and calcineurin-dependent manner 
(Wada et al., 2002).  However, NFAT also plays a role in VSMC proliferation and 
motility induced by both receptor tyrosine kinase (RTK) and G protein-coupled receptor 
agonists (GPCR), PDGF-BB and thrombin, respectively (Yellaturu et al., 2002; Liu et al., 
2004).   Taken together these findings reveal that NFAT, like CREB, is a likely candidate 
for mediating both differentiation and mitogenic effects in SMCs. 
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Few studies have directly compared NFAT and CREB signaling in SMCs.  In a 
model of VLDL-induced SMC proliferation, NFAT activation correlates with a decrease 
in phospho-CREB, suggesting that the proliferative effect of VLDL increases NFAT 
activity while reducing CREB activity (Lipskaia et al., 2003).  One caveat to these 
experiments is that in this model CREB is phosphorylated under basal conditions, an 
observation that has not been detected in other SMC culture cell systems or in intact 
arteries (Cartin et al., 2000; Pulver et al., 2004; Meller et al., 2005).   
Overall, the evidence suggests that physiological or pathological alterations in 
Ca2+ signaling pathways are likely to have effects on both CREB and NFAT function and 
have the potential to disrupt normal patterns of gene transcription in SMCs.  Future 
studies focused on CREB- and/or NFAT-dependent transcription patterns hold the 
promise of better understanding the role of excitation-transcription coupling as it relates 
to genomic effects on smooth muscle phenotype.       
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Figure  A-1B  Regulation of CREB activation through multiple signaling cascades 
in SMCs 
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Figure A- 2B  CREB is activated by SOCE in intact vascular smooth muscle.  From 
(Pulver et al., 2004), used with Permission. Rat cerebral arteries were isolated and 
incubated in HBS with normal Ca2+ (2 mmol/L), 100 nmol/L Ca2+, or 100 nmol/L 
nimodipine (Nim)  for 15 min.  Arteries were then exposed to 100 nmol/L TG for 15 min 
or 60 mM K+ for 10 min.  CREB phosphorylation was detected by anti-P-CREB 
immunofluorescence.  Shown are confocal images representing P-CREB (red), YOYO 
nuclear stain (green) and overlap of P-CREB and YOYO (white).  Bar represents 100 
μm. 
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Figure  A-3B  Regulation of NFAT via nuclear translocation in SMCs  
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